19188158	Gold	Lu W	Targeted photothermal ablation of murine melanomas with melanocyte-stimulating hormone analog-conjugated hollow gold nanospheres.	Clinical cancer research 	2009	83
19572747	Gold	Mallidi S	Multiwavelength photoacoustic imaging and plasmon resonance coupling of gold nanoparticles for selective detection of cancer.	Nano letters	2009	90
19581946	Gold	Li PC	In vivo photoacoustic molecular imaging with simultaneous multiple selective targeting using antibody-conjugated gold nanorods.	Optics express	2008	67
20080552	Gold	Choi CH	Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles.	Proceedings of the National Academy of Sciences of the United States of America	2010	144
20388791	Gold	Lu W	Tumor site-specific silencing of NF-kappaB p65 by targeted hollow gold nanosphere-mediated photothermal transfection.	Cancer research	2010	60
20410458	Gold	Chanda N	Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity.	Proceedings of the National Academy of Sciences of the United States of America	2010	54
21081567	Gold	Hainfeld JF	Micro-CT enables microlocalisation and quantification of Her2-targeted gold nanoparticles within tumour regions.	The British journal of radiology	2011	39
21097518	Gold	Pan D	Molecular photoacoustic imaging of angiogenesis with integrin-targeted gold nanobeacons.	FASEB journal 	2011	47
21508310	Gold	Thakor AS	The fate and toxicity of Raman-active silica-gold nanoparticles in mice.	Science translational medicine	2011	42
21591812	Gold	Agarwal A	Remote triggered release of doxorubicin in tumors by synergistic application of thermosensitive liposomes and gold nanorods.	ACS nano	2011	38
22131831	Gold	Reuveni T	Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study.	International journal of nanomedicine	2011	51
22865457	Gold	You J	Effective photothermal chemotherapy using doxorubicin-loaded gold nanospheres that target EphB4 receptors in tumors.	Cancer research	2012	34
23160926	Gold	Chattopadhyay N	Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation.	Breast cancer research and treatment	2013	26
25453970	Gold	Ruan S	Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles.	Biomaterials	2015	24
25493329	Gold	Pérez-Hernández M	Dissecting the molecular mechanism of apoptosis during photothermal therapy using gold nanoprisms.	ACS nano	2015	20
26761620	Gold	Liu Y	Human Induced Pluripotent Stem Cells for Tumor Targeted Delivery of Gold Nanorods and Enhanced Photothermal Therapy.	ACS nano	2016	15
8045941	ADP	Jalink K	Inhibition of lysophosphatidate- and thrombin-induced neurite retraction and neuronal cell rounding by ADP ribosylation of the small GTP-binding protein Rho.	The Journal of cell biology	1994	122
12440774	ADP	Hassa PO	The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders.	Cellular and molecular life sciences 	2002	100
17505006	ADP	Albert JM	Inhibition of poly(ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models.	Clinical cancer research 	2007	80
20125064	ADP	Park KS	Trophic molecules derived from human mesenchymal stem cells enhance survival, function, and angiogenesis of isolated islets after transplantation.	Transplantation	2010	53
20797535	ADP	Israelson A	Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS.	Neuron	2010	82
21270334	ADP	Boehler C	Poly(ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progression.	Proceedings of the National Academy of Sciences of the United States of America	2011	65
21469131	ADP	Yegutkin GG	Altered purinergic signaling in CD73-deficient mice inhibits tumor progression.	European journal of immunology	2011	43
21974986	ADP	Otvos L Jr	Design and development of a peptide-based adiponectin receptor agonist for cancer treatment.	BMC biotechnology	2011	37
22153076	ADP	Levaot N	Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism.	Cell	2011	48
22262760	ADP	Santo L	Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma.	Blood	2012	107
22440753	ADP	Waaler J	A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice.	Cancer research	2012	78
23022210	ADP	Di Vizio D	Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease.	The American journal of pathology	2012	67
23319653	ADP	Robu M	Role of poly(ADP-ribose) polymerase-1 in the removal of UV-induced DNA lesions by nucleotide excision repair.	Proceedings of the National Academy of Sciences of the United States of America	2013	49
24252090	ADP	Vassilopoulos A	SIRT3 deacetylates ATP synthase F1 complex proteins in response to nutrient- and exercise-induced stress.	Antioxidants & redox signaling	2014	33
24919149	ADP	Xu H	Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome.	Nature	2014	101
25533949	ADP	Sajish M	A human tRNA synthetase is a potent PARP1-activating effector target for resveratrol.	Nature	2015	22
25695398	ADP	Jensen TE	PT-1 selectively activates AMPK-γ1 complexes in mouse skeletal muscle, but activates all three γ subunit complexes in cultured human cells by inhibiting the respiratory chain.	The Biochemical journal	2015	15
26496606	ADP	Kazak L	A creatine-driven substrate cycle enhances energy expenditure and thermogenesis in beige fat.	Cell	2015	57
9192873	Adenosine triphosphate	Sheaff RJ	Cyclin E-CDK2 is a regulator of p27Kip1.	Genes & development	1997	233
9774334	Adenosine triphosphate	Mohammadi M	Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain.	The EMBO journal	1998	115
9850061	Adenosine triphosphate	Allikmets R	A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance.	Cancer research	1998	122
11163219	Adenosine triphosphate	Zhang X	Structure of the AAA ATPase p97.	Molecular cell	2000	132
11313485	Adenosine triphosphate	Guidi CJ	Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice.	Molecular and cellular biology	2001	99
11751413	Adenosine triphosphate	Moulder SL	Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.	Cancer research	2001	99
11796918	Adenosine triphosphate	Bunting KD	ABC transporters as phenotypic markers and functional regulators of stem cells.	Stem cells	2002	96
11801536	Adenosine triphosphate	Kim M	The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.	Clinical cancer research 	2002	95
12429862	Adenosine triphosphate	Jonker JW	The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria.	Proceedings of the National Academy of Sciences of the United States of America	2002	127
14522923	Adenosine triphosphate	French KJ	Discovery and evaluation of inhibitors of human sphingosine kinase.	Cancer research	2003	180
14718385	Adenosine triphosphate	Lecker SH	Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression.	FASEB journal 	2004	381
14985505	Adenosine triphosphate	Shaw RJ	The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress.	Proceedings of the National Academy of Sciences of the United States of America	2004	523
15191915	Adenosine triphosphate	Evans CM	Mucin is produced by clara cells in the proximal airways of antigen-challenged mice.	American journal of respiratory cell and molecular biology	2004	100
15261145	Adenosine triphosphate	Shaw RJ	The LKB1 tumor suppressor negatively regulates mTOR signaling.	Cancer cell	2004	309
15485900	Adenosine triphosphate	Stark JM	Genetic steps of mammalian homologous repair with distinct mutagenic consequences.	Molecular and cellular biology	2004	172
15680329	Adenosine triphosphate	Lum JJ	Growth factor regulation of autophagy and cell survival in the absence of apoptosis.	Cell	2005	445
15766665	Adenosine triphosphate	Gumireddy K	ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent.	Cancer cell	2005	84
15894266	Adenosine triphosphate	Plescia J	Rational design of shepherdin, a novel anticancer agent.	Cancer cell	2005	67
15899831	Adenosine triphosphate	Wedge SR	AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer.	Cancer research	2005	165
15958589	Adenosine triphosphate	MacCallum DE	Seliciclib (CYC202, R-Roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1.	Cancer research	2005	77
16054070	Adenosine triphosphate	Arany Z	Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle.	Cell metabolism	2005	205
16446141	Adenosine triphosphate	Chen CL	Runx1 determines nociceptive sensory neuron phenotype and is required for thermal and neuropathic pain.	Neuron	2006	98
16622124	Adenosine triphosphate	Yaguchi S	Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor.	Journal of the National Cancer Institute	2006	70
16862153	Adenosine triphosphate	Kerkelä R	Cardiotoxicity of the cancer therapeutic agent imatinib mesylate.	Nature medicine	2006	195
17332304	Adenosine triphosphate	Yeh TC	Biological characterization of ARRY-142886 (AZD6244), a potent, highly selective mitogen-activated protein kinase kinase 1/2 inhibitor.	Clinical cancer research 	2007	172
17519960	Adenosine triphosphate	Brendel C	Imatinib mesylate and nilotinib (AMN107) exhibit high-affinity interaction with ABCG2 on primitive hematopoietic stem cells.	Leukemia	2007	55
17699718	Adenosine triphosphate	Davies BR	AZD6244 (ARRY-142886), a potent inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 kinases: mechanism of action in vivo, pharmacokinetic/pharmacodynamic relationship, and potential for combination in preclinical models.	Molecular cancer therapeutics	2007	141
18003859	Adenosine triphosphate	Hu Y	RECQL5/Recql5 helicase regulates homologous recombination and suppresses tumor formation via disruption of Rad51 presynaptic filaments.	Genes & development	2007	144
18202014	Adenosine triphosphate	Clem B	Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth.	Molecular cancer therapeutics	2008	85
18202019	Adenosine triphosphate	Zhang T	A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells.	Molecular cancer therapeutics	2008	92
18339875	Adenosine triphosphate	Roberts WG	Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271.	Cancer research	2008	123
18454141	Adenosine triphosphate	Tasdemir E	Regulation of autophagy by cytoplasmic p53.	Nature cell biology	2008	333
18624356	Adenosine triphosphate	Franchi L	The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity.	European journal of immunology	2008	133
18680391	Adenosine triphosphate	Huang D	Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines.	Stem cells and development	2009	48
18752326	Adenosine triphosphate	Ma KL	Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice.	Hepatology	2008	59
18829547	Adenosine triphosphate	Dai CL	Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.	Cancer research	2008	95
18922779	Adenosine triphosphate	Stebbins JL	Identification of a new JNK inhibitor targeting the JNK-JIP interaction site.	Proceedings of the National Academy of Sciences of the United States of America	2008	54
19056914	Adenosine triphosphate	Polli JW	An unexpected synergist role of P-glycoprotein and breast cancer resistance protein on the central nervous system penetration of the tyrosine kinase inhibitor lapatinib (N-{3-chloro-4-(3-fluorobenzyl)oxyphenyl}-6-5-({2-(methylsulfonyl)ethylamino}methyl)-2-furyl-4-quinazolinamine; GW572016).	Drug metabolism and disposition	2009	66
19208652	Adenosine triphosphate	Park JS	A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis.	Human molecular genetics	2009	60
19251738	Adenosine triphosphate	Schnetz MP	Genomic distribution of CHD7 on chromatin tracks H3K4 methylation patterns.	Genome research	2009	87
19276158	Adenosine triphosphate	Xie H	LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer.	Molecular cancer therapeutics	2009	85
19276351	Adenosine triphosphate	Seeliger MA	Equally potent inhibition of c-Src and Abl by compounds that recognize inactive kinase conformations.	Cancer research	2009	48
19383919	Adenosine triphosphate	Dong X	Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP.	Cancer research	2009	56
19558545	Adenosine triphosphate	Donnelly-Roberts DL	Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors.	British journal of pharmacology	2009	58
19584280	Adenosine triphosphate	Yu K	Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin.	Cancer research	2009	119
19593530	Adenosine triphosphate	Kostenko S	Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology.	Cellular and molecular life sciences 	2009	89
19737566	Adenosine triphosphate	Lin JE	The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling.	Gastroenterology	2010	40
19767732	Adenosine triphosphate	Ghiringhelli F	Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors.	Nature medicine	2009	367
19789351	Adenosine triphosphate	Wang X	Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex.	Cancer research	2009	53
19805291	Adenosine triphosphate	Chen W	Abcb10 physically interacts with mitoferrin-1 (Slc25a37) to enhance its stability and function in the erythroid mitochondria.	Proceedings of the National Academy of Sciences of the United States of America	2009	63
19812205	Adenosine triphosphate	Harder J	Activation of the Nlrp3 inflammasome by Streptococcus pyogenes requires streptolysin O and NF-kappa B activation but proceeds independently of TLR signaling and P2X7 receptor.	Journal of immunology	2009	69
20033049	Adenosine triphosphate	Zhou W	Novel mutant-selective EGFR kinase inhibitors against EGFR T790M.	Nature	2009	237
20038799	Adenosine triphosphate	Samudio I	Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction.	The Journal of clinical investigation	2010	138
20048054	Adenosine triphosphate	Ni L	FKBP51 promotes assembly of the Hsp90 chaperone complex and regulates androgen receptor signaling in prostate cancer cells.	Molecular and cellular biology	2010	45
20068177	Adenosine triphosphate	Yu K	Beyond rapalog therapy: preclinical pharmacology and antitumor activity of WYE-125132, an ATP-competitive and specific inhibitor of mTORC1 and mTORC2.	Cancer research	2010	58
20072125	Adenosine triphosphate	Zhang J	Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors.	Nature	2010	140
20421486	Adenosine triphosphate	Weinberg F	Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity.	Proceedings of the National Academy of Sciences of the United States of America	2010	375
20423956	Adenosine triphosphate	Dohse M	Comparison of ATP-binding cassette transporter interactions with the tyrosine kinase inhibitors imatinib, nilotinib, and dasatinib.	Drug metabolism and disposition	2010	44
20466882	Adenosine triphosphate	Najafi-Shoushtari SH	MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis.	Science	2010	279
20471303	Adenosine triphosphate	Lai SY	Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: implications for future therapeutic approaches.	Drug resistance updates 	2010	44
20484018	Adenosine triphosphate	Munshi N	ARQ 197, a novel and selective inhibitor of the human c-Met receptor tyrosine kinase with antitumor activity.	Molecular cancer therapeutics	2010	93
20616036	Adenosine triphosphate	Yang H	Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation.	Proceedings of the National Academy of Sciences of the United States of America	2010	74
20644254	Adenosine triphosphate	Imtiyaz HZ	Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation.	The Journal of clinical investigation	2010	98
20724478	Adenosine triphosphate	Pittelli M	Inhibition of nicotinamide phosphoribosyltransferase: cellular bioenergetics reveals a mitochondrial insensitive NAD pool.	The Journal of biological chemistry	2010	41
20876799	Adenosine triphosphate	Mi YJ	Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters.	Cancer research	2010	63
20935265	Adenosine triphosphate	Calcagno AM	Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.	Journal of the National Cancer Institute	2010	76
20952483	Adenosine triphosphate	Agarwal S	The role of the breast cancer resistance protein (ABCG2) in the distribution of sorafenib to the brain.	The Journal of pharmacology and experimental therapeutics	2011	51
21085683	Adenosine triphosphate	Awad O	High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition.	PloS one	2010	54
21102522	Adenosine triphosphate	Algire C	Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo.	Oncogene	2011	48
21124451	Adenosine triphosphate	Gurumurthy S	The Lkb1 metabolic sensor maintains haematopoietic stem cell survival.	Nature	2010	135
21242526	Adenosine triphosphate	Chen T	Chemokine-containing exosomes are released from heat-stressed tumor cells via lipid raft-dependent pathway and act as efficient tumor vaccine.	Journal of immunology	2011	41
21278237	Adenosine triphosphate	Kim TH	NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1α.	Cancer research	2011	65
21317208	Adenosine triphosphate	Prasad G	Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide.	Neuro-oncology	2011	48
21351087	Adenosine triphosphate	Tang SC	Brain accumulation of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration.	International journal of cancer	2012	37
21459328	Adenosine triphosphate	Porat S	Control of pancreatic β cell regeneration by glucose metabolism.	Cell metabolism	2011	112
21576264	Adenosine triphosphate	Zaugg K	Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress.	Genes & development	2011	123
21647434	Adenosine triphosphate	Pramanik KC	Role of mitochondrial electron transport chain complexes in capsaicin mediated oxidative stress leading to apoptosis in pancreatic cancer cells.	PloS one	2011	39
21826239	Adenosine triphosphate	Young CD	Modulation of glucose transporter 1 (GLUT1) expression levels alters mouse mammary tumor cell growth in vitro and in vivo.	PloS one	2011	49
21949739	Adenosine triphosphate	White JP	The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min/+) mouse.	PloS one	2011	48
21969607	Adenosine triphosphate	Fan J	Tyrosine phosphorylation of lactate dehydrogenase A is important for NADH/NAD(+) redox homeostasis in cancer cells.	Molecular and cellular biology	2011	37
22023707	Adenosine triphosphate	Wei L	Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-κB.	Breast cancer research 	2011	40
22156303	Adenosine triphosphate	Rottiers V	MicroRNAs in metabolism and metabolic diseases.	Cold Spring Harbor symposia on quantitative biology	2011	36
22195962	Adenosine triphosphate	Hitosugi T	Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism.	Molecular cell	2011	72
22198378	Adenosine triphosphate	Gusdon AM	ATP13A2 regulates mitochondrial bioenergetics through macroautophagy.	Neurobiology of disease	2012	39
22290395	Adenosine triphosphate	Tanaka N	Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis.	Hepatology	2012	53
22333578	Adenosine triphosphate	Vazquez-Martin A	Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells.	Cell cycle	2012	38
22396493	Adenosine triphosphate	Diaconu I	Immune response is an important aspect of the antitumor effect produced by a CD40L-encoding oncolytic adenovirus.	Cancer research	2012	52
22396496	Adenosine triphosphate	Stagg J	CD73-deficient mice are resistant to carcinogenesis.	Cancer research	2012	43
22460906	Adenosine triphosphate	Liu L	Deregulated MYC expression induces dependence upon AMPK-related kinase 5.	Nature	2012	83
22472122	Adenosine triphosphate	Liang X	Inhibiting systemic autophagy during interleukin 2 immunotherapy promotes long-term tumor regression.	Cancer research	2012	36
22509024	Adenosine triphosphate	Kang R	The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia.	Proceedings of the National Academy of Sciences of the United States of America	2012	42
22539746	Adenosine triphosphate	Thomas HE	mTOR inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinoma.	Science translational medicine	2012	32
22547685	Adenosine triphosphate	Glick D	BNip3 regulates mitochondrial function and lipid metabolism in the liver.	Molecular and cellular biology	2012	47
22552292	Adenosine triphosphate	Xu L	Combined EGFR/MET or EGFR/HSP90 inhibition is effective in the treatment of lung cancers codriven by mutant EGFR containing T790M and MET.	Cancer research	2012	41
22664872	Adenosine triphosphate	Nijnik A	The role of sphingosine-1-phosphate transporter Spns2 in immune system function.	Journal of immunology	2012	32
22689530	Adenosine triphosphate	Liu Y	A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo.	Molecular cancer therapeutics	2012	78
22789543	Adenosine triphosphate	Berry T	The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma.	Cancer cell	2012	74
22814620	Adenosine triphosphate	Jouan-Lanhouet S	TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation.	Cell death and differentiation	2012	85
22948162	Adenosine triphosphate	Juliana C	Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation.	The Journal of biological chemistry	2012	116
22963440	Adenosine triphosphate	Volonté C	P2X7 receptors: channels, pores and more.	CNS & neurological disorders drug targets	2012	48
23132831	Adenosine triphosphate	Yuan S	Effective elimination of cancer stem cells by a novel drug combination strategy.	Stem cells	2013	31
23257894	Adenosine triphosphate	Shen YC	Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma.	British journal of cancer	2013	30
23287468	Adenosine triphosphate	Vazquez-Martin A	The mitochondrial H(+)-ATP synthase and the lipogenic switch: new core components of metabolic reprogramming in induced pluripotent stem (iPS) cells.	Cell cycle	2013	29
23303345	Adenosine triphosphate	Balaburski GM	A modified HSP70 inhibitor shows broad activity as an anticancer agent.	Molecular cancer research 	2013	33
23333938	Adenosine triphosphate	Atkins C	Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activity.	Cancer research	2013	91
23353822	Adenosine triphosphate	Reynolds MR	Control of glutamine metabolism by the tumor suppressor Rb.	Oncogene	2014	53
23460667	Adenosine triphosphate	Golebiewska A	Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells.	Brain 	2013	28
23486940	Adenosine triphosphate	Parone PA	Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis.	The Journal of neuroscience 	2013	51
23562078	Adenosine triphosphate	Sene A	Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration.	Cell metabolism	2013	56
23562161	Adenosine triphosphate	Ma Y	Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells.	Immunity	2013	116
23564345	Adenosine triphosphate	Yoshida S	Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis.	Proceedings of the National Academy of Sciences of the United States of America	2013	47
23698369	Adenosine triphosphate	Dykhuizen EC	BAF complexes facilitate decatenation of DNA by topoisomerase IIα.	Nature	2013	63
23810565	Adenosine triphosphate	Schumacher D	Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor.	Cancer cell	2013	91
23811600	Adenosine triphosphate	Taipale M	Chaperones as thermodynamic sensors of drug-target interactions reveal kinase inhibitor specificities in living cells.	Nature biotechnology	2013	39
23918797	Adenosine triphosphate	Garrett JT	Combination of antibody that inhibits ligand-independent HER3 dimerization and a p110α inhibitor potently blocks PI3K signaling and growth of HER2+ breast cancers.	Cancer research	2013	33
23945590	Adenosine triphosphate	Dörr JR	Synthetic lethal metabolic targeting of cellular senescence in cancer therapy.	Nature	2013	80
23960073	Adenosine triphosphate	Licciulli S	FRAX597, a small molecule inhibitor of the p21-activated kinases, inhibits tumorigenesis of neurofibromatosis type 2 (NF2)-associated Schwannomas.	The Journal of biological chemistry	2013	29
24037090	Adenosine triphosphate	Ko A	Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling.	Cell death and differentiation	2014	54
24206218	Adenosine triphosphate	Ludtmann MH	Nrf2 affects the efficiency of mitochondrial fatty acid oxidation.	The Biochemical journal	2014	25
24277820	Adenosine triphosphate	Jansen RS	ABCC6 prevents ectopic mineralization seen in pseudoxanthoma elasticum by inducing cellular nucleotide release.	Proceedings of the National Academy of Sciences of the United States of America	2013	37
24317492	Adenosine triphosphate	Morris SA	Overlapping chromatin-remodeling systems collaborate genome wide at dynamic chromatin transitions.	Nature structural & molecular biology	2014	50
24474669	Adenosine triphosphate	Garcia PD	Pan-PIM kinase inhibition provides a novel therapy for treating hematologic cancers.	Clinical cancer research 	2014	27
24500406	Adenosine triphosphate	Ma Y	High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy.	Science translational medicine	2014	49
24713656	Adenosine triphosphate	Amato KR	Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLC.	The Journal of clinical investigation	2014	21
24837364	Adenosine triphosphate	Zhou JZ	Differential impact of adenosine nucleotides released by osteocytes on breast cancer growth and bone metastasis.	Oncogene	2015	15
24948812	Adenosine triphosphate	Wang X	Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood-brain and blood-spinal cord barriers.	The Journal of neuroscience 	2014	29
24995977	Adenosine triphosphate	Lo JC	Adipsin is an adipokine that improves β cell function in diabetes.	Cell	2014	33
25015789	Adenosine triphosphate	Isayev O	Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine.	Oncotarget	2014	22
25017063	Adenosine triphosphate	Quirós PM	ATP-dependent Lon protease controls tumor bioenergetics by reprogramming mitochondrial activity.	Cell reports	2014	31
25043816	Adenosine triphosphate	Petruzzelli M	A switch from white to brown fat increases energy expenditure in cancer-associated cachexia.	Cell metabolism	2014	83
25119037	Adenosine triphosphate	Van Nostrand JL	Inappropriate p53 activation during development induces features of CHARGE syndrome.	Nature	2014	33
25208916	Adenosine triphosphate	Koks CA	Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death.	International journal of cancer	2015	41
25486274	Adenosine triphosphate	Qiu Y	P2X7 mediates ATP-driven invasiveness in prostate cancer cells.	PloS one	2014	22
25544770	Adenosine triphosphate	Zhao T	Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma.	Oncotarget	2015	22
25564520	Adenosine triphosphate	Hofman P	Genetic and pharmacological inactivation of the purinergic P2RX7 receptor dampens inflammation but increases tumor incidence in a mouse model of colitis-associated cancer.	Cancer research	2015	18
25690012	Adenosine triphosphate	Billaud M	A molecular signature in the pannexin1 intracellular loop confers channel activation by the α1 adrenoreceptor in smooth muscle cells.	Science signaling	2015	18
25724068	Adenosine triphosphate	Sag D	The cholesterol transporter ABCG1 links cholesterol homeostasis and tumour immunity.	Nature communications	2015	17
25733882	Adenosine triphosphate	Zou HY	PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutations.	Proceedings of the National Academy of Sciences of the United States of America	2015	28
25867026	Adenosine triphosphate	Sesen J	Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response.	PloS one	2015	25
25915534	Adenosine triphosphate	Qiu JG	Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter.	Oncotarget	2015	16
25916556	Adenosine triphosphate	Qiao S	A REDD1/TXNIP pro-oxidant complex regulates ATG4B activity to control stress-induced autophagy and sustain exercise capacity.	Nature communications	2015	31
26077675	Adenosine triphosphate	Ganz M	Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.	Journal of translational medicine	2015	17
26091938	Adenosine triphosphate	Song IS	FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.	Gastroenterology	2015	19
26138757	Adenosine triphosphate	McDonnell E	SIRT3 regulates progression and development of diseases of aging.	Trends in endocrinology and metabolism	2015	18
26170311	Adenosine triphosphate	Heredia A	Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice.	Proceedings of the National Academy of Sciences of the United States of America	2015	19
26216352	Adenosine triphosphate	De Rosa V	Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non-Small Cell Lung Cancer.	Clinical cancer research 	2015	15
26242575	Adenosine triphosphate	Lohman AW	Pannexin 1 channels regulate leukocyte emigration through the venous endothelium during acute inflammation.	Nature communications	2015	24
26437365	Adenosine triphosphate	Goedeke L	MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels.	Nature medicine	2015	28
26501192	Adenosine triphosphate	Wagschal A	Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis.	Nature medicine	2015	36
26572062	Adenosine triphosphate	Yang D	Caspase-11 Requires the Pannexin-1 Channel and the Purinergic P2X7 Pore to Mediate Pyroptosis and Endotoxic Shock.	Immunity	2015	42
26848154	Adenosine triphosphate	Correia-Melo C	Mitochondria are required for pro-ageing features of the senescent phenotype.	The EMBO journal	2016	48
27051063	Adenosine triphosphate	Sadhukhan S	Metabolomics-assisted proteomics identifies succinylation and SIRT5 as important regulators of cardiac function.	Proceedings of the National Academy of Sciences of the United States of America	2016	17
27251290	Adenosine triphosphate	Jia Y	Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors.	Nature	2016	47
27411589	Adenosine triphosphate	Pietrocola F	Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance.	Cancer cell	2016	34
27667687	Adenosine triphosphate	Mills EL	Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages.	Cell	2016	49
28077572	Adenosine triphosphate	Carrer A	Impact of a High-fat Diet on Tissue Acyl-CoA and Histone Acetylation Levels.	The Journal of biological chemistry	2017	6
28192788	Adenosine triphosphate	Chan LN	Metabolic gatekeeper function of B-lymphoid transcription factors.	Nature	2017	10
28289287	Adenosine triphosphate	Verhalen B	Energy transduction and alternating access of the mammalian ABC transporter P-glycoprotein.	Nature	2017	12
8334704	Guanosine triphosphate	Vojtek AB	Mammalian Ras interacts directly with the serine/threonine kinase Raf.	Cell	1993	552
11504910	Guanosine triphosphate	Gupta S	Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols.	Proceedings of the National Academy of Sciences of the United States of America	2001	108
12075356	Guanosine triphosphate	Malliri A	Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours.	Nature	2002	94
15328152	Guanosine triphosphate	Wysoczynski M	Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient.	Blood	2005	68
18519636	Guanosine triphosphate	Xue W	DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma.	Genes & development	2008	75
20484105	Guanosine triphosphate	Hendrix A	Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis.	Journal of the National Cancer Institute	2010	59
20647324	Guanosine triphosphate	Thijssen VL	Tumor cells secrete galectin-1 to enhance endothelial cell activity.	Cancer research	2010	55
21536732	Guanosine triphosphate	Finch AJ	Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome.	Genes & development	2011	66
22220215	Guanosine triphosphate	Carcamo WC	Induction of cytoplasmic rods and rings structures by inhibition of the CTP and GTP synthetic pathway in mammalian cells.	PloS one	2011	37
22494971	Guanosine triphosphate	Jeong WJ	Ras stabilization through aberrant activation of Wnt/β-catenin signaling promotes intestinal tumorigenesis.	Science signaling	2012	34
23771523	Guanosine triphosphate	Quinn BJ	Inhibition of lung tumorigenesis by metformin is associated with decreased plasma IGF-I and diminished receptor tyrosine kinase signaling.	Cancer prevention research	2013	30
26617336	Guanosine triphosphate	Bunda S	Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis.	Nature communications	2015	19
1312087	Iron	Schulze-Osthoff K	Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation.	The Journal of biological chemistry	1992	148
9380735	Iron	Poss KD	Heme oxygenase 1 is required for mammalian iron reutilization.	Proceedings of the National Academy of Sciences of the United States of America	1997	217
9380736	Iron	Poss KD	Reduced stress defense in heme oxygenase 1-deficient cells.	Proceedings of the National Academy of Sciences of the United States of America	1997	240
9537326	Iron	An WG	Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha.	Nature	1998	174
15802016	Iron	Cohen B	Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors.	Neoplasia	2005	104
15849611	Iron	Gunshin H	Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver.	The Journal of clinical investigation	2005	113
16075059	Iron	Huang FW	A mouse model of juvenile hemochromatosis.	The Journal of clinical investigation	2005	119
16446425	Iron	Berger T	Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury.	Proceedings of the National Academy of Sciences of the United States of America	2006	144
16950140	Iron	Nose Y	Ctr1 drives intestinal copper absorption and is essential for growth, iron metabolism, and neonatal cardiac function.	Cell metabolism	2006	66
17723178	Iron	Clapper ML	Dextran sulfate sodium-induced colitis-associated neoplasia: a promising model for the development of chemopreventive interventions.	Acta pharmacologica Sinica	2007	59
18326822	Iron	Pinto JP	Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha.	Blood	2008	64
20065295	Iron	Lee DH	Neogenin inhibits HJV secretion and regulates BMP-induced hepcidin expression and iron homeostasis.	Blood	2010	54
20550936	Iron	Devireddy LR	A mammalian siderophore synthesized by an enzyme with a bacterial homolog involved in enterobactin production.	Cell	2010	85
20686179	Iron	Pinnix ZK	Ferroportin and iron regulation in breast cancer progression and prognosis.	Science translational medicine	2010	83
21427356	Iron	Josson S	β2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells.	Cancer research	2011	44
21791632	Iron	Daldrup-Link HE	MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticles.	Clinical cancer research 	2011	58
22419665	Iron	Xue X	Hypoxia-inducible factor-2α activation promotes colorectal cancer progression by dysregulating iron homeostasis.	Cancer research	2012	34
22440905	Iron	Zager RA	Plasma and urinary heme oxygenase-1 in AKI.	Journal of the American Society of Nephrology 	2012	33
22513004	Iron	Chakraborty S	The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer.	Biochimica et biophysica acta	2012	99
22826563	Iron	Visconte V	SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes.	Blood	2012	55
23074173	Iron	Lui GY	The iron chelator, deferasirox, as a novel strategy for cancer treatment: oral activity against human lung tumor xenografts and molecular mechanism of action.	Molecular pharmacology	2013	28
23499446	Iron	Ternette N	Inhibition of mitochondrial aconitase by succination in fumarate hydratase deficiency.	Cell reports	2013	32
23891987	Iron	Perica K	Nanoscale artificial antigen presenting cells for T cell immunotherapy.	Nanomedicine 	2014	20
24357729	Iron	Gardenghi S	Distinct roles for hepcidin and interleukin-6 in the recovery from anemia in mice injected with heat-killed Brucella abortus.	Blood	2014	29
25662334	Iron	Guida C	A novel inflammatory pathway mediating rapid hepcidin-independent hypoferremia.	Blood	2015	35
25728673	Iron	Sun X	HSPB1 as a novel regulator of ferroptotic cancer cell death.	Oncogene	2015	25
25825391	Iron	White K	Genetic and hypoxic alterations of the microRNA-210-ISCU1/2 axis promote iron-sulfur deficiency and pulmonary hypertension.	EMBO molecular medicine	2015	22
26456827	Iron	Xu W	Lethal Cardiomyopathy in Mice Lacking Transferrin Receptor in the Heart.	Cell reports	2015	20
26675351	Iron	Vinchi F	Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.	Blood	2016	27
26752519	Iron	Cloonan SM	Mitochondrial iron chelation ameliorates cigarette smoke-induced bronchitis and emphysema in mice.	Nature medicine	2016	29
27078067	Iron	Moschen AR	Lipocalin 2 Protects from Inflammation and Tumorigenesis Associated with Gut Microbiota Alterations.	Cell host & microbe	2016	12
15044468	Heme	Krishnamurthy P	The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme.	The Journal of biological chemistry	2004	155
16122419	Heme	Handschin C	Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha.	Cell	2005	80
17128211	Heme	Nebert DW	The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis.	Nature reviews. Cancer	2006	174
17178849	Heme	Khor TO	Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis.	Cancer research	2006	117
17363558	Heme	Liby K	The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J mice.	Cancer research	2007	62
19681826	Heme	De Wilde V	Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1.	American journal of transplantation 	2009	45
20018698	Heme	Estall JL	PGC-1alpha negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erb(alpha) axis.	Proceedings of the National Academy of Sciences of the United States of America	2009	56
21362551	Heme	Katoh Y	Methionine adenosyltransferase II serves as a transcriptional corepressor of Maf oncoprotein.	Molecular cell	2011	43
22142471	Heme	Rojo AI	Signaling pathways activated by the phytochemical nordihydroguaiaretic acid contribute to a Keap1-independent regulation of Nrf2 stability: Role of glycogen synthase kinase-3.	Free radical biology & medicine	2012	33
22232210	Heme	van de Steeg E	Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver.	The Journal of clinical investigation	2012	48
24842810	Heme	Mu J	Interspecies communication between plant and mouse gut host cells through edible plant derived exosome-like nanoparticles.	Molecular nutrition & food research	2014	30
24995976	Heme	Jais A	Heme oxygenase-1 drives metaflammation and insulin resistance in mouse and man.	Cell	2014	50
26011642	Heme	Dey S	ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis.	The Journal of clinical investigation	2015	41
26085215	Heme	Sasaki K	Roles of linear ubiquitinylation, a crucial regulator of NF-κB and cell death, in the immune system.	Immunological reviews	2015	20
26269531	Heme	Hughes R	Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy.	Cancer research	2015	30
8396143	Cyclic AMP	Göke R	Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.	The Journal of biological chemistry	1993	145
10673502	Cyclic AMP	Wu M	c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi.	Genes & development	2000	114
11533709	Cyclic AMP	Sonoshita M	Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice.	Nature medicine	2001	117
11557972	Cyclic AMP	Yoon JC	Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1.	Nature	2001	492
12032351	Cyclic AMP	Travnickova-Bendova Z	Bimodal regulation of mPeriod promoters by CREB-dependent signaling and CLOCK/BMAL1 activity.	Proceedings of the National Academy of Sciences of the United States of America	2002	126
12237475	Cyclic AMP	Condorelli G	Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice.	Proceedings of the National Academy of Sciences of the United States of America	2002	125
15231873	Cyclic AMP	Razandi M	Plasma membrane estrogen receptors exist and functions as dimers.	Molecular endocrinology	2004	88
15314234	Cyclic AMP	Emami KH	A small molecule inhibitor of beta-catenin/CREB-binding protein transcription corrected.	Proceedings of the National Academy of Sciences of the United States of America	2004	219
15899904	Cyclic AMP	Shao J	Prostaglandin E2 Stimulates the beta-catenin/T cell factor-dependent transcription in colon cancer.	The Journal of biological chemistry	2005	69
15930266	Cyclic AMP	Kirschner LS	A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues.	Cancer research	2005	75
16221865	Cyclic AMP	Bolger TA	Intracellular trafficking of histone deacetylase 4 regulates neuronal cell death.	The Journal of neuroscience 	2005	68
16645038	Cyclic AMP	Pedram A	Nature of functional estrogen receptors at the plasma membrane.	Molecular endocrinology	2006	156
16862152	Cyclic AMP	Thaker PH	Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.	Nature medicine	2006	279
18689544	Cyclic AMP	Arnold J	Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation.	Blood	2008	80
18829471	Cyclic AMP	Sitkovsky MV	Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia.	Clinical cancer research 	2008	58
19029980	Cyclic AMP	Nasr R	Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation.	Nature medicine	2008	87
20234090	Cyclic AMP	Kang S	p90 ribosomal S6 kinase 2 promotes invasion and metastasis of human head and neck squamous cell carcinoma cells.	The Journal of clinical investigation	2010	48
20495567	Cyclic AMP	Sheng Z	A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications.	Nature medicine	2010	53
21118894	Cyclic AMP	Alvarez-Saavedra M	miRNA-132 orchestrates chromatin remodeling and translational control of the circadian clock.	Human molecular genetics	2011	68
21149639	Cyclic AMP	Sandén C	G protein-coupled estrogen receptor 1/G protein-coupled receptor 30 localizes in the plasma membrane and traffics intracellularly on cytokeratin intermediate filaments.	Molecular pharmacology	2011	41
21220306	Cyclic AMP	Franco AT	Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice.	Proceedings of the National Academy of Sciences of the United States of America	2011	52
21400503	Cyclic AMP	Benetatos L	MEG3 imprinted gene contribution in tumorigenesis.	International journal of cancer	2011	62
21555366	Cyclic AMP	Polytarchou C	Akt2 regulates all Akt isoforms and promotes resistance to hypoxia through induction of miR-21 upon oxygen deprivation.	Cancer research	2011	49
21990345	Cyclic AMP	Drury LJ	Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways.	Proceedings of the National Academy of Sciences of the United States of America	2011	69
22195961	Cyclic AMP	Gerhart-Hines Z	The cAMP/PKA pathway rapidly activates SIRT1 to promote fatty acid oxidation independently of changes in NAD(+).	Molecular cell	2011	90
22403610	Cyclic AMP	Zhang S	ROR1 is expressed in human breast cancer and associated with enhanced tumor-cell growth.	PloS one	2012	75
22485156	Cyclic AMP	Liang Z	Development of a unique small molecule modulator of CXCR4.	PloS one	2012	32
22710715	Cyclic AMP	Park MH	p21-Activated kinase 4 promotes prostate cancer progression through CREB.	Oncogene	2013	29
22796012	Cyclic AMP	Wu J	Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human.	Cell	2012	614
23123854	Cyclic AMP	Mitra D	An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background.	Nature	2012	86
23507145	Cyclic AMP	Du H	Cyclophilin D deficiency rescues Aβ-impaired PKA/CREB signaling and alleviates synaptic degeneration.	Biochimica et biophysica acta	2014	28
23979134	Cyclic AMP	Yang Z	MicroRNA-433 inhibits liver cancer cell migration by repressing the protein expression and function of cAMP response element-binding protein.	The Journal of biological chemistry	2013	29
24375753	Cyclic AMP	Diggs-Andrews KA	Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.	Annals of neurology	2014	23
24657774	Cyclic AMP	Xiao J	MicroRNA-132 dysregulation in Toxoplasma gondii infection has implications for dopamine signaling pathway.	Neuroscience	2014	20
24882690	Cyclic AMP	Schafer PH	Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity.	Cellular signalling	2014	24
25428932	Cyclic AMP	Lang R	Physiology, signaling, and pharmacology of galanin peptides and receptors: three decades of emerging diversity.	Pharmacological reviews	2015	30
25565142	Cyclic AMP	Modali SD	Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors.	Molecular endocrinology	2015	25
25788518	Cyclic AMP	Anastasaki C	Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.	Human molecular genetics	2015	18
25870200	Cyclic AMP	Jing L	Adenosine signaling promotes hematopoietic stem and progenitor cell emergence.	The Journal of experimental medicine	2015	19
25940704	Cyclic AMP	Li CF	The cAMP responsive element binding protein 1 transactivates epithelial membrane protein 2, a potential tumor suppressor in the urinary bladder urothelial carcinoma.	Oncotarget	2015	16
26099526	Cyclic AMP	Xu MJ	Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans.	Gastroenterology	2015	23
26118928	Cyclic AMP	Roy A	HMG-CoA Reductase Inhibitors Bind to PPARα to Upregulate Neurotrophin Expression in the Brain and Improve Memory in Mice.	Cell metabolism	2015	21
26412325	Cyclic AMP	Shchors K	Dual Targeting of the Autophagic Regulatory Circuitry in Gliomas with Repurposed Drugs Elicits Cell-Lethal Autophagy and Therapeutic Benefit.	Cancer cell	2015	20
26632666	Cyclic AMP	Duan S	PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotype.	Nature communications	2015	18
26929333	Cyclic AMP	Singhmar P	Critical role for Epac1 in inflammatory pain controlled by GRK2-mediated phosphorylation of Epac1.	Proceedings of the National Academy of Sciences of the United States of America	2016	15
3014349	7,12-Dimethylbenz[a]anthracene	Quintanilla M	Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis.	Nature	1986	193
10395330	7,12-Dimethylbenz[a]anthracene	Moore RJ	Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis.	Nature medicine	1999	181
12067981	7,12-Dimethylbenz[a]anthracene	Tiano HF	Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis.	Cancer research	2002	85
12192050	7,12-Dimethylbenz[a]anthracene	Hirao A	Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner.	Molecular and cellular biology	2002	103
15343391	7,12-Dimethylbenz[a]anthracene	Chan KS	Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis.	The Journal of clinical investigation	2004	136
16024603	7,12-Dimethylbenz[a]anthracene	Jansen AP	Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis.	Cancer research	2005	68
17254968	7,12-Dimethylbenz[a]anthracene	Sun P	PRAK is essential for ras-induced senescence and tumor suppression.	Cell	2007	111
17493263	7,12-Dimethylbenz[a]anthracene	Herschkowitz JI	Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.	Genome biology	2007	443
17578914	7,12-Dimethylbenz[a]anthracene	Azarova AM	Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies.	Proceedings of the National Academy of Sciences of the United States of America	2007	64
17890319	7,12-Dimethylbenz[a]anthracene	Cao Y	IkappaB kinase alpha kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells.	Proceedings of the National Academy of Sciences of the United States of America	2007	69
18178624	7,12-Dimethylbenz[a]anthracene	Swann JB	Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis.	Proceedings of the National Academy of Sciences of the United States of America	2008	105
18208974	7,12-Dimethylbenz[a]anthracene	Gebhardt C	RAGE signaling sustains inflammation and promotes tumor development.	The Journal of experimental medicine	2008	113
18952840	7,12-Dimethylbenz[a]anthracene	Muller AJ	Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.	Proceedings of the National Academy of Sciences of the United States of America	2008	78
19029379	7,12-Dimethylbenz[a]anthracene	Iguchi-Manaka A	Accelerated tumor growth in mice deficient in DNAM-1 receptor.	The Journal of experimental medicine	2008	52
21159633	7,12-Dimethylbenz[a]anthracene	Wang L	IL-17 enhances tumor development in carcinogen-induced skin cancer.	Cancer research	2010	52
21646541	7,12-Dimethylbenz[a]anthracene	Ma X	Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis.	Proceedings of the National Academy of Sciences of the United States of America	2011	65
21670304	7,12-Dimethylbenz[a]anthracene	Schioppa T	B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2011	60
21779166	7,12-Dimethylbenz[a]anthracene	Viarisio D	E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice.	PLoS pathogens	2011	39
22086849	7,12-Dimethylbenz[a]anthracene	Judd NP	ERK1/2 regulation of CD44 modulates oral cancer aggressiveness.	Cancer research	2012	33
23699408	7,12-Dimethylbenz[a]anthracene	Inoue S	Mule/Huwe1/Arf-BP1 suppresses Ras-driven tumorigenesis by preventing c-Myc/Miz1-mediated down-regulation of p21 and p15.	Genes & development	2013	35
10869354	Prostaglandin E2	Murakami M	Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2.	The Journal of biological chemistry	2000	163
16186186	Prostaglandin E2	Rodriguez PC	Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma.	The Journal of experimental medicine	2005	152
18495668	Prostaglandin E2	Guo X	Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer.	The Journal of biological chemistry	2008	55
19887554	Prostaglandin E2	Qamri Z	Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.	Molecular cancer therapeutics	2009	48
20804550	Prostaglandin E2	Veltman JD	COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function.	BMC cancer	2010	56
21946257	Prostaglandin E2	Baryawno N	Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target.	The Journal of clinical investigation	2011	64
22641101	Prostaglandin E2	Xin X	Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model.	Laboratory investigation; a journal of technical methods and pathology	2012	34
24793239	Prostaglandin E2	Motz GT	Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors.	Nature medicine	2014	80
26343581	Prostaglandin E2	Zelenay S	Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity.	Cell	2015	82
27045023	Prostaglandin E2	Newick K	Augmentation of CAR T-cell Trafficking and Antitumor Efficacy by Blocking Protein Kinase A Localization.	Cancer immunology research	2016	15
14511394	Adenosine monophosphate	Hawley SA	Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade.	Journal of biology	2003	485
15578517	Adenosine monophosphate	You M	The role of AMP-activated protein kinase in the action of ethanol in the liver.	Gastroenterology	2004	112
16176927	Adenosine monophosphate	Rattan R	5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase.	The Journal of biological chemistry	2005	108
16762632	Adenosine monophosphate	Bergheim I	Metformin prevents alcohol-induced liver injury in the mouse: Critical role of plasminogen activator inhibitor-1.	Gastroenterology	2006	62
16809770	Adenosine monophosphate	Laderoute KR	5'-AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments.	Molecular and cellular biology	2006	178
16873680	Adenosine monophosphate	Zang M	Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice.	Diabetes	2006	167
17609368	Adenosine monophosphate	Jäger S	AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha.	Proceedings of the National Academy of Sciences of the United States of America	2007	546
17638885	Adenosine monophosphate	Buzzai M	Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth.	Cancer research	2007	307
18006825	Adenosine monophosphate	Dowling RJ	Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells.	Cancer research	2007	269
18056705	Adenosine monophosphate	Okoshi R	Activation of AMP-activated protein kinase induces p53-dependent apoptotic cell death in response to energetic stress.	The Journal of biological chemistry	2008	88
18182616	Adenosine monophosphate	Baba M	Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys.	Journal of the National Cancer Institute	2008	79
18227155	Adenosine monophosphate	Hezel AF	Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms.	Molecular and cellular biology	2008	66
18256928	Adenosine monophosphate	Phoenix KN	Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model.	Breast cancer research and treatment	2009	47
18387000	Adenosine monophosphate	Huang X	Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice.	The Biochemical journal	2008	133
18469156	Adenosine monophosphate	Algire C	Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth.	Endocrine-related cancer	2008	64
18803638	Adenosine monophosphate	Tomimoto A	Metformin suppresses intestinal polyp growth in ApcMin/+ mice.	Cancer science	2008	58
19106626	Adenosine monophosphate	Vazquez-Martin A	The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells.	Cell cycle	2009	74
19138937	Adenosine monophosphate	Moore T	Dietary energy balance modulates signaling through the Akt/mammalian target of rapamycin pathways in multiple epithelial tissues.	Cancer prevention research	2008	54
19494812	Adenosine monophosphate	Pearce EL	Enhancing CD8 T-cell memory by modulating fatty acid metabolism.	Nature	2009	389
19539012	Adenosine monophosphate	Stanfel MN	The TOR pathway comes of age.	Biochimica et biophysica acta	2009	128
19679549	Adenosine monophosphate	Kisfalvi K	Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth.	Cancer research	2009	109
19874425	Adenosine monophosphate	Rattan R	Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner.	Journal of cellular and molecular medicine	2011	56
19883615	Adenosine monophosphate	Costanzo-Garvey DL	KSR2 is an essential regulator of AMP kinase, energy expenditure, and insulin sensitivity.	Cell metabolism	2009	49
20179192	Adenosine monophosphate	Jin D	CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression.	Cancer research	2010	87
20196784	Adenosine monophosphate	Harhaji-Trajkovic L	AMPK-mediated autophagy inhibits apoptosis in cisplatin-treated tumour cells.	Journal of cellular and molecular medicine	2009	58
20351312	Adenosine monophosphate	Krawczyk CM	Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation.	Blood	2010	205
20530718	Adenosine monophosphate	Fritz V	Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice.	Molecular cancer therapeutics	2010	45
20564343	Adenosine monophosphate	Hosono K	Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase.	Molecular carcinogenesis	2010	59
20637208	Adenosine monophosphate	Saxena NK	Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma.	Gastroenterology	2010	45
20810672	Adenosine monophosphate	Memmott RM	Metformin prevents tobacco carcinogen--induced lung tumorigenesis.	Cancer prevention research	2010	142
20824063	Adenosine monophosphate	Pereira ER	Transcriptional and post-transcriptional regulation of proangiogenic factors by the unfolded protein response.	PloS one	2010	48
20980833	Adenosine monophosphate	Vucicevic L	Compound C induces protective autophagy in cancer cells through AMPK inhibition-independent blockade of Akt/mTOR pathway.	Autophagy	2011	44
21147110	Adenosine monophosphate	Calvisi DF	Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.	Gastroenterology	2011	98
21187332	Adenosine monophosphate	Paul PK	Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice.	The Journal of cell biology	2010	68
21317389	Adenosine monophosphate	Michalek RD	Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets.	Journal of immunology	2011	329
21390184	Adenosine monophosphate	Feng L	Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate.	Neoplasia	2011	41
21543517	Adenosine monophosphate	Rocha GZ	Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth.	Clinical cancer research 	2011	76
21676631	Adenosine monophosphate	Liu J	Metformin inhibits renal cell carcinoma in vitro and in vivo xenograft.	Urologic oncology	2013	28
21690395	Adenosine monophosphate	Cheong H	Ammonia-induced autophagy is independent of ULK1/ULK2 kinases.	Proceedings of the National Academy of Sciences of the United States of America	2011	98
21840335	Adenosine monophosphate	Speakman JR	Caloric restriction.	Molecular aspects of medicine	2011	152
21941369	Adenosine monophosphate	Ng TL	The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis.	Cell death and differentiation	2012	35
22039302	Adenosine monophosphate	Ryzhov S	Adenosinergic regulation of the expansion and immunosuppressive activity of CD11b+Gr1+ cells.	Journal of immunology	2011	50
22048125	Adenosine monophosphate	Son SM	Aβ-induced formation of autophagosomes is mediated by RAGE-CaMKKβ-AMPK signaling.	Neurobiology of aging	2012	32
22079189	Adenosine monophosphate	Ditch S	The ATM protein kinase and cellular redox signaling: beyond the DNA damage response.	Trends in biochemical sciences	2012	93
22120676	Adenosine monophosphate	Kim HS	Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression.	Biochemical pharmacology	2012	34
22341444	Adenosine monophosphate	Raimundo N	Mitochondrial stress engages E2F1 apoptotic signaling to cause deafness.	Cell	2012	58
22378068	Adenosine monophosphate	Shi WY	Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy.	Cell death & disease	2012	56
22406476	Adenosine monophosphate	Din FV	Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells.	Gastroenterology	2012	91
22467081	Adenosine monophosphate	Vitale-Cross L	Metformin prevents the development of oral squamous cell carcinomas from carcinogen-induced premalignant lesions.	Cancer prevention research	2012	36
22576211	Adenosine monophosphate	Martin MJ	Metformin accelerates the growth of BRAF V600E-driven melanoma by upregulating VEGF-A.	Cancer discovery	2012	36
22643892	Adenosine monophosphate	Blandino G	Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC.	Nature communications	2012	52
23160380	Adenosine monophosphate	Avivar-Valderas A	Regulation of autophagy during ECM detachment is linked to a selective inhibition of mTORC1 by PERK.	Oncogene	2013	30
23291478	Adenosine monophosphate	McAlpine F	Regulation of nutrient-sensitive autophagy by uncoordinated 51-like kinases 1 and 2.	Autophagy	2013	35
23334421	Adenosine monophosphate	Jiang P	Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence.	Nature	2013	97
23370326	Adenosine monophosphate	Ríos M	AMPK activation by oncogenesis is required to maintain cancer cell proliferation in astrocytic tumors.	Cancer research	2013	30
23434734	Adenosine monophosphate	Pignochino Y	The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical models.	Clinical cancer research 	2013	26
23524344	Adenosine monophosphate	Rowe I	Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy.	Nature medicine	2013	60
23632475	Adenosine monophosphate	Storozhuk Y	Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK.	British journal of cancer	2013	58
23706743	Adenosine monophosphate	Leprivier G	The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation.	Cell	2013	88
23846222	Adenosine monophosphate	Wong VK	Saikosaponin-d, a novel SERCA inhibitor, induces autophagic cell death in apoptosis-defective cells.	Cell death & disease	2013	29
23983257	Adenosine monophosphate	Allard B	Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs.	Clinical cancer research 	2013	54
24095280	Adenosine monophosphate	Shen CH	Phosphorylation of BRAF by AMPK impairs BRAF-KSR1 association and cell proliferation.	Molecular cell	2013	29
24145418	Adenosine monophosphate	Yuan P	Phenformin enhances the therapeutic benefit of BRAF(V600E) inhibition in melanoma.	Proceedings of the National Academy of Sciences of the United States of America	2013	60
24145720	Adenosine monophosphate	Puppa MJ	Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma-induced cachexia.	FASEB journal 	2014	29
24419232	Adenosine monophosphate	Dallaglio K	Paradoxic effects of metformin on endothelial cells and angiogenesis.	Carcinogenesis	2014	26
24662833	Adenosine monophosphate	Nguyen HG	Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model.	Oncogene	2014	34
24743339	Adenosine monophosphate	Dai P	Modified vaccinia virus Ankara triggers type I IFN production in murine conventional dendritic cells via a cGAS/STING-mediated cytosolic DNA-sensing pathway.	PLoS pathogens	2014	24
24958099	Adenosine monophosphate	Meakin PJ	Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes but not with insulin resistance.	Molecular and cellular biology	2014	28
25070369	Adenosine monophosphate	Kone M	LKB1 and AMPK differentially regulate pancreatic β-cell identity.	FASEB journal 	2014	22
25088745	Adenosine monophosphate	Patel K	The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver.	Nature communications	2014	27
25126561	Adenosine monophosphate	Gao ZW	The roles of CD73 in cancer.	BioMed research international	2014	23
25446664	Adenosine monophosphate	Lengyel E	Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models.	American journal of obstetrics and gynecology	2015	21
25548157	Adenosine monophosphate	Reyes NL	Fnip1 regulates skeletal muscle fiber type specification, fatigue resistance, and susceptibility to muscular dystrophy.	Proceedings of the National Academy of Sciences of the United States of America	2015	15
25624476	Adenosine monophosphate	Eikawa S	Immune-mediated antitumor effect by type 2 diabetes drug, metformin.	Proceedings of the National Academy of Sciences of the United States of America	2015	57
25940306	Adenosine monophosphate	O'Brien AJ	Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis.	The Biochemical journal	2015	17
26223300	Adenosine monophosphate	Cai H	Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice.	Science translational medicine	2015	23
26431379	Adenosine monophosphate	Yu Z	Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo.	Oncotarget	2015	22
26440282	Adenosine monophosphate	Saito Y	AMPK Protects Leukemia-Initiating Cells in Myeloid Leukemias from Metabolic Stress in the Bone Marrow.	Cell stem cell	2015	25
26678338	Adenosine monophosphate	von Eyss B	A MYC-Driven Change in Mitochondrial Dynamics Limits YAP/TAZ Function in Mammary Epithelial Cells and Breast Cancer.	Cancer cell	2015	23
27193687	Adenosine monophosphate	Li J	An obligatory role for neurotensin in high-fat-diet-induced obesity.	Nature	2016	19
28089566	Adenosine monophosphate	Howell JJ	Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex.	Cell metabolism	2017	14
28099419	Adenosine monophosphate	Dey P	Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer.	Nature	2017	14
28103582	Adenosine monophosphate	Zhou C	AMPK-autophagy inhibition sensitizes icaritin-induced anti-colorectal cancer cell activity.	Oncotarget	2017	6
1549603	NAD	Zhang Y	A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure.	Proceedings of the National Academy of Sciences of the United States of America	1992	251
11274184	NAD	He CH	Identification of activating transcription factor 4 (ATF4) as an Nrf2-interacting protein. Implication for heme oxygenase-1 gene regulation.	The Journal of biological chemistry	2001	114
12006491	NAD	Langley E	Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence.	The EMBO journal	2002	237
12234984	NAD	Thimmulappa RK	Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray.	Cancer research	2002	285
15542609	NAD	Backlund MG	15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer.	The Journal of biological chemistry	2005	91
15767573	NAD	Dinkova-Kostova AT	Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress.	Proceedings of the National Academy of Sciences of the United States of America	2005	129
16618762	NAD	Heltweg B	Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes.	Cancer research	2006	120
18184747	NAD	Narala SR	SIRT1 acts as a nutrient-sensitive growth suppressor and its loss is associated with increased AMPK and telomerase activity.	Molecular biology of the cell	2008	50
18414679	NAD	Firestein R	The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth.	PloS one	2008	200
19060927	NAD	Lara E	Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect.	Oncogene	2009	69
19138955	NAD	Khor TO	Increased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer.	Cancer prevention research	2008	83
20185821	NAD	Lee J	A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition.	The Journal of biological chemistry	2010	67
21459330	NAD	Bai P	PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation.	Cell metabolism	2011	175
21472714	NAD	Alhazzazi TY	Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer.	Cancer	2011	53
22542455	NAD	Lin Z	USP22 antagonizes p53 transcriptional activation by deubiquitinating Sirt1 to suppress cell apoptosis and is required for mouse embryonic development.	Molecular cell	2012	55
23056490	NAD	Latifi A	Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors.	PloS one	2012	51
23526469	NAD	Marquardt JU	Sirtuin-6-dependent genetic and epigenetic alterations are associated with poor clinical outcome in hepatocellular carcinoma patients.	Hepatology	2013	30
12200686	Cytarabine	Konopleva M	Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins.	Leukemia	2002	102
14973255	Cytarabine	Maslov AY	Neural stem cell detection, characterization, and age-related changes in the subventricular zone of mice.	The Journal of neuroscience 	2004	149
20215516	Cytarabine	Jin Y	Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species.	Cancer research	2010	92
20876803	Cytarabine	Chiarini F	Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemia.	Cancer research	2010	56
21937694	Cytarabine	Wey S	Inducible knockout of GRP78/BiP in the hematopoietic system suppresses Pten-null leukemogenesis and AKT oncogenic signaling.	Blood	2012	31
23589674	Cytarabine	Boyerinas B	Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy.	Blood	2013	42
23676502	Cytarabine	Chen Y	CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia.	The Journal of clinical investigation	2013	49
24872388	Cytarabine	Weng H	Inhibition of miR-17 and miR-20a by oridonin triggers apoptosis and reverses chemoresistance by derepressing BIM-S.	Cancer research	2014	23
19904829	Dimethyl sulfoxide	Fan X	NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.	Stem cells	2010	203
21665937	Dimethyl sulfoxide	McGowan PM	Notch1 inhibition alters the CD44hi/CD24lo population and reduces the formation of brain metastases from breast cancer.	Molecular cancer research 	2011	38
24361467	Dimethyl sulfoxide	Ni Y	Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.	Gastroenterology	2014	102
11499871	4,4'-Methylenedianiline	Yoneda T	A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro.	Journal of bone and mineral research 	2001	129
12359858	4,4'-Methylenedianiline	Wang F	Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts.	Journal of the National Cancer Institute	2002	112
15380745	4,4'-Methylenedianiline	Chen X	MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides.	Molecular imaging and biology 	2004	75
15523088	4,4'-Methylenedianiline	Studeny M	Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents.	Journal of the National Cancer Institute	2004	237
15599396	4,4'-Methylenedianiline	Boucharaba A	Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.	The Journal of clinical investigation	2004	103
17018625	4,4'-Methylenedianiline	Cai W	In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3.	Cancer research	2006	70
17145894	4,4'-Methylenedianiline	Wang Y	Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice.	Cancer research	2006	69
17671502	4,4'-Methylenedianiline	Tomlins SA	Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.	Nature	2007	285
17785729	4,4'-Methylenedianiline	Sampath L	Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.	Journal of nuclear medicine 	2007	73
18182989	4,4'-Methylenedianiline	Grossmann ME	Effects of adiponectin on breast cancer cell growth and signaling.	British journal of cancer	2008	55
18760340	4,4'-Methylenedianiline	Yang ST	Long-term accumulation and low toxicity of single-walled carbon nanotubes in intravenously exposed mice.	Toxicology letters	2008	54
18794155	4,4'-Methylenedianiline	Stan SD	Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo.	Cancer research	2008	68
18829396	4,4'-Methylenedianiline	Karmali PP	Targeting of albumin-embedded paclitaxel nanoparticles to tumors.	Nanomedicine 	2009	58
19067525	4,4'-Methylenedianiline	Wang L	Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers.	Molecular pharmaceutics	2009	47
19190326	4,4'-Methylenedianiline	Hurst DR	Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis.	Cancer research	2009	146
19647221	4,4'-Methylenedianiline	Tormo D	Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells.	Cancer cell	2009	52
19720836	4,4'-Methylenedianiline	Lu X	Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone.	The Journal of biological chemistry	2009	67
19767768	4,4'-Methylenedianiline	Shao R	YKL-40, a secreted glycoprotein, promotes tumor angiogenesis.	Oncogene	2009	81
20145128	4,4'-Methylenedianiline	Ward CS	Noninvasive detection of target modulation following phosphatidylinositol 3-kinase inhibition using hyperpolarized 13C magnetic resonance spectroscopy.	Cancer research	2010	66
20670674	4,4'-Methylenedianiline	Park HR	A high-fat diet impairs neurogenesis: involvement of lipid peroxidation and brain-derived neurotrophic factor.	Neuroscience letters	2010	51
21189326	4,4'-Methylenedianiline	Johnson RW	TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling.	Cancer research	2011	57
22011930	4,4'-Methylenedianiline	Taskar KS	Lapatinib distribution in HER2 overexpressing experimental brain metastases of breast cancer.	Pharmaceutical research	2012	46
1321493	Calcium	Silva AJ	Impaired spatial learning in alpha-calcium-calmodulin kinase II mutant mice.	Science	1992	210
1378648	Calcium	Silva AJ	Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice.	Science	1992	227
8929530	Calcium	Fletcher CF	Absence epilepsy in tottering mutant mice is associated with calcium channel defects.	Cell	1996	124
9515964	Calcium	Ranger AM	The transcription factor NF-ATc is essential for cardiac valve formation.	Nature	1998	153
10684258	Calcium	Hazan RB	Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis.	The Journal of cell biology	2000	195
10843385	Calcium	Saitoh S	LAT is essential for Fc(epsilon)RI-mediated mast cell activation.	Immunity	2000	101
12065840	Calcium	Sommers CL	A LAT mutation that inhibits T cell development yet induces lymphoproliferation.	Science	2002	87
12626353	Calcium	Phillips RJ	The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases.	American journal of respiratory and critical care medicine	2003	111
12818157	Calcium	Jun JE	Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis.	Immunity	2003	104
14532116	Calcium	Hetz C	Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein.	The EMBO journal	2003	102
14667502	Calcium	Liang H	Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue.	Cancer cell	2003	92
15284207	Calcium	Bai X	Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders.	Endocrinology	2004	74
15364929	Calcium	Jenkins CM	Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities.	The Journal of biological chemistry	2004	219
15764707	Calcium	Zhang N	A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1.	Proceedings of the National Academy of Sciences of the United States of America	2005	70
16103352	Calcium	Schinzel AC	Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia.	Proceedings of the National Academy of Sciences of the United States of America	2005	250
16179367	Calcium	Bilancio A	Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110delta function in B cells.	Blood	2006	60
16684820	Calcium	Matias I	Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia.	The Journal of clinical endocrinology and metabolism	2006	125
16847323	Calcium	Luo S	GRP78/BiP is required for cell proliferation and protecting the inner cell mass from apoptosis during early mouse embryonic development.	Molecular and cellular biology	2006	132
16885372	Calcium	Walser TC	Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer.	Cancer research	2006	64
16973730	Calcium	Wang RS	Androgen receptor in sertoli cell is essential for germ cell nursery and junctional complex formation in mouse testes.	Endocrinology	2006	64
17178918	Calcium	Erlacher M	Puma cooperates with Bim, the rate-limiting BH3-only protein in cell death during lymphocyte development, in apoptosis induction.	The Journal of experimental medicine	2006	104
17600736	Calcium	Pao LI	B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity.	Immunity	2007	94
17700640	Calcium	Keller S	CD24 is a marker of exosomes secreted into urine and amniotic fluid.	Kidney international	2007	78
18378184	Calcium	Assinder SJ	Transgelin: an actin-binding protein and tumour suppressor.	The international journal of biochemistry & cell biology	2009	62
18487609	Calcium	Aqeilan RI	The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism.	The Journal of biological chemistry	2008	54
18694980	Calcium	Bouillon R	Vitamin D and human health: lessons from vitamin D receptor null mice.	Endocrine reviews	2008	262
18695040	Calcium	Köttgen M	TRPP2 and TRPV4 form a polymodal sensory channel complex.	The Journal of cell biology	2008	143
19185847	Calcium	Yang S	Orai1 and STIM1 are critical for breast tumor cell migration and metastasis.	Cancer cell	2009	165
20554944	Calcium	Ding X	Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.	Journal of the National Cancer Institute	2010	46
20947496	Calcium	Pi M	GPRC6A mediates the non-genomic effects of steroids.	The Journal of biological chemistry	2010	45
21160030	Calcium	Slominski AT	20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells.	American journal of physiology. Cell physiology	2011	57
21407177	Calcium	Zhang K	The unfolded protein response transducer IRE1α prevents ER stress-induced hepatic steatosis.	The EMBO journal	2011	88
21515789	Calcium	Qi J	Painful pathways induced by TLR stimulation of dorsal root ganglion neurons.	Journal of immunology	2011	45
21572519	Calcium	Zheng L	Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer.	PloS one	2011	62
21610146	Calcium	Moon EK	Expression of a functional CCR2 receptor enhances tumor localization and tumor eradication by retargeted human T cells expressing a mesothelin-specific chimeric antibody receptor.	Clinical cancer research 	2011	82
21685359	Calcium	Sack U	Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.	Journal of the National Cancer Institute	2011	50
21697531	Calcium	Sutendra G	The role of Nogo and the mitochondria-endoplasmic reticulum unit in pulmonary hypertension.	Science translational medicine	2011	56
22446186	Calcium	Selvaraj S	Neurotoxin-induced ER stress in mouse dopaminergic neurons involves downregulation of TRPC1 and inhibition of AKT/mTOR signaling.	The Journal of clinical investigation	2012	42
22454149	Calcium	Swami S	Dietary vitamin D₃ and 1,25-dihydroxyvitamin D₃ (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer.	Endocrinology	2012	32
22524474	Calcium	Danecek P	High levels of RNA-editing site conservation amongst 15 laboratory mouse strains.	Genome biology	2012	69
22556257	Calcium	Stanley SA	Radio-wave heating of iron oxide nanoparticles can regulate plasma glucose in mice.	Science	2012	69
22647055	Calcium	Zhao H	Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice.	BMC gastroenterology	2012	41
22911669	Calcium	Brennen WN	Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug.	Journal of the National Cancer Institute	2012	43
22915123	Calcium	Oulès B	Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease.	The Journal of neuroscience 	2012	45
23149668	Calcium	Dromparis P	Attenuating endoplasmic reticulum stress as a novel therapeutic strategy in pulmonary hypertension.	Circulation	2013	28
23202294	Calcium	Ito N	Activation of calcium signaling through Trpv1 by nNOS and peroxynitrite as a key trigger of skeletal muscle hypertrophy.	Nature medicine	2013	48
23213054	Calcium	Kuhne MR	BMS-936564/MDX-1338: a fully human anti-CXCR4 antibody induces apoptosis in vitro and shows antitumor activity in vivo in hematologic malignancies.	Clinical cancer research 	2013	55
23328481	Calcium	Ryu S	Suppression of miRNA-708 by polycomb group promotes metastases by calcium-induced cell migration.	Cancer cell	2013	34
23434461	Calcium	Roti G	Complementary genomic screens identify SERCA as a therapeutic target in NOTCH1 mutated cancer.	Cancer cell	2013	30
23922331	Calcium	Weidinger C	STIM1 and STIM2-mediated Ca(2+) influx regulates antitumour immunity by CD8(+) T cells.	EMBO molecular medicine	2013	29
24552833	Calcium	Jeltsch M	CCBE1 enhances lymphangiogenesis via A disintegrin and metalloprotease with thrombospondin motifs-3-mediated vascular endothelial growth factor-C activation.	Circulation	2014	25
24733928	Calcium	Heinecke JL	Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression.	Proceedings of the National Academy of Sciences of the United States of America	2014	34
24752171	Calcium	Giudice J	Alternative splicing regulates vesicular trafficking genes in cardiomyocytes during postnatal heart development.	Nature communications	2014	32
25119035	Calcium	Li J	Piezo1 integration of vascular architecture with physiological force.	Nature	2014	77
25263449	Calcium	Andruska N	Anticipatory estrogen activation of the unfolded protein response is linked to cell proliferation and poor survival in estrogen receptor α-positive breast cancer.	Oncogene	2015	16
25328135	Calcium	Bai XL	Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/β-catenin signaling.	Oncogene	2015	19
25422446	Calcium	Lu S	A calcium-dependent protease as a potential therapeutic target for Wolfram syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2014	23
25544762	Calcium	Giorgi C	Intravital imaging reveals p53-dependent cancer cell death induced by phototherapy via calcium signaling.	Oncotarget	2015	23
25842288	Calcium	Mathieu AL	PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator-dependent autoimmunity.	The Journal of allergy and clinical immunology	2015	15
26457758	Calcium	Waning DL	Excess TGF-β mediates muscle weakness associated with bone metastases in mice.	Nature medicine	2015	41
26878232	Calcium	Schneider RK	Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9.	Nature medicine	2016	24
27142453	Calcium	Martin TJ	Parathyroid Hormone-Related Protein, Its Regulation of Cartilage and Bone Development, and Role in Treating Bone Diseases.	Physiological reviews	2016	10
27864307	Calcium	Dahan T	Pancreatic β-Cells Express the Fetal Islet Hormone Gastrin in Rodent and Human Diabetes.	Diabetes	2017	5
17981559	Epigallocatechin gallate	Shankar S	EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer.	Frontiers in bioscience 	2008	56
20395211	Epigallocatechin gallate	Slusarz A	Common botanical compounds inhibit the hedgehog signaling pathway in prostate cancer.	Cancer research	2010	55
21965273	Epigallocatechin gallate	Wang H	Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1α.	Carcinogenesis	2011	45
23348740	Epigallocatechin gallate	Kumazoe M	67-kDa laminin receptor increases cGMP to induce cancer-selective apoptosis.	The Journal of clinical investigation	2013	30
25875356	Epigallocatechin gallate	Pan H	Mitochondrial modulation by Epigallocatechin 3-Gallate ameliorates cisplatin induced renal injury through decreasing oxidative/nitrative stress, inflammation and NF-kB in mice.	PloS one	2015	15
9143691	Glutathione	MacMicking J	Nitric oxide and macrophage function.	Annual review of immunology	1997	695
10064598	Glutathione	Adler V	Regulation of JNK signaling by GSTp.	The EMBO journal	1999	193
11309284	Glutathione	McMahon M	The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes.	Cancer research	2001	152
11782393	Glutathione	Kuppusamy P	Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels.	Cancer research	2002	81
12193649	Glutathione	Dinkova-Kostova AT	Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants.	Proceedings of the National Academy of Sciences of the United States of America	2002	420
12506115	Glutathione	Kwak MK	Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival.	The Journal of biological chemistry	2003	186
12750453	Glutathione	Gao N	The role of hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes.	Molecular endocrinology	2003	77
14871826	Glutathione	Chu FF	Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 genes.	Cancer research	2004	85
15531919	Glutathione	Elchuri S	CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life.	Oncogene	2005	165
15764812	Glutathione	Singh SV	Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species.	The Journal of biological chemistry	2005	94
16107336	Glutathione	Xue X	Tumor necrosis factor alpha (TNFalpha) induces the unfolded protein response (UPR) in a reactive oxygen species (ROS)-dependent fashion, and the UPR counteracts ROS accumulation by TNFalpha.	The Journal of biological chemistry	2005	109
17878511	Glutathione	Samuelsson B	Membrane prostaglandin E synthase-1: a novel therapeutic target.	Pharmacological reviews	2007	117
18006848	Glutathione	Nefedova Y	Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells.	Cancer research	2007	79
18372916	Glutathione	Frohlich DA	The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis.	Oncogene	2008	58
19074896	Glutathione	Hahn MA	Methylation of polycomb target genes in intestinal cancer is mediated by inflammation.	Cancer research	2008	73
19289149	Glutathione	Brigelius-Flohé R	Glutathione peroxidases in different stages of carcinogenesis.	Biochimica et biophysica acta	2009	63
19776219	Glutathione	Zhang Y	Mice deficient in both Mn superoxide dismutase and glutathione peroxidase-1 have increased oxidative damage and a greater incidence of pathology but no reduction in longevity.	The journals of gerontology. Series A, Biological sciences and medical sciences	2009	70
19914374	Glutathione	Chowdhry S	Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis.	Free radical biology & medicine	2010	54
20446773	Glutathione	Singh A	Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance.	Antioxidants & redox signaling	2010	44
20855962	Glutathione	Martinez-Outschoorn UE	Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment.	Cell cycle	2010	136
21397861	Glutathione	Ishimoto T	CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth.	Cancer cell	2011	212
21907929	Glutathione	De Raedt T	Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors.	Cancer cell	2011	80
22267010	Glutathione	Shen BQ	Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates.	Nature biotechnology	2012	106
22416140	Glutathione	Yu W	SIRT3 protein deacetylates isocitrate dehydrogenase 2 (IDH2) and regulates mitochondrial redox status.	The Journal of biological chemistry	2012	89
23221387	Glutathione	Barrett CW	Tumor suppressor function of the plasma glutathione peroxidase gpx3 in colitis-associated carcinoma.	Cancer research	2013	31
24292713	Glutathione	Glasauer A	Targeting SOD1 reduces experimental non–small-cell lung cancer.	The Journal of clinical investigation	2014	31
24439385	Glutathione	Yang WS	Regulation of ferroptotic cancer cell death by GPX4.	Cell	2014	151
24637114	Glutathione	Pekovic-Vaughan V	The circadian clock regulates rhythmic activation of the NRF2/glutathione-mediated antioxidant defense pathway to modulate pulmonary fibrosis.	Genes & development	2014	44
24747074	Glutathione	Chian S	Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo.	Biochemical and biophysical research communications	2014	23
25006124	Glutathione	Tessoulin B	PRIMA-1Met induces myeloma cell death independent of p53 by impairing the GSH/ROS balance.	Blood	2014	26
25159108	Glutathione	Yager JD	Mechanisms of estrogen carcinogenesis: The role of E2/E1-quinone metabolites suggests new approaches to preventive intervention--A review.	Steroids	2015	22
25187363	Glutathione	Keshari KR	Noninvasive in vivo imaging of diabetes-induced renal oxidative stress and response to therapy using hyperpolarized 13C dehydroascorbate magnetic resonance.	Diabetes	2015	17
25607840	Glutathione	Sellers K	Pyruvate carboxylase is critical for non-small-cell lung cancer proliferation.	The Journal of clinical investigation	2015	84
25613188	Glutathione	Zheng L	Fumarate induces redox-dependent senescence by modifying glutathione metabolism.	Nature communications	2015	27
26463424	Glutathione	Canli Ö	Glutathione peroxidase 4 prevents necroptosis in mouse erythroid precursors.	Blood	2016	13
26541605	Glutathione	Yun J	Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH.	Science	2015	73
26838680	Glutathione	Ye ZW	Glutathione S-Transferase P-Mediated Protein S-Glutathionylation of Resident Endoplasmic Reticulum Proteins Influences Sensitivity to Drug-Induced Unfolded Protein Response.	Antioxidants & redox signaling	2017	8
26844296	Glutathione	Dóka É	A novel persulfide detection method reveals protein persulfide- and polysulfide-reducing functions of thioredoxin and glutathione systems.	Science advances	2016	20
27842070	Glutathione	Doll S	ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition.	Nature chemical biology	2017	28
27869804	Glutathione	Cramer SL	Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth.	Nature medicine	2017	17
8790408	Oxygen	Lebovitz RM	Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice.	Proceedings of the National Academy of Sciences of the United States of America	1996	226
9207108	Oxygen	Rosenquist TA	Cloning and characterization of a mammalian 8-oxoguanine DNA glycosylase.	Proceedings of the National Academy of Sciences of the United States of America	1997	105
9606183	Oxygen	Ryan HE	HIF-1 alpha is required for solid tumor formation and embryonic vascularization.	The EMBO journal	1998	372
10485709	Oxygen	Suh YA	Cell transformation by the superoxide-generating oxidase Mox1.	Nature	1999	288
10557315	Oxygen	Klungland A	Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage.	Proceedings of the National Academy of Sciences of the United States of America	1999	210
10640274	Oxygen	Ravi R	Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.	Genes & development	2000	226
10775435	Oxygen	Boiteux S	The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis.	Archives of biochemistry and biophysics	2000	92
11034104	Oxygen	Lee CG	Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.	Cancer research	2000	118
11454679	Oxygen	de Souza-Pinto NC	Repair of 8-oxodeoxyguanosine lesions in mitochondrial dna depends on the oxoguanine dna glycosylase (OGG1) gene and 8-oxoguanine accumulates in the mitochondrial dna of OGG1-defective mice.	Cancer research	2001	94
11832451	Oxygen	Okuda M	Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein.	Gastroenterology	2002	204
12011461	Oxygen	Jögi A	Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype.	Proceedings of the National Academy of Sciences of the United States of America	2002	104
12414638	Oxygen	Ran S	Increased exposure of anionic phospholipids on the surface of tumor blood vessels.	Cancer research	2002	93
12453409	Oxygen	Ellisen LW	REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species.	Molecular cell	2002	131
12671019	Oxygen	Yeo EJ	YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1.	Journal of the National Cancer Institute	2003	89
12761491	Oxygen	Unruh A	The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy.	Oncogene	2003	84
12891360	Oxygen	Neumann CA	Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression.	Nature	2003	182
14645546	Oxygen	Hu CJ	Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation.	Molecular and cellular biology	2003	356
14707072	Oxygen	Kusmartsev S	Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.	Journal of immunology	2004	220
14764894	Oxygen	Wakabayashi N	Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers.	Proceedings of the National Academy of Sciences of the United States of America	2004	235
14985465	Oxygen	Zimmer M	Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL-/- tumors.	Molecular cancer research 	2004	82
15126346	Oxygen	Xie Y	Deficiencies in mouse Myh and Ogg1 result in tumor predisposition and G to T mutations in codon 12 of the K-ras oncogene in lung tumors.	Cancer research	2004	73
15150115	Oxygen	Mitsushita J	The superoxide-generating oxidase Nox1 is functionally required for Ras oncogene transformation.	Cancer research	2004	77
15315937	Oxygen	Higgins DF	Hypoxic induction of Ctgf is directly mediated by Hif-1.	American journal of physiology. Renal physiology	2004	83
15647368	Oxygen	Petros JA	mtDNA mutations increase tumorigenicity in prostate cancer.	Proceedings of the National Academy of Sciences of the United States of America	2005	249
15738389	Oxygen	Xu Z	Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia.	Proceedings of the National Academy of Sciences of the United States of America	2005	77
15811878	Oxygen	Komarova EA	p53 is a suppressor of inflammatory response in mice.	FASEB journal 	2005	70
15989949	Oxygen	Maeda S	IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis.	Cell	2005	334
16001073	Oxygen	Radisky DC	Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability.	Nature	2005	352
16054088	Oxygen	Mansfield KD	Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation.	Cell metabolism	2005	191
16178638	Oxygen	Sorg BS	Hyperspectral imaging of hemoglobin saturation in tumor microvasculature and tumor hypoxia development.	Journal of biomedical optics	2005	71
16286925	Oxygen	Sablina AA	The antioxidant function of the p53 tumor suppressor.	Nature medicine	2005	299
16446448	Oxygen	Vartanian V	The metabolic syndrome resulting from a knockout of the NEIL1 DNA glycosylase.	Proceedings of the National Academy of Sciences of the United States of America	2006	80
16516379	Oxygen	Hu R	Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice.	Cancer letters	2006	70
16517740	Oxygen	Gersuk GM	Dectin-1 and TLRs permit macrophages to distinguish between different Aspergillus fumigatus cellular states.	Journal of immunology	2006	110
16642001	Oxygen	Erler JT	Lysyl oxidase is essential for hypoxia-induced metastasis.	Nature	2006	431
16728594	Oxygen	Matoba S	p53 regulates mitochondrial respiration.	Science	2006	485
16847346	Oxygen	Kondratov RV	Early aging and age-related pathologies in mice deficient in BMAL1, the core componentof the circadian clock.	Genes & development	2006	272
16869771	Oxygen	Bissell MJ	Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes.	Cold Spring Harbor symposia on quantitative biology	2005	100
17055439	Oxygen	St-Pierre J	Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators.	Cell	2006	567
17082319	Oxygen	Isenberg JS	Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation.	Blood	2007	61
17084552	Oxygen	Blazek ER	Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia.	International journal of radiation oncology, biology, physics	2007	60
17097563	Oxygen	Holmquist-Mengelbier L	Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype.	Cancer cell	2006	192
17284606	Oxygen	Gruber M	Acute postnatal ablation of Hif-2alpha results in anemia.	Proceedings of the National Academy of Sciences of the United States of America	2007	157
17434127	Oxygen	Li F	Regulation of HIF-1alpha stability through S-nitrosylation.	Molecular cell	2007	135
17545548	Oxygen	Dings RP	Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization.	Clinical cancer research 	2007	89
17545622	Oxygen	De Milito A	Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species.	Cancer research	2007	67
17562481	Oxygen	Aleksunes LM	Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease.	Toxicologic pathology	2007	86
17917680	Oxygen	Chen Y	Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells.	Cell death and differentiation	2008	131
18074631	Oxygen	Spiegelman BM	Transcriptional control of mitochondrial energy metabolism through the PGC1 coactivators.	Novartis Foundation symposium	2007	59
18096761	Oxygen	Minamishima YA	Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure.	Blood	2008	89
18216297	Oxygen	Wernig G	The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes.	Blood	2008	50
18281474	Oxygen	Furuta E	Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1.	Cancer research	2008	91
18288196	Oxygen	Arany Z	HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha.	Nature	2008	306
18347341	Oxygen	Ginouvès A	PHDs overactivation during chronic hypoxia "desensitizes" HIFalpha and protects cells from necrosis.	Proceedings of the National Academy of Sciences of the United States of America	2008	69
18394557	Oxygen	Duran A	The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis.	Cancer cell	2008	181
18403674	Oxygen	Dostert C	Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica.	Science	2008	694
18413749	Oxygen	Derdak Z	The mitochondrial uncoupling protein-2 promotes chemoresistance in cancer cells.	Cancer research	2008	56
18490920	Oxygen	Rankin EB	Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice.	Oncogene	2008	53
18521188	Oxygen	Meira LB	DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice.	The Journal of clinical investigation	2008	152
18694732	Oxygen	Li W	Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis.	Biochemical pharmacology	2008	106
18754859	Oxygen	Ono M	Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy.	Cancer science	2008	96
18832739	Oxygen	Youn JI	Subsets of myeloid-derived suppressor cells in tumor-bearing mice.	Journal of immunology	2008	503
19033663	Oxygen	Sonveaux P	Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice.	The Journal of clinical investigation	2008	332
19047182	Oxygen	Sung SY	Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis.	Cancer research	2008	56
19057015	Oxygen	Botusan IR	Stabilization of HIF-1alpha is critical to improve wound healing in diabetic mice.	Proceedings of the National Academy of Sciences of the United States of America	2008	81
19065050	Oxygen	Cantley J	Deletion of the von Hippel-Lindau gene in pancreatic beta cells impairs glucose homeostasis in mice.	The Journal of clinical investigation	2009	53
19118006	Oxygen	Cano CE	Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function.	Cancer research	2009	46
19190247	Oxygen	Lucas DM	The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo.	Blood	2009	55
19217150	Oxygen	Mazzone M	Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization.	Cell	2009	222
19223554	Oxygen	Eubank TD	Granulocyte macrophage colony-stimulating factor inhibits breast cancer growth and metastasis by invoking an anti-angiogenic program in tumor-educated macrophages.	Cancer research	2009	56
19362020	Oxygen	Allen IC	The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA.	Immunity	2009	310
19369943	Oxygen	Cao J	Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity.	The EMBO journal	2009	92
19380816	Oxygen	Corzo CA	Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells.	Journal of immunology	2009	166
19383922	Oxygen	Kopetz S	Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress.	Cancer research	2009	48
19404261	Oxygen	Liu J	Bmi1 regulates mitochondrial function and the DNA damage response pathway.	Nature	2009	171
19413947	Oxygen	Lebedeva MA	Loss of p53 causes mitochondrial DNA depletion and altered mitochondrial reactive oxygen species homeostasis.	Biochimica et biophysica acta	2009	62
19524509	Oxygen	Mathew R	Autophagy suppresses tumorigenesis through elimination of p62.	Cell	2009	502
19720742	Oxygen	Minamishima YA	A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo.	Molecular and cellular biology	2009	50
19786027	Oxygen	Xue J	Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKbeta independent of hydroxylase activity.	Gastroenterology	2010	42
19902481	Oxygen	Bamboat ZM	Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury.	Hepatology	2010	65
19920251	Oxygen	Hitosugi T	Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth.	Science signaling	2009	221
20010815	Oxygen	Campaner S	Cdk2 suppresses cellular senescence induced by the c-myc oncogene.	Nature cell biology	2010	83
20160076	Oxygen	Alexander A	ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS.	Proceedings of the National Academy of Sciences of the United States of America	2010	181
20169192	Oxygen	Coppé JP	A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen.	PloS one	2010	118
20197461	Oxygen	Xu Y	CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma.	Cancer research	2010	59
20203261	Oxygen	Swords RT	Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia.	Blood	2010	75
20215551	Oxygen	Nagaraj S	Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer.	Clinical cancer research 	2010	93
20227042	Oxygen	He G	Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation.	Cancer cell	2010	113
20237412	Oxygen	Jablonska J	Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model.	The Journal of clinical investigation	2010	94
20354168	Oxygen	Juntilla MM	AKT1 and AKT2 maintain hematopoietic stem cell function by regulating reactive oxygen species.	Blood	2010	82
20530669	Oxygen	Jiang T	High levels of Nrf2 determine chemoresistance in type II endometrial cancer.	Cancer research	2010	80
20620956	Oxygen	Lim JH	Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha.	Molecular cell	2010	169
20660313	Oxygen	Mazumdar J	HIF-2alpha deletion promotes Kras-driven lung tumor development.	Proceedings of the National Academy of Sciences of the United States of America	2010	52
20663956	Oxygen	Li M	The ATM-p53 pathway suppresses aneuploidy-induced tumorigenesis.	Proceedings of the National Academy of Sciences of the United States of America	2010	71
20711182	Oxygen	Luciani A	Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition.	Nature cell biology	2010	129
20841473	Oxygen	Doedens AL	Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression.	Cancer research	2010	137
20884632	Oxygen	Zhao Y	Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapy.	Cancer research	2010	56
21040902	Oxygen	Abbas HA	Mdm2 is required for survival of hematopoietic stem cells/progenitors via dampening of ROS-induced p53 activity.	Cell stem cell	2010	50
21113129	Oxygen	Yalcin S	ROS-mediated amplification of AKT/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3(-/-) mice.	The EMBO journal	2010	41
21300795	Oxygen	Kim MJ	Involvement of autophagy in oncogenic K-Ras-induced malignant cell transformation.	The Journal of biological chemistry	2011	76
21307302	Oxygen	Sapieha P	5-Lipoxygenase metabolite 4-HDHA is a mediator of the antiangiogenic effect of ω-3 polyunsaturated fatty acids.	Science translational medicine	2011	67
21307849	Oxygen	Sahin E	Telomere dysfunction induces metabolic and mitochondrial compromise.	Nature	2011	324
21326871	Oxygen	Garrido-Urbani S	Targeting vascular NADPH oxidase 1 blocks tumor angiogenesis through a PPARα mediated mechanism.	PloS one	2011	55
21358671	Oxygen	Bell EL	SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production.	Oncogene	2011	130
21421804	Oxygen	Raina D	Dependence on the MUC1-C oncoprotein in non-small cell lung cancer cells.	Molecular cancer therapeutics	2011	62
21421844	Oxygen	Cullen M	GPR124, an orphan G protein-coupled receptor, is required for CNS-specific vascularization and establishment of the blood-brain barrier.	Proceedings of the National Academy of Sciences of the United States of America	2011	50
21497090	Oxygen	Bosch M	Caveolin-1 deficiency causes cholesterol-dependent mitochondrial dysfunction and apoptotic susceptibility.	Current biology 	2011	52
21525939	Oxygen	Donadelli M	Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism.	Cell death & disease	2011	45
21555567	Oxygen	Shaw AT	Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress.	Proceedings of the National Academy of Sciences of the United States of America	2011	56
21606348	Oxygen	Billia F	PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart function.	Proceedings of the National Academy of Sciences of the United States of America	2011	78
21710835	Oxygen	Kamp DW	Chronic inflammation and cancer: the role of the mitochondria.	Oncology	2011	51
21734707	Oxygen	DeNicola GM	Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis.	Nature	2011	434
21753854	Oxygen	Raj L	Selective killing of cancer cells by a small molecule targeting the stress response to ROS.	Nature	2011	255
21791085	Oxygen	Maurer GD	Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy.	BMC cancer	2011	41
21825039	Oxygen	Ding ZB	Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation.	Clinical cancer research 	2011	38
21849978	Oxygen	Frezza C	Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase.	Nature	2011	153
21853114	Oxygen	Hahm ER	Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species.	PloS one	2011	52
21876161	Oxygen	Goodwin AC	Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis.	Proceedings of the National Academy of Sciences of the United States of America	2011	54
21884940	Oxygen	Karisch R	Global proteomic assessment of the classical protein-tyrosine phosphatome and "Redoxome".	Cell	2011	49
21983037	Oxygen	Suh YA	Multiple stress signals activate mutant p53 in vivo.	Cancer research	2011	35
21984483	Oxygen	Jing Y	Cadmium increases HIF-1 and VEGF expression through ROS, ERK, and AKT signaling pathways and induces malignant transformation of human bronchial epithelial cells.	Toxicological sciences 	2012	42
22011623	Oxygen	Gong K	Shikonin, a Chinese plant-derived naphthoquinone, induces apoptosis in hepatocellular carcinoma cells through reactive oxygen species: A potential new treatment for hepatocellular carcinoma.	Free radical biology & medicine	2011	36
22056359	Oxygen	Woo DK	Mitochondrial genome instability and ROS enhance intestinal tumorigenesis in APC(Min/+) mice.	The American journal of pathology	2012	37
22079466	Oxygen	Piao LS	CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma.	Cancer letters	2012	53
22094260	Oxygen	Skrtić M	Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia.	Cancer cell	2011	91
22138754	Oxygen	Xue Y	PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells.	Nature medicine	2011	42
22144182	Oxygen	Valentin-Vega YA	Mitochondrial dysfunction in ataxia-telangiectasia.	Blood	2012	95
22225988	Oxygen	Schwab LP	Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer.	Breast cancer research 	2012	48
22284662	Oxygen	López J	Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance.	BMC cancer	2012	44
22333951	Oxygen	Raju D	Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans.	Gastroenterology	2012	40
22426208	Oxygen	Skuli N	Endothelial HIF-2α regulates murine pathological angiogenesis and revascularization processes.	The Journal of clinical investigation	2012	60
22450551	Oxygen	Maes C	Hypoxia-driven pathways in bone development, regeneration and disease.	Nature reviews. Rheumatology	2012	45
22529296	Oxygen	Jayaraman P	Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release.	Journal of immunology	2012	35
22585996	Oxygen	Frese KK	nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer.	Cancer discovery	2012	93
22589271	Oxygen	Haigis MC	SIRT3 is a mitochondrial tumor suppressor: a scientific tale that connects aberrant cellular ROS, the Warburg effect, and carcinogenesis.	Cancer research	2012	52
22682249	Oxygen	Li T	Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence.	Cell	2012	235
22705006	Oxygen	Seki E	A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches.	Gastroenterology	2012	113
22750447	Oxygen	Zhou J	Roles of thioredoxin binding protein (TXNIP) in oxidative stress, apoptosis and cancer.	Mitochondrion	2013	28
22797809	Oxygen	Okuno Y	Pathological neoangiogenesis depends on oxidative stress regulation by ATM.	Nature medicine	2012	44
22897481	Oxygen	Sheng SL	Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma.	The FEBS journal	2012	42
22917578	Oxygen	Frank M	Mitophagy is triggered by mild oxidative stress in a mitochondrial fission dependent manner.	Biochimica et biophysica acta	2012	90
22925884	Oxygen	Sasaki M	D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function.	Genes & development	2012	79
22983397	Oxygen	Idris NM	In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers.	Nature medicine	2012	104
23027866	Oxygen	Prantner D	5,6-Dimethylxanthenone-4-acetic acid (DMXAA) activates stimulator of interferon gene (STING)-dependent innate immune pathways and is regulated by mitochondrial membrane potential.	The Journal of biological chemistry	2012	39
23027923	Oxygen	Croci DO	Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma.	The Journal of experimental medicine	2012	36
23104132	Oxygen	Zhang S	Identification of the molecular basis of doxorubicin-induced cardiotoxicity.	Nature medicine	2012	183
23108410	Oxygen	Higgs MR	Hepatitis C virus-induced activation of β-catenin promotes c-Myc expression and a cascade of pro-carcinogenetic events.	Oncogene	2013	27
23159440	Oxygen	Sakai J	Reactive oxygen species-induced actin glutathionylation controls actin dynamics in neutrophils.	Immunity	2012	41
23222255	Oxygen	Iskander KN	Cecal ligation and puncture-induced murine sepsis does not cause lung injury.	Critical care medicine	2013	28
23395000	Oxygen	Huber AL	p58(IPK)-mediated attenuation of the proapoptotic PERK-CHOP pathway allows malignant progression upon low glucose.	Molecular cell	2013	26
23461901	Oxygen	Selvakumaran M	Autophagy inhibition sensitizes colon cancer cells to antiangiogenic and cytotoxic therapy.	Clinical cancer research 	2013	41
23524583	Oxygen	Zhang S	Generation of cancer stem-like cells through the formation of polyploid giant cancer cells.	Oncogene	2014	58
23589885	Oxygen	Kucharzewska P	Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development.	Proceedings of the National Academy of Sciences of the United States of America	2013	148
23633453	Oxygen	Nawrocki ST	Disrupting protein NEDDylation with MLN4924 is a novel strategy to target cisplatin resistance in ovarian cancer.	Clinical cancer research 	2013	32
23637463	Oxygen	Volonte D	Inhibition of nuclear factor-erythroid 2-related factor (Nrf2) by caveolin-1 promotes stress-induced premature senescence.	Molecular biology of the cell	2013	26
23811687	Oxygen	Du W	TAp73 enhances the pentose phosphate pathway and supports cell proliferation.	Nature cell biology	2013	64
23828498	Oxygen	Markowitz J	Myeloid-derived suppressor cells in breast cancer.	Breast cancer research and treatment	2013	32
23857982	Oxygen	Gorrini C	BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival.	The Journal of experimental medicine	2013	41
24019511	Oxygen	Zhang Q	Mitochondrial localized Stat3 promotes breast cancer growth via phosphorylation of serine 727.	The Journal of biological chemistry	2013	38
24095676	Oxygen	Rouault-Pierre K	HIF-2α protects human hematopoietic stem/progenitors and acute myeloid leukemic cells from apoptosis induced by endoplasmic reticulum stress.	Cell stem cell	2013	32
24097820	Oxygen	Zhang Y	Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance.	Cancer research	2013	43
24115572	Oxygen	Pereira L	Inhibition of p38 MAPK sensitizes tumour cells to cisplatin-induced apoptosis mediated by reactive oxygen species and JNK.	EMBO molecular medicine	2013	28
24209622	Oxygen	Emerling BM	Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumors.	Cell	2013	34
24220244	Oxygen	Laoui D	Tumor hypoxia does not drive differentiation of tumor-associated macrophages but rather fine-tunes the M2-like macrophage population.	Cancer research	2014	67
24240701	Oxygen	Shin DH	SIRT1 and AMPK mediate hypoxia-induced resistance of non-small cell lung cancers to cisplatin and doxorubicin.	Cancer research	2014	20
24477002	Oxygen	Sayin VI	Antioxidants accelerate lung cancer progression in mice.	Science translational medicine	2014	136
24509161	Oxygen	Crosas-Molist E	The NADPH oxidase NOX4 inhibits hepatocyte proliferation and liver cancer progression.	Free radical biology & medicine	2014	20
24525732	Oxygen	Kang SU	Nonthermal plasma induces head and neck cancer cell death: the potential involvement of mitogen-activated protein kinase-dependent mitochondrial reactive oxygen species.	Cell death & disease	2014	33
24583638	Oxygen	Ogrunc M	Oncogene-induced reactive oxygen species fuel hyperproliferation and DNA damage response activation.	Cell death and differentiation	2014	46
24613345	Oxygen	Zucker SN	Nrf2 amplifies oxidative stress via induction of Klf9.	Molecular cell	2014	35
24622326	Oxygen	Shao L	Total body irradiation causes long-term mouse BM injury via induction of HSC premature senescence in an Ink4a- and Arf-independent manner.	Blood	2014	34
24695224	Oxygen	Gad H	MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool.	Nature	2014	83
24700124	Oxygen	Xu Y	Endothelial PFKFB3 plays a critical role in angiogenesis.	Arteriosclerosis, thrombosis, and vascular biology	2014	33
24703840	Oxygen	Imai Y	Crosstalk between the Rb pathway and AKT signaling forms a quiescence-senescence switch.	Cell reports	2014	24
24717514	Oxygen	Kraus D	Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity.	Nature	2014	70
24786789	Oxygen	Xu Y	Oxidative stress activates SIRT2 to deacetylate and stimulate phosphoglycerate mutase.	Cancer research	2014	23
24811539	Oxygen	Cichon MA	ROS-induced epithelial-mesenchymal transition in mammary epithelial cells is mediated by NF-kB-dependent activation of Snail.	Oncotarget	2014	40
24836575	Oxygen	Schwab L	Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage.	Nature medicine	2014	30
24953182	Oxygen	Paul MK	Dynamic changes in intracellular ROS levels regulate airway basal stem cell homeostasis through Nrf2-dependent Notch signaling.	Cell stem cell	2014	52
25079327	Oxygen	Santos MA	DNA-damage-induced differentiation of leukaemic cells as an anti-cancer barrier.	Nature	2014	40
25149532	Oxygen	Babae N	Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma.	Oncotarget	2014	26
25168343	Oxygen	Santen RJ	Estrogen metabolites and breast cancer.	Steroids	2015	25
25200065	Oxygen	Zhang D	Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer.	Molecular cancer	2014	25
25201986	Oxygen	Duque-Correa MA	Macrophage arginase-1 controls bacterial growth and pathology in hypoxic tuberculosis granulomas.	Proceedings of the National Academy of Sciences of the United States of America	2014	29
25238263	Oxygen	Chen MF	IL-6-stimulated CD11b+ CD14+ HLA-DR- myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus.	Oncotarget	2014	23
25255025	Oxygen	Shepardson KM	Myeloid derived hypoxia inducible factor 1-alpha is required for protection against pulmonary Aspergillus fumigatus infection.	PLoS pathogens	2014	23
25378412	Oxygen	Usui F	Inflammasome activation by mitochondrial oxidative stress in macrophages leads to the development of angiotensin II-induced aortic aneurysm.	Arteriosclerosis, thrombosis, and vascular biology	2015	20
25409149	Oxygen	Venkatanarayan A	IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo.	Nature	2015	29
25438054	Oxygen	Ma B	Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase.	Nature cell biology	2015	41
25440060	Oxygen	Walter KM	Hif-2α promotes degradation of mammalian peroxisomes by selective autophagy.	Cell metabolism	2014	20
25512378	Oxygen	Volonte D	Oxidative stress-induced inhibition of Sirt1 by caveolin-1 promotes p53-dependent premature senescence and stimulates the secretion of interleukin 6 (IL-6).	The Journal of biological chemistry	2015	15
25535359	Oxygen	Amelio I	TAp73 opposes tumor angiogenesis by promoting hypoxia-inducible factor 1α degradation.	Proceedings of the National Academy of Sciences of the United States of America	2015	26
25553116	Oxygen	Mallidi S	Prediction of tumor recurrence and therapy monitoring using ultrasound-guided photoacoustic imaging.	Theranostics	2015	21
25583481	Oxygen	Bartesaghi S	Inhibition of oxidative metabolism leads to p53 genetic inactivation and transformation in neural stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2015	15
25585152	Oxygen	Wu JB	Monoamine oxidase A inhibitor-near-infrared dye conjugate reduces prostate tumor growth.	Journal of the American Chemical Society	2015	16
25590811	Oxygen	Singer E	Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma.	Cell death & disease	2015	18
25692960	Oxygen	Hou Z	UV-emitting upconversion-based TiO2 photosensitizing nanoplatform: near-infrared light mediated in vivo photodynamic therapy via mitochondria-involved apoptosis pathway.	ACS nano	2015	18
25739764	Oxygen	Hatfield SM	Immunological mechanisms of the antitumor effects of supplemental oxygenation.	Science translational medicine	2015	47
25751304	Oxygen	Kotagiri N	Breaking the depth dependency of phototherapy with Cerenkov radiation and low-radiance-responsive nanophotosensitizers.	Nature nanotechnology	2015	32
25799988	Oxygen	Jiang L	Ferroptosis as a p53-mediated activity during tumour suppression.	Nature	2015	117
25833396	Oxygen	Schlie K	Survival of effector CD8+ T cells during influenza infection is dependent on autophagy.	Journal of immunology	2015	17
25882048	Oxygen	Itsumi M	Idh1 protects murine hepatocytes from endotoxin-induced oxidative stress by regulating the intracellular NADP(+)/NADPH ratio.	Cell death and differentiation	2015	17
25883318	Oxygen	Okoye I	T cell metabolism. The protein LEM promotes CD8⁺ T cell immunity through effects on mitochondrial respiration.	Science	2015	22
25981581	Oxygen	Hao W	Licochalcone A-induced human gastric cancer BGC-823 cells apoptosis by regulating ROS-mediated MAPKs and PI3K/AKT signaling pathways.	Scientific reports	2015	16
25982278	Oxygen	Hubackova S	IFNγ induces oxidative stress, DNA damage and tumor cell senescence via TGFβ/SMAD signaling-dependent induction of Nox4 and suppression of ANT2.	Oncogene	2016	12
26028023	Oxygen	Chen CC	The matricellular protein CCN1 suppresses hepatocarcinogenesis by inhibiting compensatory proliferation.	Oncogene	2016	14
26095252	Oxygen	Truitt ML	Differential Requirements for eIF4E Dose in Normal Development and Cancer.	Cell	2015	41
26194913	Oxygen	Yang WJ	Semaphorin-3C signals through Neuropilin-1 and PlexinD1 receptors to inhibit pathological angiogenesis.	EMBO molecular medicine	2015	24
26206559	Oxygen	Noman MZ	Tumor-Promoting Effects of Myeloid-Derived Suppressor Cells Are Potentiated by Hypoxia-Induced Expression of miR-210.	Cancer research	2015	20
26245371	Oxygen	Wu D	Structural integration in hypoxia-inducible factors.	Nature	2015	34
26308771	Oxygen	Jayavelu AK	NOX4-driven ROS formation mediates PTP inactivation and cell transformation in FLT3ITD-positive AML cells.	Leukemia	2016	11
26420419	Oxygen	Reich M	TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro.	Gut	2016	16
26454217	Oxygen	Yeh PS	Honokiol induces autophagy of neuroblastoma cells through activating the PI3K/Akt/mTOR and endoplasmic reticular stress/ERK1/2 signaling pathways and suppressing cell migration.	Cancer letters	2016	14
26919427	Oxygen	Olenchock BA	EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection.	Cell	2016	19
26934227	Oxygen	Ma C	NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.	Nature	2016	37
26936504	Oxygen	Garg AD	Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma.	Science translational medicine	2016	31
26976644	Oxygen	Kapitsinou PP	The Endothelial Prolyl-4-Hydroxylase Domain 2/Hypoxia-Inducible Factor 2 Axis Regulates Pulmonary Artery Pressure in Mice.	Molecular and cellular biology	2016	16
26976705	Oxygen	Nóbrega-Pereira S	G6PD protects from oxidative damage and improves healthspan in mice.	Nature communications	2016	12
27003603	Oxygen	Wörmann SM	Loss of P53 Function Activates JAK2-STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival.	Gastroenterology	2016	17
27049944	Oxygen	Seifert L	The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression.	Nature	2016	29
27501247	Oxygen	Cho SH	Germinal centre hypoxia and regulation of antibody qualities by a hypoxia response system.	Nature	2016	17
27516533	Oxygen	Guo JY	Autophagy provides metabolic substrates to maintain energy charge and nucleotide pools in Ras-driven lung cancer cells.	Genes & development	2016	16
27798602	Oxygen	Tyrakis PA	S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate.	Nature	2016	28
27892954	Oxygen	Plovier H	A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice.	Nature medicine	2017	36
27918563	Oxygen	Himburg HA	Dickkopf-1 promotes hematopoietic regeneration via direct and niche-mediated mechanisms.	Nature medicine	2017	6
28082439	Oxygen	Hankir MK	Dissociation Between Brown Adipose Tissue 18F-FDG Uptake and Thermogenesis in Uncoupling Protein 1-Deficient Mice.	Journal of nuclear medicine 	2017	8
28273069	Oxygen	Rodríguez-Colman MJ	Interplay between metabolic identities in the intestinal crypt supports stem cell function.	Nature	2017	13
28423341	Oxygen	Mak TW	Glutathione Primes T Cell Metabolism for Inflammation.	Immunity	2017	10
28479188	Oxygen	Cabezas-Wallscheid N	Vitamin A-Retinoic Acid Signaling Regulates Hematopoietic Stem Cell Dormancy.	Cell	2017	8
7560060	Dexamethasone	Schinkel AH	Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.	The Journal of clinical investigation	1995	122
8806883	Dexamethasone	Fernandez-Salguero PM	Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity.	Toxicology and applied pharmacology	1996	131
15987954	Dexamethasone	Ridder S	Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions.	The Journal of neuroscience 	2005	78
16304055	Dexamethasone	Alpdogan O	Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration.	Blood	2006	64
16482496	Dexamethasone	Schledzewski K	Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis.	The Journal of pathology	2006	67
16862141	Dexamethasone	Strom E	Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation.	Nature chemical biology	2006	108
18172311	Dexamethasone	Matsui W	Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance.	Cancer research	2008	174
18362173	Dexamethasone	Flex E	Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia.	The Journal of experimental medicine	2008	101
19009291	Dexamethasone	Galustian C	The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells.	Cancer immunology, immunotherapy 	2009	89
19509164	Dexamethasone	Ikeda H	The monoclonal antibody nBT062 conjugated to cytotoxic Maytansinoids has selective cytotoxicity against CD138-positive multiple myeloma cells in vitro and in vivo.	Clinical cancer research 	2009	52
19584292	Dexamethasone	McMillin DW	Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235.	Cancer research	2009	46
19762485	Dexamethasone	Kurtova AV	Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance.	Blood	2009	89
20382844	Dexamethasone	Görgün G	A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma.	Blood	2010	94
20647567	Dexamethasone	Bachmann PS	Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition.	Blood	2010	44
21098398	Dexamethasone	Chen SS	Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL.	Blood	2011	35
21257720	Dexamethasone	Ritchie JP	SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis.	Clinical cancer research 	2011	60
22474390	Dexamethasone	Martínez-Corral I	In vivo imaging of lymphatic vessels in development, wound healing, inflammation, and tumor metastasis.	Proceedings of the National Academy of Sciences of the United States of America	2012	34
22996336	Dexamethasone	Zheng Y	PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma.	Leukemia	2013	30
23281394	Dexamethasone	Porporato PE	Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice.	The Journal of clinical investigation	2013	41
23658244	Dexamethasone	Aboody KS	Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.	Science translational medicine	2013	60
24016618	Dexamethasone	Skor MN	Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer.	Clinical cancer research 	2013	36
24030633	Dexamethasone	Saha MN	PRIMA-1Met/APR-246 displays high antitumor activity in multiple myeloma by induction of p73 and Noxa.	Molecular cancer therapeutics	2013	26
24391219	Dexamethasone	Li L	MicroRNA-155 and MicroRNA-21 promote the expansion of functional myeloid-derived suppressor cells.	Journal of immunology	2014	33
25064128	Dexamethasone	Gibbs J	An epithelial circadian clock controls pulmonary inflammation and glucocorticoid action.	Nature medicine	2014	55
25482130	Dexamethasone	Rosilio C	L-type amino-acid transporter 1 (LAT1): a therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma/T-cell acute lymphoblastic leukemia.	Leukemia	2015	21
25888260	Dexamethasone	Surace L	Complement is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response.	Immunity	2015	24
11156248	Folic acid	Sirotnak FM	Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase.	Clinical cancer research 	2000	98
15763623	Folic acid	Lee ES	Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor.	Journal of controlled release 	2005	95
16421170	Folic acid	Waterland RA	Post-weaning diet affects genomic imprinting at the insulin-like growth factor 2 (Igf2) locus.	Human molecular genetics	2006	83
17613255	Folic acid	Yamaguchi T	Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor.	Immunity	2007	82
18941113	Folic acid	Houot R	T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy.	Blood	2009	54
21546571	Folic acid	Song DG	In vivo persistence, tumor localization, and antitumor activity of CAR-engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB).	Cancer research	2011	59
22949852	Folic acid	Singh S	Epigenetic effects of environmental chemicals bisphenol A and phthalates.	International journal of molecular sciences	2012	52
26921342	Folic acid	Huang YH	Delivery of Therapeutics Targeting the mRNA-Binding Protein HuR Using 3DNA Nanocarriers Suppresses Ovarian Tumor Growth.	Cancer research	2016	13
26584049	Mitomycin	García-Rubio ML	The Fanconi Anemia Pathway Protects Genome Integrity from R-loops.	PLoS genetics	2015	40
9501205	Vorinostat	Richon VM	A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.	Proceedings of the National Academy of Sciences of the United States of America	1998	134
11016644	Vorinostat	Butler LM	Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo.	Cancer research	2000	143
15596714	Vorinostat	Shao Y	Apoptotic and autophagic cell death induced by histone deacetylase inhibitors.	Proceedings of the National Academy of Sciences of the United States of America	2004	169
17325656	Vorinostat	Lin HS	Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents.	British journal of pharmacology	2007	58
18413790	Vorinostat	Fournel M	MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo.	Molecular cancer therapeutics	2008	75
18568076	Vorinostat	Reddy P	Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice.	The Journal of clinical investigation	2008	98
22038994	Vorinostat	Landreville S	Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.	Clinical cancer research 	2012	66
22140466	Vorinostat	Mielcarek M	SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6/2 mouse model of Huntington's disease.	PloS one	2011	49
22461695	Vorinostat	Yang D	Decitabine and vorinostat cooperate to sensitize colon carcinoma cells to Fas ligand-induced apoptosis in vitro and tumor suppression in vivo.	Journal of immunology	2012	30
24396039	Vorinostat	Xie M	Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy.	Circulation	2014	68
24603818	Vorinostat	Sanders YY	Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice.	The European respiratory journal	2014	24
26136424	Vorinostat	Paschall AV	H3K9 Trimethylation Silences Fas Expression To Confer Colon Carcinoma Immune Escape and 5-Fluorouracil Chemoresistance.	Journal of immunology	2015	17
17122772	Vitamin D3	O'Brien CA	A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.	Nature	2007	1111
17363299	Vitamin D3	Santiago C	Structures of T Cell immunoglobulin mucin receptors 1 and 2 reveal mechanisms for regulation of immune responses by the TIM receptor family.	Immunity	2007	59
17369830	Vitamin D3	Kitamura T	SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion.	Nature genetics	2007	94
17584991	Vitamin D3	Jung KM	A key role for diacylglycerol lipase-alpha in metabotropic glutamate receptor-dependent endocannabinoid mobilization.	Molecular pharmacology	2007	67
19328876	Vitamin D3	Lin S	The absence of LPA2 attenuates tumor formation in an experimental model of colitis-associated cancer.	Gastroenterology	2009	48
22446628	Vitamin D3	Everitt AR	IFITM3 restricts the morbidity and mortality associated with influenza.	Nature	2012	208
24778162	Vitamin D3	Ortiz ML	Myeloid-derived suppressor cells in the development of lung cancer.	Cancer immunology research	2014	24
15793561	L-Phenylalanine	James C	A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.	Nature	2005	687
17267906	L-Phenylalanine	Scott LM	JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.	The New England journal of medicine	2007	231
21406728	L-Phenylalanine	Miliani de Marval PL	The RP-Mdm2-p53 pathway and tumorigenesis.	Oncotarget	2011	40
22461506	L-Phenylalanine	Vaught DB	HER3 is required for HER2-induced preneoplastic changes to the breast epithelium and tumor formation.	Cancer research	2012	38
23714121	L-Phenylalanine	Shi P	Elastin-based protein polymer nanoparticles carrying drug at both corona and core suppress tumor growth in vivo.	Journal of controlled release 	2013	26
25196138	L-Phenylalanine	Orecchioni S	The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells.	International journal of cancer	2015	30
18318442	L-Methionine	Martínez-Chantar ML	Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice.	Hepatology	2008	84
19234449	L-Methionine	Keng VW	A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma.	Nature biotechnology	2009	88
20215504	L-Methionine	Schoeberl B	An ErbB3 antibody, MM-121, is active in cancers with ligand-dependent activation.	Cancer research	2010	94
20564331	L-Methionine	Ding W	Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion.	Hepatology	2010	52
20805998	L-Methionine	Kong D	Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells.	PloS one	2010	132
20852131	L-Methionine	Ashworth TD	Deletion-based mechanisms of Notch1 activation in T-ALL: key roles for RAG recombinase and a conserved internal translational start site in Notch1.	Blood	2010	42
21878621	L-Methionine	Teng YW	Deletion of betaine-homocysteine S-methyltransferase in mice perturbs choline and 1-carbon metabolism, resulting in fatty liver and hepatocellular carcinomas.	The Journal of biological chemistry	2011	51
23241961	L-Methionine	Yang H	MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma.	The Journal of clinical investigation	2013	35
25525250	L-Methionine	Funato K	Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation.	Science	2014	60
25736301	L-Methionine	Tanaka N	Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet.	Biochimica et biophysica acta	2015	20
27523608	L-Methionine	Damgaard RB	The Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and Autoimmunity.	Cell	2016	25
28263309	L-Methionine	Mohammad F	EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas.	Nature medicine	2017	17
10912000	Deoxyuridine triphosphate	Nilsen H	Uracil-DNA glycosylase (UNG)-deficient mice reveal a primary role of the enzyme during DNA replication.	Molecular cell	2000	99
16952555	Deoxyuridine triphosphate	Fukata M	Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine.	Gastroenterology	2006	119
17545551	Deoxyuridine triphosphate	Lin YG	Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway.	Clinical cancer research 	2007	87
17681179	Deoxyuridine triphosphate	Li P	Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity.	Gastroenterology	2007	59
18471519	Deoxyuridine triphosphate	Sureban SM	Knockdown of RNA binding protein musashi-1 leads to tumor regression in vivo.	Gastroenterology	2008	60
19509158	Deoxyuridine triphosphate	Li J	MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor.	Clinical cancer research 	2009	102
20145154	Deoxyuridine triphosphate	Kaneda H	FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growth.	Cancer research	2010	53
20179157	Deoxyuridine triphosphate	Beljanski V	A novel sphingosine kinase inhibitor induces autophagy in tumor cells.	The Journal of pharmacology and experimental therapeutics	2010	45
20197468	Deoxyuridine triphosphate	Becher OJ	Preclinical evaluation of radiation and perifosine in a genetically and histologically accurate model of brainstem glioma.	Cancer research	2010	55
9590696	Progesterone	Fryer CJ	Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex.	Nature	1998	139
11719442	Progesterone	Hayward SW	Malignant transformation in a nontumorigenic human prostatic epithelial cell line.	Cancer research	2001	105
11969254	Progesterone	Welm BE	Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population.	Developmental biology	2002	152
14578209	Progesterone	Lin EY	Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases.	The American journal of pathology	2003	356
14996752	Progesterone	Kuang SQ	AIB1/SRC-3 deficiency affects insulin-like growth factor I signaling pathway and suppresses v-Ha-ras-induced breast cancer initiation and progression in mice.	Cancer research	2004	73
15617686	Progesterone	Clarke RB	A putative human breast stem cell population is enriched for steroid receptor-positive cells.	Developmental biology	2005	89
15919749	Progesterone	Muñoz-de-Toro M	Perinatal exposure to bisphenol-A alters peripubertal mammary gland development in mice.	Endocrinology	2005	84
16176985	Progesterone	Tranguch S	Cochaperone immunophilin FKBP52 is critical to uterine receptivity for embryo implantation.	Proceedings of the National Academy of Sciences of the United States of America	2005	75
16339279	Progesterone	Condon JC	Up-regulation of the progesterone receptor (PR)-C isoform in laboring myometrium by activation of nuclear factor-kappaB may contribute to the onset of labor through inhibition of PR function.	Molecular endocrinology	2006	85
16452162	Progesterone	Mallepell S	Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland.	Proceedings of the National Academy of Sciences of the United States of America	2006	128
16803960	Progesterone	Musatov S	RNAi-mediated silencing of estrogen receptor {alpha} in the ventromedial nucleus of hypothalamus abolishes female sexual behaviors.	Proceedings of the National Academy of Sciences of the United States of America	2006	69
16849684	Progesterone	Asselin-Labat ML	Steroid hormone receptor status of mouse mammary stem cells.	Journal of the National Cancer Institute	2006	98
17190790	Progesterone	Sleeman KE	Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland.	The Journal of cell biology	2007	122
17785410	Progesterone	Feng Y	Estrogen receptor-alpha expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice.	Proceedings of the National Academy of Sciences of the United States of America	2007	77
19109434	Progesterone	Wang S	Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation.	Proceedings of the National Academy of Sciences of the United States of America	2009	50
19440038	Progesterone	Liu B	Metformin induces unique biological and molecular responses in triple negative breast cancer cells.	Cell cycle	2009	123
20133621	Progesterone	Beleut M	Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland.	Proceedings of the National Academy of Sciences of the United States of America	2010	105
20679727	Progesterone	Jiang Z	Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status.	The Journal of clinical investigation	2010	58
20739412	Progesterone	Brisken C	Hormone action in the mammary gland.	Cold Spring Harbor perspectives in biology	2010	107
20813035	Progesterone	Prat A	Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer.	Breast cancer research 	2010	582
20881963	Progesterone	Gonzalez-Suarez E	RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis.	Nature	2010	124
21369698	Progesterone	Catchpole S	PLU-1/JARID1B/KDM5B is required for embryonic survival and contributes to cell proliferation in the mammary gland and in ER+ breast cancer cells.	International journal of oncology	2011	45
22264274	Progesterone	Chan SR	STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas.	Breast cancer research 	2012	56
22367781	Progesterone	Rao R	Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells.	Molecular cancer therapeutics	2012	40
22446188	Progesterone	Ma CX	Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models.	The Journal of clinical investigation	2012	63
22495674	Progesterone	Filardo EJ	Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology.	Endocrinology	2012	73
22496457	Progesterone	Palafox M	RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis.	Cancer research	2012	44
22583478	Progesterone	Rivas MA	Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.	Breast cancer research 	2012	37
22613095	Progesterone	Tate CR	Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat.	Breast cancer research 	2012	55
22698676	Progesterone	Mercier I	Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug.	The American journal of pathology	2012	68
22821401	Progesterone	Kabos P	Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures.	Breast cancer research and treatment	2012	40
23088371	Progesterone	Shehata M	Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland.	Breast cancer research 	2012	88
23375371	Progesterone	Pal B	Global changes in the mammary epigenome are induced by hormonal cues and coordinated by Ezh2.	Cell reports	2013	32
23621987	Progesterone	Meier-Abt F	Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium.	Breast cancer research 	2013	35
23737486	Progesterone	Zhang X	A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models.	Cancer research	2013	94
24248265	Progesterone	Xiang L	Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer.	Journal of molecular medicine	2014	26
24265601	Progesterone	Jones A	Role of DNA methylation and epigenetic silencing of HAND2 in endometrial cancer development.	PLoS medicine	2013	27
24449892	Progesterone	Inoue S	TAp73 is required for spermatogenesis and the maintenance of male fertility.	Proceedings of the National Academy of Sciences of the United States of America	2014	23
24569463	Progesterone	Yoshida T	Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.	British journal of cancer	2014	48
24844244	Progesterone	Wang Y	MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells.	eLife	2014	27
25359727	Progesterone	Nakagawa S	The lncRNA Neat1 is required for corpus luteum formation and the establishment of pregnancy in a subpopulation of mice.	Development	2014	39
26266985	Progesterone	Van Keymeulen A	Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity.	Nature	2015	51
27322743	Progesterone	Nolan E	RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers.	Nature medicine	2016	23
27775705	Progesterone	Horiuchi D	PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression.	Nature medicine	2016	12
7634330	Ceramide (d18:1/12:0)	Bose R	Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals.	Cell	1995	133
8706124	Ceramide (d18:1/12:0)	Santana P	Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis.	Cell	1996	121
9806545	Ceramide (d18:1/12:0)	Wang ZG	PML is essential for multiple apoptotic pathways.	Nature genetics	1998	128
10700234	Ceramide (d18:1/12:0)	Galve-Roperh I	Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation.	Nature medicine	2000	96
12890694	Ceramide (d18:1/12:0)	Pettus BJ	The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-alpha.	FASEB journal 	2003	83
16632640	Ceramide (d18:1/12:0)	French KJ	Antitumor activity of sphingosine kinase inhibitors.	The Journal of pharmacology and experimental therapeutics	2006	79
17090686	Ceramide (d18:1/12:0)	Oskouian B	Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancer.	Proceedings of the National Academy of Sciences of the United States of America	2006	76
17308067	Ceramide (d18:1/12:0)	Senkal CE	Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas.	Molecular cancer therapeutics	2007	59
18567738	Ceramide (d18:1/12:0)	Smith EL	The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases.	FASEB journal 	2008	67
19425170	Ceramide (d18:1/12:0)	Salazar M	Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells.	The Journal of clinical investigation	2009	173
19801672	Ceramide (d18:1/12:0)	Imgrund S	Adult ceramide synthase 2 (CERS2)-deficient mice exhibit myelin sheath defects, cerebellar degeneration, and hepatocarcinomas.	The Journal of biological chemistry	2009	60
20061445	Ceramide (d18:1/12:0)	French KJ	Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2.	The Journal of pharmacology and experimental therapeutics	2010	94
20110366	Ceramide (d18:1/12:0)	Pewzner-Jung Y	A critical role for ceramide synthase 2 in liver homeostasis: II. insights into molecular changes leading to hepatopathy.	The Journal of biological chemistry	2010	57
21695182	Ceramide (d18:1/12:0)	Lee H	Mitochondrial ceramide-rich macrodomains functionalize Bax upon irradiation.	PloS one	2011	52
21769103	Ceramide (d18:1/12:0)	Kim CH	Conditioning for hematopoietic transplantation activates the complement cascade and induces a proteolytic environment in bone marrow: a novel role for bioactive lipids and soluble C5b-C9 as homing factors.	Leukemia	2012	49
22038835	Ceramide (d18:1/12:0)	Jennemann R	Loss of ceramide synthase 3 causes lethal skin barrier disruption.	Human molecular genetics	2012	45
22466649	Ceramide (d18:1/12:0)	Rotolo J	Anti-ceramide antibody prevents the radiation gastrointestinal syndrome in mice.	The Journal of clinical investigation	2012	33
23166225	Ceramide (d18:1/12:0)	Rosa R	Sphingosine kinase 1 overexpression contributes to cetuximab resistance in human colorectal cancer models.	Clinical cancer research 	2013	27
23293083	Ceramide (d18:1/12:0)	Borrego F	The CD300 molecules: an emerging family of regulators of the immune system.	Blood	2013	34
23926298	Ceramide (d18:1/12:0)	Oaks JJ	Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies.	Blood	2013	31
26071354	Ceramide (d18:1/12:0)	Chen MB	MicroRNA-101 down-regulates sphingosine kinase 1 in colorectal cancer cells.	Biochemical and biophysical research communications	2015	28
26670557	Ceramide (d18:1/12:0)	Jiang C	Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction.	Nature communications	2015	37
27639801	Ceramide (d18:1/12:0)	Gonzalez FJ	An Intestinal Microbiota-Farnesoid X Receptor Axis Modulates Metabolic Disease.	Gastroenterology	2016	15
28223344	Ceramide (d18:1/12:0)	Xie C	An Intestinal Farnesoid X Receptor-Ceramide Signaling Axis Modulates Hepatic Gluconeogenesis in Mice.	Diabetes	2017	8
17406000	Dihydrotestosterone	Miyamoto H	Promotion of bladder cancer development and progression by androgen receptor signals.	Journal of the National Cancer Institute	2007	100
18639551	Dihydrotestosterone	Ma WL	Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma.	Gastroenterology	2008	59
19866465	Dihydrotestosterone	Leon CG	Alterations in cholesterol regulation contribute to the production of intratumoral androgens during progression to castration-resistant prostate cancer in a mouse xenograft model.	The Prostate	2010	63
21303972	Dihydrotestosterone	Mohler JL	Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancer.	Cancer research	2011	47
21795608	Dihydrotestosterone	Chang KH	Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer.	Proceedings of the National Academy of Sciences of the United States of America	2011	84
26030522	Dihydrotestosterone	Li Z	Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer.	Nature	2015	44
26342199	Dihydrotestosterone	Kawahara T	ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.	Oncotarget	2015	18
12093876	Chloroacetic acid	Crowe NY	A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas.	The Journal of experimental medicine	2002	102
16129707	Chloroacetic acid	Smyth MJ	NKG2D function protects the host from tumor initiation.	The Journal of experimental medicine	2005	81
16275765	Chloroacetic acid	Crowe NY	Differential antitumor immunity mediated by NKT cell subsets in vivo.	The Journal of experimental medicine	2005	122
16680149	Chloroacetic acid	Uno T	Eradication of established tumors in mice by a combination antibody-based therapy.	Nature medicine	2006	66
26513738	Chloroacetic acid	Helfinger V	The NADPH Oxidase Nox4 mediates tumour angiogenesis.	Acta physiologica	2016	11
1884998	L-Leucine	Williams SC	A family of C/EBP-related proteins capable of forming covalently linked leucine zipper dimers in vitro.	Genes & development	1991	153
7958932	L-Leucine	Hemesath TJ	microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family.	Genes & development	1994	139
9930862	L-Leucine	Walczak H	Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.	Nature medicine	1999	463
11084031	L-Leucine	Futaki S	Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery.	The Journal of biological chemistry	2001	209
12101249	L-Leucine	Peng T	The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation.	Molecular and cellular biology	2002	119
12766759	L-Leucine	Inohara N	NODs: intracellular proteins involved in inflammation and apoptosis.	Nature reviews. Immunology	2003	203
16705038	L-Leucine	Politi K	Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors.	Genes & development	2006	130
16885365	L-Leucine	Zhao M	Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice.	Cancer research	2006	96
17722061	L-Leucine	Nakano I	Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells.	Journal of neuroscience research	2008	64
18550571	L-Leucine	Bi X	Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation.	Carcinogenesis	2008	52
18556417	L-Leucine	Souza RF	Acid, bile, and CDX: the ABCs of making Barrett's metaplasia.	American journal of physiology. Gastrointestinal and liver physiology	2008	51
18688028	L-Leucine	Goldoni S	An antimetastatic role for decorin in breast cancer.	The American journal of pathology	2008	52
18716624	L-Leucine	Soucek L	Modelling Myc inhibition as a cancer therapy.	Nature	2008	250
18798267	L-Leucine	Goldoni S	Tumor microenvironment: Modulation by decorin and related molecules harboring leucine-rich tandem motifs.	International journal of cancer	2008	69
19092804	L-Leucine	Barker N	Crypt stem cells as the cells-of-origin of intestinal cancer.	Nature	2009	611
19234121	L-Leucine	Coffelt SB	The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells.	Proceedings of the National Academy of Sciences of the United States of America	2009	83
19676123	L-Leucine	May R	Doublecortin and CaM kinase-like-1 and leucine-rich-repeat-containing G-protein-coupled receptor mark quiescent and cycling intestinal stem cells, respectively.	Stem cells	2009	61
19749763	L-Leucine	Gascoyne DM	The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development.	Nature immunology	2009	138
19766244	L-Leucine	Yam C	Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer.	The Journal of surgical research	2010	59
19995955	L-Leucine	Kamizono S	Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo.	The Journal of experimental medicine	2009	97
20052801	L-Leucine	Qin Z	Pivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes.	Journal of leukocyte biology	2010	64
20080798	L-Leucine	Lu T	Regulation of NF-kappaB by NSD1/FBXL11-dependent reversible lysine methylation of p65.	Proceedings of the National Academy of Sciences of the United States of America	2010	84
20384634	L-Leucine	Uchida H	Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in colorectal cancer.	Cancer science	2010	48
20385749	L-Leucine	Allen IC	The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer.	The Journal of experimental medicine	2010	180
20417836	L-Leucine	Barker N	Leucine-rich repeat-containing G-protein-coupled receptors as markers of adult stem cells.	Gastroenterology	2010	100
20486765	L-Leucine	Hu R	Regulation of NF-E2-related factor 2 signaling for cancer chemoprevention: antioxidant coupled with antiinflammatory.	Antioxidants & redox signaling	2010	49
21262964	L-Leucine	Xie R	Microtubule-associated protein 1S (MAP1S) bridges autophagic components with microtubules and mitochondria to affect autophagosomal biogenesis and degradation.	The Journal of biological chemistry	2011	35
21703540	L-Leucine	Allen IC	NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-κB signaling pathways.	Immunity	2011	103
21829496	L-Leucine	Walker F	LGR5 is a negative regulator of tumourigenicity, antagonizes Wnt signalling and regulates cell adhesion in colorectal cancer cell lines.	PloS one	2011	39
22855427	L-Leucine	Schepers AG	Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas.	Science	2012	334
22992524	L-Leucine	Tussiwand R	Compensatory dendritic cell development mediated by BATF-IRF interactions.	Nature	2012	108
23029096	L-Leucine	Buraschi S	Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model.	PloS one	2012	37
23283305	L-Leucine	Chung S	Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer.	Oncotarget	2012	40
23339114	L-Leucine	Gu C	Tumor-specific activation of the C-JUN/MELK pathway regulates glioma stem cell growth in a p53-dependent manner.	Stem cells	2013	34
23644456	L-Leucine	Styrkarsdottir U	Nonsense mutation in the LGR4 gene is associated with several human diseases and other traits.	Nature	2013	64
23712846	L-Leucine	Wang Y	Lgr4 regulates mammary gland development and stem cell activity through the pluripotency transcription factor Sox2.	Stem cells	2013	29
23818853	L-Leucine	Chavarría-Smith J	Direct proteolytic cleavage of NLRP1B is necessary and sufficient for inflammasome activation by anthrax lethal factor.	PLoS pathogens	2013	46
23868260	L-Leucine	Wang X	LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling.	Nature	2013	47
24014241	L-Leucine	Willems L	Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia.	Blood	2013	56
24052624	L-Leucine	Wang Q	Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor development.	Journal of the National Cancer Institute	2013	31
24480070	L-Leucine	Moreth K	Biglycan-triggered TLR-2- and TLR-4-signaling exacerbates the pathophysiology of ischemic acute kidney injury.	Matrix biology 	2014	24
24550486	L-Leucine	Heuberger J	Shp2/MAPK signaling controls goblet/paneth cell fate decisions in the intestine.	Proceedings of the National Academy of Sciences of the United States of America	2014	24
24560620	L-Leucine	Zhang L	NLRC3, a member of the NLR family of proteins, is a negative regulator of innate immune signaling induced by the DNA sensor STING.	Immunity	2014	56
24657167	L-Leucine	Tenthorey JL	Molecular basis for specific recognition of bacterial ligands by NAIP/NLRC4 inflammasomes.	Molecular cell	2014	51
24703948	L-Leucine	Wang P	Both decreased and increased SRPK1 levels promote cancer by interfering with PHLPP-mediated dephosphorylation of Akt.	Molecular cell	2014	21
24825302	L-Leucine	Chang RM	MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase.	Hepatology	2014	38
24885567	L-Leucine	Du T	Maternal embryonic leucine zipper kinase enhances gastric cancer progression via the FAK/Paxillin pathway.	Molecular cancer	2014	21
25038433	L-Leucine	Tsai YH	ADAM10 regulates Notch function in intestinal stem cells of mice.	Gastroenterology	2014	22
25074917	L-Leucine	Engler DB	Effective treatment of allergic airway inflammation with Helicobacter pylori immunomodulators requires BATF3-dependent dendritic cells and IL-10.	Proceedings of the National Academy of Sciences of the United States of America	2014	26
25558062	L-Leucine	Posokhova E	GPR124 functions as a WNT7-specific coactivator of canonical β-catenin signaling.	Cell reports	2015	28
25725098	L-Leucine	Williams TM	The NLRP1 inflammasome attenuates colitis and colitis-associated tumorigenesis.	Journal of immunology	2015	21
25725293	L-Leucine	Sigal M	Helicobacter pylori Activates and Expands Lgr5(+) Stem Cells Through Direct Colonization of the Gastric Glands.	Gastroenterology	2015	38
27064449	L-Leucine	Luo J	LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption.	Nature medicine	2016	25
27455510	L-Leucine	Moon JS	NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages.	Nature medicine	2016	21
28358093	L-Leucine	de Sousa e Melo F	A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer.	Nature	2017	30
28380376	L-Leucine	Anderson KA	SIRT4 Is a Lysine Deacylase that Controls Leucine Metabolism and Insulin Secretion.	Cell metabolism	2017	18
11017141	Sphing-4-enine-1-phosphate	Morita Y	Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy.	Nature medicine	2000	100
16397235	Sphing-4-enine-1-phosphate	LaMontagne K	Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization.	Cancer research	2006	76
16530706	Sphing-4-enine-1-phosphate	Visentin B	Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages.	Cancer cell	2006	148
16980623	Sphing-4-enine-1-phosphate	Kohno M	Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation.	Molecular and cellular biology	2006	89
18544649	Sphing-4-enine-1-phosphate	Guillermet-Guibert J	The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma.	Proceedings of the National Academy of Sciences of the United States of America	2008	128
18824518	Sphing-4-enine-1-phosphate	Kawamori T	Role for sphingosine kinase 1 in colon carcinogenesis.	FASEB journal 	2009	86
19723667	Sphing-4-enine-1-phosphate	Kapitonov D	Targeting sphingosine kinase 1 inhibits Akt signaling, induces apoptosis, and suppresses growth of human glioblastoma cells and xenografts.	Cancer research	2009	63
20959468	Sphing-4-enine-1-phosphate	Pchejetski D	FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1.	Cancer research	2010	43
22298596	Sphing-4-enine-1-phosphate	Nagahashi M	Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis.	Cancer research	2012	90
22707406	Sphing-4-enine-1-phosphate	Ponnusamy S	Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis.	EMBO molecular medicine	2012	41
22723910	Sphing-4-enine-1-phosphate	Hisano Y	Mouse SPNS2 functions as a sphingosine-1-phosphate transporter in vascular endothelial cells.	PloS one	2012	53
22884261	Sphing-4-enine-1-phosphate	Miller E	Identification of serum-derived sphingosine-1-phosphate as a small molecule regulator of YAP.	Chemistry & biology	2012	85
23143305	Sphing-4-enine-1-phosphate	Çuburu N	Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses.	The Journal of clinical investigation	2012	44
23273921	Sphing-4-enine-1-phosphate	Liang J	Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer.	Cancer cell	2013	151
23861887	Sphing-4-enine-1-phosphate	Rex K	Sphingosine kinase activity is not required for tumor cell viability.	PloS one	2013	26
24812669	Sphing-4-enine-1-phosphate	Tang CH	Inhibition of ER stress-associated IRE-1/XBP-1 pathway reduces leukemic cell survival.	The Journal of clinical investigation	2014	37
24859201	Sphing-4-enine-1-phosphate	Hait NC	Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory.	Nature neuroscience	2014	37
25274307	Sphing-4-enine-1-phosphate	Muppidi JR	Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma.	Nature	2014	40
25347472	Sphing-4-enine-1-phosphate	Degagné E	Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs.	The Journal of clinical investigation	2014	34
25831442	Sphing-4-enine-1-phosphate	Proia RL	Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy.	The Journal of clinical investigation	2015	63
27956387	Sphing-4-enine-1-phosphate	Powell JA	Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemia.	Blood	2017	5
28052056	Sphing-4-enine-1-phosphate	van der Weyden L	Genome-wide in vivo screen identifies novel host regulators of metastatic colonization.	Nature	2017	19
2649981	L-Alanine	Baker SJ	Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.	Science	1989	361
7729684	L-Alanine	Matsuoka S	p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.	Genes & development	1995	194
11565035	L-Alanine	Malek NP	A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase.	Nature	2001	87
12588983	L-Alanine	Razandi M	Identification of a structural determinant necessary for the localization and function of estrogen receptor alpha at the plasma membrane.	Molecular and cellular biology	2003	89
16166381	L-Alanine	Ruvinsky I	Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis.	Genes & development	2005	197
16785532	L-Alanine	Teeling JL	The biological activity of human CD20 monoclonal antibodies is linked to unique epitopes on CD20.	Journal of immunology	2006	127
19528295	L-Alanine	Li M	Loss of spindle assembly checkpoint-mediated inhibition of Cdc20 promotes tumorigenesis in mice.	The Journal of cell biology	2009	47
20093775	L-Alanine	Bamboat ZM	Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion.	The Journal of clinical investigation	2010	65
21123452	L-Alanine	Dijkgraaf GJ	Small molecule inhibition of GDC-0449 refractory smoothened mutants and downstream mechanisms of drug resistance.	Cancer research	2011	106
21149604	L-Alanine	Chinnasamy N	A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancer.	Journal of immunology	2011	48
23791526	L-Alanine	Martínez P	RAP1 protects from obesity through its extratelomeric role regulating gene expression.	Cell reports	2013	27
24919570	L-Alanine	Shiwarski DJ	To "grow" or "go": TMEM16A expression as a switch between tumor growth and metastasis in SCCHN.	Clinical cancer research 	2014	24
25813021	L-Alanine	Korangath P	Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate.	Clinical cancer research 	2015	26
26409216	L-Alanine	Liang HW	Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122.	Journal of hepatology	2016	13
27075625	L-Alanine	Wang H	NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis.	Science translational medicine	2016	21
11533658	APC	Ryo A	Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC.	Nature cell biology	2001	132
17377531	APC	Sansom OJ	Myc deletion rescues Apc deficiency in the small intestine.	Nature	2007	215
17942902	APC	Hinoi T	Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation.	Cancer research	2007	108
19336570	APC	Huang EH	Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.	Cancer research	2009	338
20809552	APC	Lin J	Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth.	The Prostate	2011	38
21458673	APC	Premsrirut PK	A rapid and scalable system for studying gene function in mice using conditional RNA interference.	Cell	2011	112
17906635	Palmitic acid	Matsuzaka T	Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance.	Nature medicine	2007	117
22753171	Palmitic acid	Matsuzaka T	Elovl6 promotes nonalcoholic steatohepatitis.	Hepatology	2012	37
24947355	Palmitic acid	Tubbs E	Mitochondria-associated endoplasmic reticulum membrane (MAM) integrity is required for insulin signaling and is implicated in hepatic insulin resistance.	Diabetes	2014	36
25242226	Palmitic acid	Kratz M	Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages.	Cell metabolism	2014	76
25445398	Palmitic acid	Idrissova L	TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess.	Journal of hepatology	2015	20
25550510	Palmitic acid	López-Vicario C	Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides.	Proceedings of the National Academy of Sciences of the United States of America	2015	24
25586377	Palmitic acid	Niso-Santano M	Unsaturated fatty acids induce non-canonical autophagy.	The EMBO journal	2015	17
25848059	Palmitic acid	Youssef OA	Potential role for snoRNAs in PKR activation during metabolic stress.	Proceedings of the National Academy of Sciences of the United States of America	2015	19
27974793	Palmitic acid	Pascual G	Targeting metastasis-initiating cells through the fatty acid receptor CD36.	Nature	2017	46
9501191	17a-Ethynylestradiol	Lavinsky RM	Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes.	Proceedings of the National Academy of Sciences of the United States of America	1998	112
10411913	17a-Ethynylestradiol	Vasioukhin V	The magical touch: genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin.	Proceedings of the National Academy of Sciences of the United States of America	1999	237
10696569	17a-Ethynylestradiol	Liehr JG	Is estradiol a genotoxic mutagenic carcinogen?	Endocrine reviews	2000	97
10976058	17a-Ethynylestradiol	Dupont S	Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes.	Development	2000	257
11306549	17a-Ethynylestradiol	Vooijs M	A highly efficient ligand-regulated Cre recombinase mouse line shows that LoxP recombination is position dependent.	EMBO reports	2001	116
11929836	17a-Ethynylestradiol	Stabile LP	Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen.	Cancer research	2002	104
12756295	17a-Ethynylestradiol	Yadav N	Specific protein methylation defects and gene expression perturbations in coactivator-associated arginine methyltransferase 1-deficient mice.	Proceedings of the National Academy of Sciences of the United States of America	2003	96
14729654	17a-Ethynylestradiol	Paruthiyil S	Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest.	Cancer research	2004	147
15001666	17a-Ethynylestradiol	Bourdeau V	Genome-wide identification of high-affinity estrogen response elements in human and mouse.	Molecular endocrinology	2004	102
15199112	17a-Ethynylestradiol	Shou J	Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer.	Journal of the National Cancer Institute	2004	288
15380517	17a-Ethynylestradiol	Torres-Arzayus MI	High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene.	Cancer cell	2004	148
15601818	17a-Ethynylestradiol	McLean GW	Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression.	Genes & development	2004	89
15735034	17a-Ethynylestradiol	Stabile LP	Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects.	Cancer research	2005	86
16885386	17a-Ethynylestradiol	Wolf I	15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.	Cancer research	2006	63
17046690	17a-Ethynylestradiol	Wintermantel TM	Definition of estrogen receptor pathway critical for estrogen positive feedback to gonadotropin-releasing hormone neurons and fertility.	Neuron	2006	189
17138902	17a-Ethynylestradiol	Poole AJ	Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist.	Science	2006	85
17235397	17a-Ethynylestradiol	Amaravadi RK	Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma.	The Journal of clinical investigation	2007	390
17456738	17a-Ethynylestradiol	Hameyer D	Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues.	Physiological genomics	2007	67
17470737	17a-Ethynylestradiol	Arpino G	Treatment of human epidermal growth factor receptor 2-overexpressing breast cancer xenografts with multiagent HER-targeted therapy.	Journal of the National Cancer Institute	2007	62
17590085	17a-Ethynylestradiol	Kurihara I	COUP-TFII mediates progesterone regulation of uterine implantation by controlling ER activity.	PLoS genetics	2007	71
17626182	17a-Ethynylestradiol	Liu X	Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer.	Proceedings of the National Academy of Sciences of the United States of America	2007	115
18055862	17a-Ethynylestradiol	Ricke WA	Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling.	FASEB journal 	2008	57
18375767	17a-Ethynylestradiol	Tan-Wong SM	Dynamic interactions between the promoter and terminator regions of the mammalian BRCA1 gene.	Proceedings of the National Academy of Sciences of the United States of America	2008	62
18794137	17a-Ethynylestradiol	Creighton CJ	Development of resistance to targeted therapies transforms the clinically associated molecular profile subtype of breast tumor xenografts.	Cancer research	2008	50
18957414	17a-Ethynylestradiol	Zhang X	Esrrb activates Oct4 transcription and sustains self-renewal and pluripotency in embryonic stem cells.	The Journal of biological chemistry	2008	60
19202070	17a-Ethynylestradiol	Yu JJ	Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells.	Proceedings of the National Academy of Sciences of the United States of America	2009	64
19477432	17a-Ethynylestradiol	Liu S	Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases.	Cancer cell	2009	128
19483720	17a-Ethynylestradiol	Walter M	Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells.	Oncogene	2009	70
19531256	17a-Ethynylestradiol	Rene Gonzalez R	Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer.	Breast cancer research 	2009	56
19602591	17a-Ethynylestradiol	Hartman J	Tumor repressive functions of estrogen receptor beta in SW480 colon cancer cells.	Cancer research	2009	52
19838210	17a-Ethynylestradiol	Hao L	Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells.	Oncogene	2010	43
20133657	17a-Ethynylestradiol	McPherson SJ	Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated.	Proceedings of the National Academy of Sciences of the United States of America	2010	51
20203690	17a-Ethynylestradiol	Chan QK	Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest.	Cell death and differentiation	2010	54
20484027	17a-Ethynylestradiol	Meyer MJ	CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer.	Cancer research	2010	57
20484414	17a-Ethynylestradiol	Wilson BJ	An acetylation switch modulates the transcriptional activity of estrogen-related receptor alpha.	Molecular endocrinology	2010	52
20577047	17a-Ethynylestradiol	Chambliss KL	Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice.	The Journal of clinical investigation	2010	83
21057539	17a-Ethynylestradiol	Patel JB	Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.	Oncogene	2011	39
21372033	17a-Ethynylestradiol	Subbaramaiah K	Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland.	Cancer prevention research	2011	124
21445275	17a-Ethynylestradiol	Kawazu M	Histone demethylase JMJD2B functions as a co-factor of estrogen receptor in breast cancer proliferation and mammary gland development.	PloS one	2011	56
21482677	17a-Ethynylestradiol	Meyer DS	Luminal expression of PIK3CA mutant H1047R in the mammary gland induces heterogeneous tumors.	Cancer research	2011	43
21553120	17a-Ethynylestradiol	Guttilla IK	Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs.	Breast cancer research and treatment	2012	38
22056872	17a-Ethynylestradiol	Vesuna F	Twist contributes to hormone resistance in breast cancer by downregulating estrogen receptor-α.	Oncogene	2012	49
22158945	17a-Ethynylestradiol	Nasser MW	S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways.	Cancer research	2012	38
22411819	17a-Ethynylestradiol	Xu X	Evidence for type II cells as cells of origin of K-Ras-induced distal lung adenocarcinoma.	Proceedings of the National Academy of Sciences of the United States of America	2012	65
22537901	17a-Ethynylestradiol	Tseng LM	CIP2A is a target of bortezomib in human triple negative breast cancer cells.	Breast cancer research 	2012	33
22632819	17a-Ethynylestradiol	Zhi X	YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor.	The American journal of pathology	2012	33
22875023	17a-Ethynylestradiol	Ramaswamy B	Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway.	Cancer research	2012	60
22993197	17a-Ethynylestradiol	Motiani RK	Orai3 is an estrogen receptor α-regulated Ca²⁺ channel that promotes tumorigenesis.	FASEB journal 	2013	45
23047698	17a-Ethynylestradiol	Song H	Functional characterization of pulmonary neuroendocrine cells in lung development, injury, and tumorigenesis.	Proceedings of the National Academy of Sciences of the United States of America	2012	55
23272133	17a-Ethynylestradiol	Sheth S	Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway.	PloS one	2012	53
23379261	17a-Ethynylestradiol	Li Y	Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer.	Molecular cancer	2013	37
23442322	17a-Ethynylestradiol	Ithimakin S	HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumab.	Cancer research	2013	62
24210818	17a-Ethynylestradiol	Wu Q	27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth.	Cell reports	2013	58
24288332	17a-Ethynylestradiol	Nelson ER	27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology.	Science	2013	122
24469049	17a-Ethynylestradiol	Cyr AR	TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis.	Oncogene	2015	22
24495410	17a-Ethynylestradiol	Ge LC	Involvement of activating ERK1/2 through G protein coupled receptor 30 and estrogen receptor α/β in low doses of bisphenol A promoting growth of Sertoli TM4 cells.	Toxicology letters	2014	21
24874954	17a-Ethynylestradiol	Feng Q	An epigenomic approach to therapy for tamoxifen-resistant breast cancer.	Cell research	2014	45
24928945	17a-Ethynylestradiol	Cook KL	Hydroxychloroquine inhibits autophagy to potentiate antiestrogen responsiveness in ER+ breast cancer.	Clinical cancer research 	2014	25
24957076	17a-Ethynylestradiol	Fuentes-Mattei E	Effects of obesity on transcriptomic changes and cancer hallmarks in estrogen receptor-positive breast cancer.	Journal of the National Cancer Institute	2014	32
25011475	17a-Ethynylestradiol	Jin UH	The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis.	BMC cancer	2014	22
25013076	17a-Ethynylestradiol	Yu M	Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility.	Science	2014	167
25017071	17a-Ethynylestradiol	Nagarajan S	Bromodomain protein BRD4 is required for estrogen receptor-dependent enhancer activation and gene transcription.	Cell reports	2014	41
25538079	17a-Ethynylestradiol	Martz CA	Systematic identification of signaling pathways with potential to confer anticancer drug resistance.	Science signaling	2014	47
26189910	17a-Ethynylestradiol	Prossnitz ER	What have we learned about GPER function in physiology and disease from knockout mice?	The Journal of steroid biochemistry and molecular biology	2015	19
26286584	17a-Ethynylestradiol	Strong AL	Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers.	Breast cancer research 	2015	20
26459763	17a-Ethynylestradiol	Gernapudi R	MicroRNA 140 Promotes Expression of Long Noncoding RNA NEAT1 in Adipogenesis.	Molecular and cellular biology	2016	16
26599602	17a-Ethynylestradiol	Tam A	Sex Differences in Airway Remodeling in a Mouse Model of Chronic Obstructive Pulmonary Disease.	American journal of respiratory and critical care medicine	2016	15
26777690	17a-Ethynylestradiol	Wei W	Ligand Activation of ERRα by Cholesterol Mediates Statin and Bisphosphonate Effects.	Cell metabolism	2016	13
28154167	17a-Ethynylestradiol	Ohoka N	In Vivo Knockdown of Pathogenic Proteins via Specific and Nongenetic Inhibitor of Apoptosis Protein (IAP)-dependent Protein Erasers (SNIPERs).	The Journal of biological chemistry	2017	8
28186560	17a-Ethynylestradiol	Riar AK	Sex specific activation of the ERα axis of the mitochondrial UPR (UPRmt) in the G93A-SOD1 mouse model of familial ALS.	Human molecular genetics	2017	6
18426915	Guanine	Wu Y	FANCJ helicase defective in Fanconia anemia and breast cancer unwinds G-quadruplex DNA to defend genomic stability.	Molecular and cellular biology	2008	147
24163102	Guanine	Henderson A	Detection of G-quadruplex DNA in mammalian cells.	Nucleic acids research	2014	86
25079319	Guanine	Wolfe AL	RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer.	Nature	2014	99
26690702	Guanine	Yu J	Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation.	The Journal of clinical investigation	2016	24
12748309	Platinum	Abrams TJ	SU11248 inhibits KIT and platelet-derived growth factor receptor beta in preclinical models of human small cell lung cancer.	Molecular cancer therapeutics	2003	147
16914580	Platinum	Halder J	Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy.	Clinical cancer research 	2006	90
18418074	Platinum	Borst P	How do real tumors become resistant to cisplatin?	Cell cycle	2008	51
18451150	Platinum	Shafee N	Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors.	Cancer research	2008	99
18971340	Platinum	Rottenberg S	High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs.	Proceedings of the National Academy of Sciences of the United States of America	2008	204
19805294	Platinum	Bertolini G	Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.	Proceedings of the National Academy of Sciences of the United States of America	2009	248
20205720	Platinum	Ta LE	Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice.	Molecular pain	2010	43
20395368	Platinum	Oliver TG	Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer.	Genes & development	2010	66
20889728	Platinum	Landen CN Jr	Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer.	Molecular cancer therapeutics	2010	114
21041624	Platinum	Su F	Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer.	Proceedings of the National Academy of Sciences of the United States of America	2010	56
21068376	Platinum	Doles J	Suppression of Rev3, the catalytic subunit of Pol{zeta}, sensitizes drug-resistant lung tumors to chemotherapy.	Proceedings of the National Academy of Sciences of the United States of America	2010	62
21765211	Platinum	Lesterhuis WJ	Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice.	The Journal of clinical investigation	2011	41
22172724	Platinum	Drost R	BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance.	Cancer cell	2011	63
22696230	Platinum	Chung LY	Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2.	Clinical cancer research 	2012	37
23881923	Platinum	Shen Y	BMN 673, a novel and highly potent PARP1/2 inhibitor for the treatment of human cancers with DNA repair deficiency.	Clinical cancer research 	2013	74
24168967	Platinum	Sun C	miR-9 regulation of BRCA1 and ovarian cancer sensitivity to cisplatin and PARP inhibition.	Journal of the National Cancer Institute	2013	30
24560445	Platinum	Topp MD	Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts.	Molecular oncology	2014	30
24886434	Platinum	Abubaker K	Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden.	BMC cancer	2014	23
24889897	Platinum	Ma DL	Antagonizing STAT3 dimerization with a rhodium(III) complex.	Angewandte Chemie	2014	21
24909985	Platinum	Affara NI	B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas.	Cancer cell	2014	58
24929208	Platinum	Thayanithy V	Tumor-stromal cross talk: direct cell-to-cell transfer of oncogenic microRNAs via tunneling nanotubes.	Translational research 	2014	30
25398436	Platinum	Galanis E	Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer.	Cancer research	2015	44
25552556	Platinum	Jenkins PM	Giant ankyrin-G: a critical innovation in vertebrate evolution of fast and integrated neuronal signaling.	Proceedings of the National Academy of Sciences of the United States of America	2015	25
26234182	Platinum	Janzen DM	An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer.	Nature communications	2015	16
26321251	Platinum	Elias KM	Beyond genomics: critical evaluation of cell line utility for ovarian cancer research.	Gynecologic oncology	2015	16
1851332	Thymidine	Martuza RL	Experimental therapy of human glioma by means of a genetically engineered virus mutant.	Science	1991	143
7684692	Thymidine	Graham CH	Establishment and characterization of first trimester human trophoblast cells with extended lifespan.	Experimental cell research	1993	198
8157999	Thymidine	Ahmed SA	A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to 3Hthymidine incorporation assay.	Journal of immunological methods	1994	176
11751395	Thymidine	McCart JA	Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes.	Cancer research	2001	109
11752178	Thymidine	Fernandez M	Genetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease.	Journal of virology	2002	85
14747554	Thymidine	Feng WH	Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas.	Journal of virology	2004	84
17495131	Thymidine	Yang J	AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo.	Blood	2007	67
17942938	Thymidine	Zhang Q	Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus.	Cancer research	2007	98
17965776	Thymidine	Thorne SH	Rational strain selection and engineering creates a broad-spectrum, systemically effective oncolytic poxvirus, JX-963.	The Journal of clinical investigation	2007	68
18162040	Thymidine	Kirn DH	Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus.	PLoS medicine	2007	83
19143470	Thymidine	Curtin JF	HMGB1 mediates endogenous TLR2 activation and brain tumor regression.	PLoS medicine	2009	128
19244169	Thymidine	Vlashi E	In vivo imaging, tracking, and targeting of cancer stem cells.	Journal of the National Cancer Institute	2009	85
20432254	Thymidine	Nejak-Bowen KN	Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant beta-catenin.	Hepatology	2010	58
20530679	Thymidine	Coffelt SB	Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions.	Cancer research	2010	76
21911392	Thymidine	O'Connell JT	VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization.	Proceedings of the National Academy of Sciences of the United States of America	2011	68
22186794	Thymidine	Parato KA	The oncolytic poxvirus JX-594 selectively replicates in and destroys cancer cells driven by genetic pathways commonly activated in cancers.	Molecular therapy 	2012	54
1359541	L-Tyrosine	Guy CT	Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.	Proceedings of the National Academy of Sciences of the United States of America	1992	334
1579166	L-Tyrosine	Molina TJ	Profound block in thymocyte development in mice lacking p56lck.	Nature	1992	191
1849459	L-Tyrosine	Klein R	The trk proto-oncogene encodes a receptor for nerve growth factor.	Cell	1991	188
2156626	L-Tyrosine	Kaplan DR	PDGF beta-receptor stimulates tyrosine phosphorylation of GAP and association of GAP with a signaling complex.	Cell	1990	151
2448137	L-Tyrosine	Yarden Y	Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.	The EMBO journal	1987	250
2784195	L-Tyrosine	Veillette A	Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosine-protein kinase p56lck.	Nature	1989	163
2987699	L-Tyrosine	Whitman M	Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation.	Nature	1985	230
3262426	L-Tyrosine	Veillette A	The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck.	Cell	1988	366
7477353	L-Tyrosine	Cheng AM	Syk tyrosine kinase required for mouse viability and B-cell development.	Nature	1995	150
7526156	L-Tyrosine	Reynolds AB	Identification of a new catenin: the tyrosine kinase substrate p120cas associates with E-cadherin complexes.	Molecular and cellular biology	1994	124
7529876	L-Tyrosine	Calalb MB	Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases.	Molecular and cellular biology	1995	263
7724599	L-Tyrosine	Kaipainen A	Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.	Proceedings of the National Academy of Sciences of the United States of America	1995	260
8052651	L-Tyrosine	Nishikawa R	A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.	Proceedings of the National Academy of Sciences of the United States of America	1994	242
8114940	L-Tyrosine	Schuchardt A	Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret.	Nature	1994	271
8548747	L-Tyrosine	Buchdunger E	Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative.	Cancer research	1996	138
8571133	L-Tyrosine	Hotamisligil GS	IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance.	Science	1996	400
8643691	L-Tyrosine	Damen JE	The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase.	Proceedings of the National Academy of Sciences of the United States of America	1996	111
9168116	L-Tyrosine	Baskaran R	Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation.	Nature	1997	112
9171349	L-Tyrosine	Saxton TM	Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2.	The EMBO journal	1997	124
9321394	L-Tyrosine	Skorski T	Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway.	The EMBO journal	1997	118
9338785	L-Tyrosine	Howell BW	Neuronal position in the developing brain is regulated by mouse disabled-1.	Nature	1997	145
9360930	L-Tyrosine	Lacronique V	A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia.	Science	1997	170
9403702	L-Tyrosine	Petit AM	Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.	The American journal of pathology	1997	120
9438854	L-Tyrosine	Hirota S	Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.	Science	1998	720
9566874	L-Tyrosine	Turkson J	Stat3 activation by Src induces specific gene regulation and is required for cell transformation.	Molecular and cellular biology	1998	157
9626554	L-Tyrosine	Bole-Feysot C	Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice.	Endocrine reviews	1998	196
9694867	L-Tyrosine	Yu DH	Protein-tyrosine phosphatase Shp-2 regulates cell spreading, migration, and focal adhesion.	The Journal of biological chemistry	1998	103
9697697	L-Tyrosine	Honda H	Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130Cas.	Nature genetics	1998	101
9815926	L-Tyrosine	Goldstein NI	Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model.	Clinical cancer research 	1995	123
9865697	L-Tyrosine	Cheng AM	Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation.	Cell	1998	101
9892193	L-Tyrosine	Fong TA	SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types.	Cancer research	1999	147
10075741	L-Tyrosine	Biscardi JS	c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function.	The Journal of biological chemistry	1999	182
10078198	L-Tyrosine	Wu Z	Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity.	Molecular cell	1999	203
10205169	L-Tyrosine	Siegel PM	Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer.	The EMBO journal	1999	146
10207053	L-Tyrosine	Frasca F	Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells.	Molecular and cellular biology	1999	199
10224280	L-Tyrosine	Li S	The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.	The Journal of experimental medicine	1999	131
10228160	L-Tyrosine	Klinghoffer RA	Src family kinases are required for integrin but not PDGFR signal transduction.	The EMBO journal	1999	219
10391249	L-Tyrosine	Gong JG	The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage.	Nature	1999	223
10395191	L-Tyrosine	Hotamisligil GS	The role of TNFalpha and TNF receptors in obesity and insulin resistance.	Journal of internal medicine	1999	97
10500097	L-Tyrosine	Plattner R	c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF.	Genes & development	1999	133
10611246	L-Tyrosine	Lee RJ	Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway.	Molecular and cellular biology	2000	96
10631169	L-Tyrosine	De Moerlooze L	An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis.	Development	2000	213
10678165	L-Tyrosine	Tominaga T	Diaphanous-related formins bridge Rho GTPase and Src tyrosine kinase signaling.	Molecular cell	2000	107
10786682	L-Tyrosine	Wood JM	PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.	Cancer research	2000	127
10815932	L-Tyrosine	Ciardiello F	Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor.	Clinical cancer research 	2000	110
11042681	L-Tyrosine	Lee JH	A novel germ line juxtamembrane Met mutation in human gastric cancer.	Oncogene	2000	90
11090077	L-Tyrosine	Mizuki M	Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways.	Blood	2000	106
11146556	L-Tyrosine	Ogawa K	The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization.	Oncogene	2000	96
11278868	L-Tyrosine	Schroeder JA	Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland.	The Journal of biological chemistry	2001	94
11331881	L-Tyrosine	Bergsten E	PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor.	Nature cell biology	2001	101
11350918	L-Tyrosine	Ciardiello F	Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.	Clinical cancer research 	2001	85
11359907	L-Tyrosine	Laughner E	HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression.	Molecular and cellular biology	2001	265
11449275	L-Tyrosine	Gu H	Essential role for Gab2 in the allergic response.	Nature	2001	90
11684709	L-Tyrosine	Mariotti A	EGF-R signaling through Fyn kinase disrupts the function of integrin alpha6beta4 at hemidesmosomes: role in epithelial cell migration and carcinoma invasion.	The Journal of cell biology	2001	88
11756186	L-Tyrosine	Kelly LM	FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model.	Blood	2002	101
11818567	L-Tyrosine	Roberts RB	Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis.	Proceedings of the National Academy of Sciences of the United States of America	2002	88
11970899	L-Tyrosine	Cheng A	Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B.	Developmental cell	2002	121
11984589	L-Tyrosine	Crone SA	ErbB2 is essential in the prevention of dilated cardiomyopathy.	Nature medicine	2002	178
12010785	L-Tyrosine	Levis M	A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo.	Blood	2002	90
12086849	L-Tyrosine	Lopez T	Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis.	Cancer cell	2002	80
12086877	L-Tyrosine	Inoue M	VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis.	Cancer cell	2002	83
12123694	L-Tyrosine	Mach DB	Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur.	Neuroscience	2002	109
12124177	L-Tyrosine	Sattler M	Critical role for Gab2 in transformation by BCR/ABL.	Cancer cell	2002	93
12130661	L-Tyrosine	Okkenhaug K	Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice.	Science	2002	247
12359756	L-Tyrosine	Pietras K	Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy.	Cancer research	2002	106
12384534	L-Tyrosine	Wakeling AE	ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy.	Cancer research	2002	135
12398893	L-Tyrosine	Hiratsuka S	MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis.	Cancer cell	2002	185
12424235	L-Tyrosine	Haj FG	Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatase-1B.	The Journal of biological chemistry	2003	84
12499271	L-Tyrosine	Carlomagno F	ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases.	Cancer research	2002	115
12526739	L-Tyrosine	Arnaud L	Fyn tyrosine kinase is a critical regulator of disabled-1 during brain development.	Current biology 	2003	90
12538684	L-Tyrosine	Brown JA	Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.	Journal of immunology	2003	212
12615911	L-Tyrosine	Hsia DA	Differential regulation of cell motility and invasion by FAK.	The Journal of cell biology	2003	143
12648463	L-Tyrosine	Falls DL	Neuregulins: functions, forms, and signaling strategies.	Experimental cell research	2003	255
12695504	L-Tyrosine	Schenk S	Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution.	The Journal of cell biology	2003	78
12727920	L-Tyrosine	Bergers G	Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors.	The Journal of clinical investigation	2003	337
12748302	L-Tyrosine	Hamilton TG	Evolutionary divergence of platelet-derived growth factor alpha receptor signaling mechanisms.	Molecular and cellular biology	2003	119
12808151	L-Tyrosine	Siegel PM	Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis.	Proceedings of the National Academy of Sciences of the United States of America	2003	134
15067119	L-Tyrosine	Noren NK	Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.	Proceedings of the National Academy of Sciences of the United States of America	2004	72
15126356	L-Tyrosine	Hutchinson JN	Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion.	Cancer research	2004	81
15273746	L-Tyrosine	Araki T	Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation.	Nature medicine	2004	139
15289326	L-Tyrosine	Basile JR	Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B.	Cancer research	2004	77
15289342	L-Tyrosine	Huang S	Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor.	Cancer research	2004	74
15329723	L-Tyrosine	Douma S	Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB.	Nature	2004	163
15705894	L-Tyrosine	Yang J	Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation.	Cancer research	2005	135
15710330	L-Tyrosine	Mohi MG	Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations.	Cancer cell	2005	90
15719031	L-Tyrosine	Ren R	Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.	Nature reviews. Cancer	2005	186
15749926	L-Tyrosine	Xu C	Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium.	Stem cells	2005	76
15768830	L-Tyrosine	Williams TM	The Caveolin genes: from cell biology to medicine.	Annals of medicine	2004	121
15776112	L-Tyrosine	Zhuang L	Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts.	The Journal of clinical investigation	2005	130
15831234	L-Tyrosine	Giannini C	Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme.	Neuro-oncology	2005	169
15833866	L-Tyrosine	Chinnaiyan P	Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva).	Cancer research	2005	89
15895073	L-Tyrosine	Chiarle R	Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target.	Nature medicine	2005	134
15922853	L-Tyrosine	Christensen JG	c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention.	Cancer letters	2005	120
15967113	L-Tyrosine	Hu X	mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.	Neoplasia	2005	65
16124853	L-Tyrosine	Tartaglia M	Noonan syndrome and related disorders: genetics and pathogenesis.	Annual review of genomics and human genetics	2005	89
16413489	L-Tyrosine	Foo SS	Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly.	Cell	2006	145
16452222	L-Tyrosine	Konecny GE	Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells.	Cancer research	2006	223
16452232	L-Tyrosine	Burgess T	Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors.	Cancer research	2006	67
16507829	L-Tyrosine	Carlomagno F	BAY 43-9006 inhibition of oncogenic RET mutants.	Journal of the National Cancer Institute	2006	94
16507911	L-Tyrosine	Trevino JG	Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model.	The American journal of pathology	2006	71
16585512	L-Tyrosine	Vajkoczy P	Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival.	Proceedings of the National Academy of Sciences of the United States of America	2006	76
16648858	L-Tyrosine	Ferby I	Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation.	Nature medicine	2006	95
16651418	L-Tyrosine	Cabodi S	p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.	Cancer research	2006	65
16672372	L-Tyrosine	Ji H	Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors.	Proceedings of the National Academy of Sciences of the United States of America	2006	73
16682621	L-Tyrosine	Xin L	Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor.	Proceedings of the National Academy of Sciences of the United States of America	2006	60
16738850	L-Tyrosine	Roovers RC	Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR Nanobodies.	Cancer immunology, immunotherapy 	2007	58
16845389	L-Tyrosine	Bence KK	Neuronal PTP1B regulates body weight, adiposity and leptin action.	Nature medicine	2006	174
16862147	L-Tyrosine	Noren NK	The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway.	Nature cell biology	2006	96
16901783	L-Tyrosine	Guo W	Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis.	Cell	2006	177
17030180	L-Tyrosine	Janssen KP	APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.	Gastroenterology	2006	94
17060635	L-Tyrosine	Zhao JJ	The p110alpha isoform of PI3K is essential for proper growth factor signaling and oncogenic transformation.	Proceedings of the National Academy of Sciences of the United States of America	2006	80
17062691	L-Tyrosine	Martens T	A novel one-armed anti-c-Met antibody inhibits glioblastoma growth in vivo.	Clinical cancer research 	2006	91
17129786	L-Tyrosine	Wildenberg GA	p120-catenin and p190RhoGAP regulate cell-cell adhesion by coordinating antagonism between Rac and Rho.	Cell	2006	179
17183644	L-Tyrosine	Zaleskas VM	Molecular pathogenesis and therapy of polycythemia induced in mice by JAK2 V617F.	PloS one	2006	76
17259984	L-Tyrosine	Julien SG	Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis.	Nature genetics	2007	75
17290308	L-Tyrosine	Zhang H	PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR.	The Journal of clinical investigation	2007	121
17308108	L-Tyrosine	Sawada K	c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion.	Cancer research	2007	92
17347513	L-Tyrosine	Bentires-Alj M	Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer.	Cancer research	2007	64
17363608	L-Tyrosine	Lin MI	Caveolin-1-deficient mice have increased tumor microvascular permeability, angiogenesis, and growth.	Cancer research	2007	60
17409396	L-Tyrosine	Nicoli S	Mammalian tumor xenografts induce neovascularization in zebrafish embryos.	Cancer research	2007	59
17446858	L-Tyrosine	Ursini-Siegel J	Insights from transgenic mouse models of ERBB2-induced breast cancer.	Nature reviews. Cancer	2007	97
17541402	L-Tyrosine	Pardanani A	TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations.	Leukemia	2007	71
17613438	L-Tyrosine	Li D	Bronchial and peripheral murine lung carcinomas induced by T790M-L858R mutant EGFR respond to HKI-272 and rapamycin combination therapy.	Cancer cell	2007	79
17620431	L-Tyrosine	Kumar R	Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity.	Molecular cancer therapeutics	2007	111
17625570	L-Tyrosine	Soda M	Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.	Nature	2007	1116
17699871	L-Tyrosine	Ritter CA	Human breast cancer cells selected for resistance to trastuzumab in vivo overexpress epidermal growth factor receptor and ErbB ligands and remain dependent on the ErbB receptor network.	Clinical cancer research 	2007	172
17724080	L-Tyrosine	Delibegovic M	Improved glucose homeostasis in mice with muscle-specific deletion of protein-tyrosine phosphatase 1B.	Molecular and cellular biology	2007	57
17785413	L-Tyrosine	Tward AD	Distinct pathways of genomic progression to benign and malignant tumors of the liver.	Proceedings of the National Academy of Sciences of the United States of America	2007	71
17927446	L-Tyrosine	Gong Y	Induction of BIM is essential for apoptosis triggered by EGFR kinase inhibitors in mutant EGFR-dependent lung adenocarcinomas.	PLoS medicine	2007	118
17943726	L-Tyrosine	Matsui J	E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibition.	International journal of cancer	2008	54
17999740	L-Tyrosine	Sibilia M	The epidermal growth factor receptor: from development to tumorigenesis.	Differentiation; research in biological diversity	2007	90
18023370	L-Tyrosine	Van Laethem F	Deletion of CD4 and CD8 coreceptors permits generation of alphabetaT cells that recognize antigens independently of the MHC.	Immunity	2007	67
18079969	L-Tyrosine	Brantley-Sieders DM	The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.	The Journal of clinical investigation	2008	95
18192401	L-Tyrosine	Ohnishi N	Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse.	Proceedings of the National Academy of Sciences of the United States of America	2008	172
18195107	L-Tyrosine	Lim Y	PyK2 and FAK connections to p190Rho guanine nucleotide exchange factor regulate RhoA activity, focal adhesion formation, and cell motility.	The Journal of cell biology	2008	92
18230792	L-Tyrosine	Zhang W	Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia.	Journal of the National Cancer Institute	2008	109
18281274	L-Tyrosine	Zabolotny JM	Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo.	The Journal of biological chemistry	2008	91
18391070	L-Tyrosine	Weis SM	Compensatory role for Pyk2 during angiogenesis in adult mice lacking endothelial cell FAK.	The Journal of cell biology	2008	65
18431473	L-Tyrosine	Curtin JF	Treg depletion inhibits efficacy of cancer immunotherapy: implications for clinical trials.	PloS one	2008	51
18451159	L-Tyrosine	Park SI	Targeting SRC family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse model.	Cancer research	2008	103
18477770	L-Tyrosine	Porkka K	Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia.	Blood	2008	64
18559524	L-Tyrosine	Hilberg F	BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy.	Cancer research	2008	140
18568074	L-Tyrosine	Guix M	Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins.	The Journal of clinical investigation	2008	177
18594512	L-Tyrosine	Tammela T	Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation.	Nature	2008	224
18606858	L-Tyrosine	Sun JC	Tolerance of NK cells encountering their viral ligand during development.	The Journal of experimental medicine	2008	51
18620091	L-Tyrosine	Wagh PK	Met-related receptor tyrosine kinase Ron in tumor growth and metastasis.	Advances in cancer research	2008	58
18632637	L-Tyrosine	Shimamura T	Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance.	Cancer research	2008	57
18800267	L-Tyrosine	Burgess AW	EGFR family: structure physiology signalling and therapeutic targets.	Growth factors	2008	73
18818206	L-Tyrosine	Nasser MW	Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1.	The Journal of biological chemistry	2008	137
18829493	L-Tyrosine	Huynh H	Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma.	Clinical cancer research 	2008	59
18948590	L-Tyrosine	Cooper MA	Loss of ephrin-A5 function disrupts lens fiber cell packing and leads to cataract.	Proceedings of the National Academy of Sciences of the United States of America	2008	51
19064915	L-Tyrosine	Soda M	A mouse model for EML4-ALK-positive lung cancer.	Proceedings of the National Academy of Sciences of the United States of America	2008	131
19074988	L-Tyrosine	Delibegovic M	Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress.	Diabetes	2009	82
19144821	L-Tyrosine	Buschman MD	The novel adaptor protein Tks4 (SH3PXD2B) is required for functional podosome formation.	Molecular biology of the cell	2009	64
19169797	L-Tyrosine	Zhao J	Signal transduction by focal adhesion kinase in cancer.	Cancer metastasis reviews	2009	187
19179468	L-Tyrosine	Chan G	Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis.	Blood	2009	53
19208839	L-Tyrosine	Nasarre P	Host-derived angiopoietin-2 affects early stages of tumor development and vessel maturation but is dispensable for later stages of tumor growth.	Cancer research	2009	47
19244130	L-Tyrosine	Parri M	EphA2 reexpression prompts invasion of melanoma cells shifting from mesenchymal to amoeboid-like motility style.	Cancer research	2009	48
19249681	L-Tyrosine	Ebos JM	Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis.	Cancer cell	2009	509
19255442	L-Tyrosine	Belkina NV	LOK is a major ERM kinase in resting lymphocytes and regulates cytoskeletal rearrangement through ERM phosphorylation.	Proceedings of the National Academy of Sciences of the United States of America	2009	47
19276342	L-Tyrosine	Ozao-Choy J	The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies.	Cancer research	2009	161
19330021	L-Tyrosine	Lagadec C	TrkA overexpression enhances growth and metastasis of breast cancer cells.	Oncogene	2009	49
19349464	L-Tyrosine	Nair MG	Alternatively activated macrophage-derived RELM-{alpha} is a negative regulator of type 2 inflammation in the lung.	The Journal of experimental medicine	2009	108
19364815	L-Tyrosine	Pedersen K	A naturally occurring HER2 carboxy-terminal fragment promotes mammary tumor growth and metastasis.	Molecular and cellular biology	2009	47
19414595	L-Tyrosine	Smit MA	A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis.	Molecular and cellular biology	2009	64
19435801	L-Tyrosine	Tomar A	A FAK-p120RasGAP-p190RhoGAP complex regulates polarity in migrating cells.	Journal of cell science	2009	54
19491323	L-Tyrosine	Chen Y	P-glycoprotein and breast cancer resistance protein influence brain distribution of dasatinib.	The Journal of pharmacology and experimental therapeutics	2009	51
19617568	L-Tyrosine	Ponzo MG	Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer.	Proceedings of the National Academy of Sciences of the United States of America	2009	82
19620785	L-Tyrosine	Taulli R	The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation.	The Journal of clinical investigation	2009	103
19684613	L-Tyrosine	Li C	Nuclear EGFR contributes to acquired resistance to cetuximab.	Oncogene	2009	96
19759520	L-Tyrosine	Regales L	Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer.	The Journal of clinical investigation	2009	119
19789626	L-Tyrosine	Dubreuil P	Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.	PloS one	2009	59
19809159	L-Tyrosine	Taylor JG 6th	Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models.	The Journal of clinical investigation	2009	81
19828702	L-Tyrosine	Wang Y	Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cells.	Blood	2009	50
19843665	L-Tyrosine	Wang W	Crosstalk to stromal fibroblasts induces resistance of lung cancer to epidermal growth factor receptor tyrosine kinase inhibitors.	Clinical cancer research 	2009	69
20038814	L-Tyrosine	Ma J	Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade.	The Journal of clinical investigation	2010	76
20067773	L-Tyrosine	Zhang X	A novel small-molecule disrupts Stat3 SH2 domain-phosphotyrosine interactions and Stat3-dependent tumor processes.	Biochemical pharmacology	2010	52
20068149	L-Tyrosine	Novosyadlyy R	Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes.	Cancer research	2010	96
20072130	L-Tyrosine	Janes MR	Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor.	Nature medicine	2010	137
20072652	L-Tyrosine	Lin L	A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells.	Neoplasia	2010	54
20130650	L-Tyrosine	Naka K	TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia.	Nature	2010	152
20145120	L-Tyrosine	Holland SJ	R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer.	Cancer research	2010	121
20197548	L-Tyrosine	Akada H	Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease.	Blood	2010	86
20333297	L-Tyrosine	Mahajan K	Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation.	PloS one	2010	48
20371352	L-Tyrosine	Bais C	PlGF blockade does not inhibit angiogenesis during primary tumor growth.	Cell	2010	51
20385788	L-Tyrosine	Tyner JW	CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms.	Blood	2010	63
20406969	L-Tyrosine	Ko JS	Direct and differential suppression of myeloid-derived suppressor cell subsets by sunitinib is compartmentally constrained.	Cancer research	2010	85
20442405	L-Tyrosine	Lim ST	Knock-in mutation reveals an essential role for focal adhesion kinase activity in blood vessel morphogenesis and cell motility-polarity but not cell proliferation.	The Journal of biological chemistry	2010	40
20445537	L-Tyrosine	Wang Y	Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.	Nature	2010	265
20457905	L-Tyrosine	Ulanet DB	Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy.	Proceedings of the National Academy of Sciences of the United States of America	2010	86
20460524	L-Tyrosine	Dey JH	Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.	Cancer research	2010	55
20501804	L-Tyrosine	Hammers HJ	Reversible epithelial to mesenchymal transition and acquired resistance to sunitinib in patients with renal cell carcinoma: evidence from a xenograft study.	Molecular cancer therapeutics	2010	56
20519932	L-Tyrosine	Pavlides S	Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the "reverse Warburg effect": a transcriptional informatics analysis with validation.	Cell cycle	2010	98
20615965	L-Tyrosine	Honigberg LA	The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy.	Proceedings of the National Academy of Sciences of the United States of America	2010	276
20713723	L-Tyrosine	Yao Z	TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer.	Proceedings of the National Academy of Sciences of the United States of America	2010	110
20856934	L-Tyrosine	Gong Y	Wnt isoform-specific interactions with coreceptor specify inhibition or potentiation of signaling by LRP6 antibodies.	PloS one	2010	41
20924128	L-Tyrosine	Buck E	Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale for cotargeting IGF-1R and IR in cancer.	Molecular cancer therapeutics	2010	74
21037017	L-Tyrosine	Chang TH	Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor.	American journal of respiratory and critical care medicine	2011	41
21057535	L-Tyrosine	Vuoriluoto K	Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer.	Oncogene	2011	153
21119598	L-Tyrosine	Mitra AK	Ligand-independent activation of c-Met by fibronectin and α(5)β(1)-integrin regulates ovarian cancer invasion and metastasis.	Oncogene	2011	81
21151131	L-Tyrosine	Griffiths DS	LIF-independent JAK signalling to chromatin in embryonic stem cells uncovered from an adult stem cell disease.	Nature cell biology	2011	38
21170960	L-Tyrosine	Wilhelm SM	Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity.	International journal of cancer	2011	169
21199794	L-Tyrosine	Zha X	Lactate dehydrogenase B is critical for hyperactive mTOR-mediated tumorigenesis.	Cancer research	2011	37
21216930	L-Tyrosine	Song L	JAK1 activates STAT3 activity in non-small-cell lung cancer cells and IL-6 neutralizing antibodies can suppress JAK1-STAT3 signaling.	Molecular cancer therapeutics	2011	38
21237299	L-Tyrosine	Greten TF	Myeloid derived suppressor cells in human diseases.	International immunopharmacology	2011	112
21324877	L-Tyrosine	Choufani S	A novel approach identifies new differentially methylated regions (DMRs) associated with imprinted genes.	Genome research	2011	43
21325052	L-Tyrosine	Sun Q	Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth.	Proceedings of the National Academy of Sciences of the United States of America	2011	150
21350004	L-Tyrosine	Vanhecke E	Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival.	Clinical cancer research 	2011	36
21354226	L-Tyrosine	Tai WT	Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma.	Journal of hepatology	2011	46
21383697	L-Tyrosine	Oneyama C	MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways.	Oncogene	2011	44
21398220	L-Tyrosine	Chan G	Essential role for Ptpn11 in survival of hematopoietic stem and progenitor cells.	Blood	2011	36
21422473	L-Tyrosine	Herman SE	Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765.	Blood	2011	188
21504625	L-Tyrosine	Yuan Y	Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP.	Journal of hematology & oncology	2011	40
21586612	L-Tyrosine	Corcoran RB	STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis.	Cancer research	2011	113
21712475	L-Tyrosine	Rai K	Liposomal delivery of MicroRNA-7-expressing plasmid overcomes epidermal growth factor receptor tyrosine kinase inhibitor-resistance in lung cancer cells.	Molecular cancer therapeutics	2011	41
21809363	L-Tyrosine	Zhang JF	Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling.	Hepatology	2011	39
21810604	L-Tyrosine	Sharda DR	Regulation of macrophage arginase expression and tumor growth by the Ron receptor tyrosine kinase.	Journal of immunology	2011	41
21810913	L-Tyrosine	Noman MZ	Blocking hypoxia-induced autophagy in tumors restores cytotoxic T-cell activity and promotes regression.	Cancer research	2011	47
21908557	L-Tyrosine	Fox EM	A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer.	Cancer research	2011	58
21926191	L-Tyrosine	Yakes FM	Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth.	Molecular cancer therapeutics	2011	173
21975932	L-Tyrosine	Jin X	EGFR-AKT-Smad signaling promotes formation of glioma stem-like cells and tumor angiogenesis by ID3-driven cytokine induction.	Cancer research	2011	45
21984450	L-Tyrosine	Lechertier T	Focal adhesion kinase and tumour angiogenesis.	The Journal of pathology	2012	36
21985784	L-Tyrosine	Ebi H	Receptor tyrosine kinases exert dominant control over PI3K signaling in human KRAS mutant colorectal cancers.	The Journal of clinical investigation	2011	69
21996738	L-Tyrosine	Feng H	Dynamin 2 mediates PDGFRα-SHP-2-promoted glioblastoma growth and invasion.	Oncogene	2012	33
22057914	L-Tyrosine	Cheng Y	MK-2206, a novel allosteric inhibitor of Akt, synergizes with gefitinib against malignant glioma via modulating both autophagy and apoptosis.	Molecular cancer therapeutics	2012	40
22080864	L-Tyrosine	Feng H	Activation of Rac1 by Src-dependent phosphorylation of Dock180(Y1811) mediates PDGFRα-stimulated glioma tumorigenesis in mice and humans.	The Journal of clinical investigation	2011	39
22105169	L-Tyrosine	Fukuoka H	EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas.	The Journal of clinical investigation	2011	37
22180443	L-Tyrosine	Ponader S	The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo.	Blood	2012	171
22203239	L-Tyrosine	Mineo M	Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a Src-dependent fashion.	Angiogenesis	2012	65
22207735	L-Tyrosine	Yuan H	Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis.	Blood	2012	53
22238366	L-Tyrosine	Gozgit JM	Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models.	Molecular cancer therapeutics	2012	71
22264731	L-Tyrosine	Chen XL	VEGF-induced vascular permeability is mediated by FAK.	Developmental cell	2012	87
22286129	L-Tyrosine	Hantschel O	BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia.	Nature chemical biology	2012	57
22307624	L-Tyrosine	Drake JM	Oncogene-specific activation of tyrosine kinase networks during prostate cancer progression.	Proceedings of the National Academy of Sciences of the United States of America	2012	43
22317763	L-Tyrosine	Wang W	Met kinase inhibitor E7050 reverses three different mechanisms of hepatocyte growth factor-induced tyrosine kinase inhibitor resistance in EGFR mutant lung cancer.	Clinical cancer research 	2012	32
22322096	L-Tyrosine	Stokes MP	PTMScan direct: identification and quantification of peptides from critical signaling proteins by immunoaffinity enrichment coupled with LC-MS/MS.	Molecular & cellular proteomics 	2012	35
22343031	L-Tyrosine	Holopainen T	Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis.	Journal of the National Cancer Institute	2012	62
22354171	L-Tyrosine	Malinge S	Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome.	The Journal of clinical investigation	2012	35
22368270	L-Tyrosine	Man CH	Sorafenib treatment of FLT3-ITD(+) acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation.	Blood	2012	62
22500798	L-Tyrosine	Duncan JS	Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer.	Cell	2012	190
22541434	L-Tyrosine	Kumar MS	The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer.	Cell	2012	94
22635005	L-Tyrosine	Peinado H	Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET.	Nature medicine	2012	678
22641068	L-Tyrosine	Buurman R	Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.	Gastroenterology	2012	52
22689860	L-Tyrosine	Tai YT	Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma.	Blood	2012	48
22705009	L-Tyrosine	Ma S	Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.	Gastroenterology	2012	30
22713237	L-Tyrosine	Carrassa L	Combined inhibition of Chk1 and Wee1: in vitro synergistic effect translates to tumor growth inhibition in vivo.	Cell cycle	2012	37
22777352	L-Tyrosine	Gil-Henn H	Arg/Abl2 promotes invasion and attenuates proliferation of breast cancer in vivo.	Oncogene	2013	37
22806877	L-Tyrosine	Shimamura T	Ganetespib (STA-9090), a nongeldanamycin HSP90 inhibitor, has potent antitumor activity in in vitro and in vivo models of non-small cell lung cancer.	Clinical cancer research 	2012	42
22837387	L-Tyrosine	Singh D	Transforming fusions of FGFR and TACC genes in human glioblastoma.	Science	2012	184
22844075	L-Tyrosine	Nakagawa T	Combined therapy with mutant-selective EGFR inhibitor and Met kinase inhibitor for overcoming erlotinib resistance in EGFR-mutant lung cancer.	Molecular cancer therapeutics	2012	31
22890323	L-Tyrosine	Linger RM	Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer.	Oncogene	2013	44
22891351	L-Tyrosine	Couto JP	STAT3 negatively regulates thyroid tumorigenesis.	Proceedings of the National Academy of Sciences of the United States of America	2012	43
22908275	L-Tyrosine	Greulich H	Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2.	Proceedings of the National Academy of Sciences of the United States of America	2012	73
22941188	L-Tyrosine	Peifer M	Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer.	Nature genetics	2012	256
22958930	L-Tyrosine	Chu SH	FLT3-ITD knockin impairs hematopoietic stem cell quiescence/homeostasis, leading to myeloproliferative neoplasm.	Cell stem cell	2012	40
23027128	L-Tyrosine	Zheng Y	Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT.	Oncogene	2013	25
23063650	L-Tyrosine	Tiwari AK	Nilotinib potentiates anticancer drug sensitivity in murine ABCB1-, ABCG2-, and ABCC10-multidrug resistance xenograft models.	Cancer letters	2013	28
23085373	L-Tyrosine	Mohapatra B	Protein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligases.	Biochimica et biophysica acta	2013	55
23104879	L-Tyrosine	Odiete O	Neuregulin in cardiovascular development and disease.	Circulation research	2012	46
23108136	L-Tyrosine	Terme M	VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancer.	Cancer research	2013	70
23209031	L-Tyrosine	Gerdes CA	GA201 (RG7160): a novel, humanized, glycoengineered anti-EGFR antibody with enhanced ADCC and superior in vivo efficacy compared with cetuximab.	Clinical cancer research 	2013	31
23242808	L-Tyrosine	Girotti MR	Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma.	Cancer discovery	2013	106
23246963	L-Tyrosine	Montero JC	Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer.	Oncogene	2014	29
23248284	L-Tyrosine	Choi BD	Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma.	Proceedings of the National Academy of Sciences of the United States of America	2013	39
23259948	L-Tyrosine	Burstyn-Cohen T	Genetic dissection of TAM receptor-ligand interaction in retinal pigment epithelial cell phagocytosis.	Neuron	2012	44
23299311	L-Tyrosine	Zhang B	Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-β-catenin signaling.	Blood	2013	70
23318419	L-Tyrosine	Brouxhon SM	Soluble E-cadherin: a critical oncogene modulating receptor tyrosine kinases, MAPK and PI3K/Akt/mTOR signaling.	Oncogene	2014	22
23325226	L-Tyrosine	Lou S	Runx1 controls terminal morphology and mechanosensitivity of VGLUT3-expressing C-mechanoreceptors.	The Journal of neuroscience 	2013	44
23334327	L-Tyrosine	Do TV	Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion.	Oncogene	2014	35
23418360	L-Tyrosine	Du WW	MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling.	Journal of cell science	2013	44
23441129	L-Tyrosine	Walters DM	Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib.	Neoplasia	2013	28
23454899	L-Tyrosine	Molina-Arcas M	Coordinate direct input of both KRAS and IGF1 receptor to activation of PI3 kinase in KRAS-mutant lung cancer.	Cancer discovery	2013	37
23484006	L-Tyrosine	Navis AC	Effects of dual targeting of tumor cells and stroma in human glioblastoma xenografts with a tyrosine kinase inhibitor against c-MET and VEGFR2.	PloS one	2013	28
23509284	L-Tyrosine	Knight JF	Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancer.	Proceedings of the National Academy of Sciences of the United States of America	2013	28
23532334	L-Tyrosine	Bean GR	PUMA and BIM are required for oncogene inactivation-induced apoptosis.	Science signaling	2013	36
23583981	L-Tyrosine	Zhang J	Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas.	Nature genetics	2013	151
23585477	L-Tyrosine	Schlegel J	MERTK receptor tyrosine kinase is a therapeutic target in melanoma.	The Journal of clinical investigation	2013	46
23603816	L-Tyrosine	Jameson KL	IQGAP1 scaffold-kinase interaction blockade selectively targets RAS-MAP kinase-driven tumors.	Nature medicine	2013	51
23619564	L-Tyrosine	Herman SE	Modeling tumor-host interactions of chronic lymphocytic leukemia in xenografted mice to study tumor biology and evaluate targeted therapy.	Leukemia	2013	27
23620405	L-Tyrosine	Hudecek M	Receptor affinity and extracellular domain modifications affect tumor recognition by ROR1-specific chimeric antigen receptor T cells.	Clinical cancer research 	2013	105
23630186	L-Tyrosine	Gassenmaier M	CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.	Stem cells	2013	27
23720580	L-Tyrosine	Chintalgattu V	Coronary microvascular pericytes are the cellular target of sunitinib malate-induced cardiotoxicity.	Science translational medicine	2013	28
23737459	L-Tyrosine	Lonskaya I	Tyrosine kinase inhibition increases functional parkin-Beclin-1 interaction and enhances amyloid clearance and cognitive performance.	EMBO molecular medicine	2013	25
23771907	L-Tyrosine	Cui B	Targeting ROR1 inhibits epithelial-mesenchymal transition and metastasis.	Cancer research	2013	33
23818496	L-Tyrosine	Graveel CR	MET: a critical player in tumorigenesis and therapeutic target.	Cold Spring Harbor perspectives in biology	2013	33
23863940	L-Tyrosine	Yang W	Ptpn11 deletion in a novel progenitor causes metachondromatosis by inducing hedgehog signalling.	Nature	2013	41
23867499	L-Tyrosine	Cook RS	MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis.	The Journal of clinical investigation	2013	28
23878224	L-Tyrosine	Bosurgi L	Paradoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancer.	Proceedings of the National Academy of Sciences of the United States of America	2013	38
23970380	L-Tyrosine	Walker CJ	Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias.	Blood	2013	40
24011590	L-Tyrosine	Francavilla C	Functional proteomics defines the molecular switch underlying FGF receptor trafficking and cellular outputs.	Molecular cell	2013	26
24046014	L-Tyrosine	Zimmerman EI	Crenolanib is active against models of drug-resistant FLT3-ITD-positive acute myeloid leukemia.	Blood	2013	43
24122810	L-Tyrosine	Arai Y	Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma.	Hepatology	2014	45
24165158	L-Tyrosine	Rho JK	MET and AXL inhibitor NPS-1034 exerts efficacy against lung cancer cells resistant to EGFR kinase inhibitors because of MET or AXL activation.	Cancer research	2014	30
24216507	L-Tyrosine	Chen X	Induction of myelodysplasia by myeloid-derived suppressor cells.	The Journal of clinical investigation	2013	42
24247719	L-Tyrosine	Mok S	Inhibition of CSF-1 receptor improves the antitumor efficacy of adoptive cell transfer immunotherapy.	Cancer research	2014	62
24311722	L-Tyrosine	Woyach JA	Bruton's tyrosine kinase (BTK) function is important to the development and expansion of chronic lymphocytic leukemia (CLL).	Blood	2014	48
24379361	L-Tyrosine	Widhopf GF 2nd	ROR1 can interact with TCL1 and enhance leukemogenesis in Eμ-TCL1 transgenic mice.	Proceedings of the National Academy of Sciences of the United States of America	2014	22
24401374	L-Tyrosine	Fantin A	Neuropilin 1 (NRP1) hypomorphism combined with defective VEGF-A binding reveals novel roles for NRP1 in developmental and pathological angiogenesis.	Development	2014	35
24421390	L-Tyrosine	Wang JY	The capable ABL: what is its biological function?	Molecular and cellular biology	2014	29
24440149	L-Tyrosine	Nabekura T	Costimulatory molecule DNAM-1 is essential for optimal differentiation of memory natural killer cells during mouse cytomegalovirus infection.	Immunity	2014	41
24440599	L-Tyrosine	Kats LM	Proto-oncogenic role of mutant IDH2 in leukemia initiation and maintenance.	Cell stem cell	2014	44
24446483	L-Tyrosine	Jean C	Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function.	The Journal of cell biology	2014	27
24451154	L-Tyrosine	Rexer BN	Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells.	Breast cancer research 	2014	23
24535670	L-Tyrosine	de Bruin EC	Reduced NF1 expression confers resistance to EGFR inhibition in lung cancer.	Cancer discovery	2014	42
24553136	L-Tyrosine	Paolino M	The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells.	Nature	2014	80
24656836	L-Tyrosine	Zhang Y	Activation of vascular endothelial growth factor receptor-3 in macrophages restrains TLR4-NF-κB signaling and protects against endotoxin shock.	Immunity	2014	25
24658326	L-Tyrosine	Knubel KH	MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme.	Oncotarget	2014	22
24681959	L-Tyrosine	Bharadwaj U	Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer.	Oncogene	2015	30
24747441	L-Tyrosine	Seguin L	An integrin β₃-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition.	Nature cell biology	2014	77
24747973	L-Tyrosine	Eden CJ	Orthotopic models of pediatric brain tumors in zebrafish.	Oncogene	2015	15
24813888	L-Tyrosine	Pirazzoli V	Acquired resistance of EGFR-mutant lung adenocarcinomas to afatinib plus cetuximab is associated with activation of mTORC1.	Cell reports	2014	23
24911146	L-Tyrosine	Park KS	CRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistance.	The Journal of clinical investigation	2014	20
24939055	L-Tyrosine	Qu Y	Antitumor activity of selective MEK1/2 inhibitor AZD6244 in combination with PI3K/mTOR inhibitor BEZ235 in gefitinib-resistant NSCLC xenograft models.	Journal of experimental & clinical cancer research 	2014	24
24957147	L-Tyrosine	Gallipoli P	JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34+ cells in vitro and in vivo.	Blood	2014	24
25053825	L-Tyrosine	Fiskus W	BET protein antagonist JQ1 is synergistically lethal with FLT3 tyrosine kinase inhibitor (TKI) and overcomes resistance to FLT3-TKI in AML cells expressing FLT-ITD.	Molecular cancer therapeutics	2014	40
25066121	L-Tyrosine	Porporato PE	A mitochondrial switch promotes tumor metastasis.	Cell reports	2014	80
25193870	L-Tyrosine	Degryse S	JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model.	Blood	2014	27
25207766	L-Tyrosine	Roberts KG	Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.	The New England journal of medicine	2014	178
25214559	L-Tyrosine	Gao W	Selective antitumor activity of ibrutinib in EGFR-mutant non-small cell lung cancer cells.	Journal of the National Cancer Institute	2014	22
25248370	L-Tyrosine	Yan X	miR-143 and miR-145 synergistically regulate ERBB3 to suppress cell proliferation and invasion in breast cancer.	Molecular cancer	2014	35
25250573	L-Tyrosine	Stanford JC	Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution.	The Journal of clinical investigation	2014	24
25267792	L-Tyrosine	Jia XM	CARD9 mediates Dectin-1-induced ERK activation by linking Ras-GRF1 to H-Ras for antifungal immunity.	The Journal of experimental medicine	2014	24
25381264	L-Tyrosine	Ciamporcero E	Combination strategy targeting VEGF and HGF/c-met in human renal cell carcinoma models.	Molecular cancer therapeutics	2015	19
25383899	L-Tyrosine	Lee YS	Mechanism and treatment for learning and memory deficits in mouse models of Noonan syndrome.	Nature neuroscience	2014	25
25391651	L-Tyrosine	Liang H	miR-193a-3p functions as a tumor suppressor in lung cancer by down-regulating ERBB4.	The Journal of biological chemistry	2015	20
25411317	L-Tyrosine	Zhang S	Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy.	Proceedings of the National Academy of Sciences of the United States of America	2014	38
25446031	L-Tyrosine	Busada JT	Retinoic acid regulates Kit translation during spermatogonial differentiation in the mouse.	Developmental biology	2015	18
25529917	L-Tyrosine	Chen Y	CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice.	Hepatology	2015	47
25572173	L-Tyrosine	Ran L	Combined inhibition of MAP kinase and KIT signaling synergistically destabilizes ETV1 and suppresses GIST tumor growth.	Cancer discovery	2015	22
25635707	L-Tyrosine	Hakanpaa L	Endothelial destabilization by angiopoietin-2 via integrin β1 activation.	Nature communications	2015	36
25644060	L-Tyrosine	Raimondo S	Chronic myeloid leukemia-derived exosomes promote tumor growth through an autocrine mechanism.	Cell communication and signaling 	2015	24
25646015	L-Tyrosine	Gritsina G	Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth.	Molecular cancer therapeutics	2015	17
25658601	L-Tyrosine	Bertaux-Skeirik N	CD44 plays a functional role in Helicobacter pylori-induced epithelial cell proliferation.	PLoS pathogens	2015	25
25662332	L-Tyrosine	Sagiv-Barfi I	Ibrutinib enhances the antitumor immune response induced by intratumoral injection of a TLR9 ligand in mouse lymphoma.	Blood	2015	18
25663685	L-Tyrosine	Eke I	Simultaneous β1 integrin-EGFR targeting and radiosensitization of human head and neck cancer.	Journal of the National Cancer Institute	2015	22
25731159	L-Tyrosine	Taniguchi K	A gp130-Src-YAP module links inflammation to epithelial regeneration.	Nature	2015	84
25799995	L-Tyrosine	Chen Z	Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia.	Nature	2015	30
25838351	L-Tyrosine	Hing ZA	Selinexor is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemia.	Blood	2015	16
25852057	L-Tyrosine	Flynn R	Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease.	Blood	2015	19
25861727	L-Tyrosine	Costa PM	MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.	Journal of controlled release 	2015	22
25865556	L-Tyrosine	Han T	PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients.	Journal of hepatology	2015	19
25925741	L-Tyrosine	Dong S	The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.	Journal of hematology & oncology	2015	26
26168295	L-Tyrosine	Burggraaf J	Detection of colorectal polyps in humans using an intravenously administered fluorescent peptide targeted against c-Met.	Nature medicine	2015	31
26261265	L-Tyrosine	Qian BZ	FLT1 signaling in metastasis-associated macrophages activates an inflammatory signature that promotes breast cancer metastasis.	The Journal of experimental medicine	2015	21
26282169	L-Tyrosine	Soucheray M	Intratumoral Heterogeneity in EGFR-Mutant NSCLC Results in Divergent Resistance Mechanisms in Response to EGFR Tyrosine Kinase Inhibition.	Cancer research	2015	19
26286850	L-Tyrosine	Larrue C	Proteasome inhibitors induce FLT3-ITD degradation through autophagy in AML cells.	Blood	2016	14
26337386	L-Tyrosine	Lin CH	Microenvironment rigidity modulates responses to the HER2 receptor tyrosine kinase inhibitor lapatinib via YAP and TAZ transcription factors.	Molecular biology of the cell	2015	19
26444240	L-Tyrosine	Wiesner T	Alternative transcription initiation leads to expression of a novel ALK isoform in cancer.	Nature	2015	31
26459520	L-Tyrosine	Nurmi H	VEGF-C is required for intestinal lymphatic vessel maintenance and lipid absorption.	EMBO molecular medicine	2015	18
26545934	L-Tyrosine	Suzawa K	Antitumor effect of afatinib, as a human epidermal growth factor receptor 2-targeted therapy, in lung cancers harboring HER2 oncogene alterations.	Cancer science	2016	15
26582643	L-Tyrosine	Chen SS	BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemia.	Leukemia	2016	18
26655835	L-Tyrosine	Guo X	Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis.	Nature cell biology	2016	14
26660519	L-Tyrosine	Niemann CU	Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II Study.	Clinical cancer research 	2016	19
26701983	L-Tyrosine	Zhou X	Enhancer of Zeste Homolog 2 Inhibition Attenuates Renal Fibrosis by Maintaining Smad7 and Phosphatase and Tensin Homolog Expression.	Journal of the American Society of Nephrology 	2016	13
26715645	L-Tyrosine	Gunderson AJ	Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer.	Cancer discovery	2016	44
26786851	L-Tyrosine	Wang Y	Novel ALK inhibitor AZD3463 inhibits neuroblastoma growth by overcoming crizotinib resistance and inducing apoptosis.	Scientific reports	2016	14
26797476	L-Tyrosine	Achyut BR	Chimeric Mouse model to track the migration of bone marrow derived cells in glioblastoma following anti-angiogenic treatments.	Cancer biology & therapy	2016	10
26855149	L-Tyrosine	Ambrogio C	Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma.	Nature medicine	2016	20
26880800	L-Tyrosine	Stiff A	Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment.	Cancer research	2016	16
27013234	L-Tyrosine	Li P	αE-catenin inhibits a Src-YAP1 oncogenic module that couples tyrosine kinases and the effector of Hippo signaling pathway.	Genes & development	2016	15
27044097	L-Tyrosine	Peterson TE	Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages.	Proceedings of the National Academy of Sciences of the United States of America	2016	27
27213690	L-Tyrosine	Delconte RB	CIS is a potent checkpoint in NK cell-mediated tumor immunity.	Nature immunology	2016	20
27281222	L-Tyrosine	Abraham SA	Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells.	Nature	2016	23
27362227	L-Tyrosine	Chen YN	Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases.	Nature	2016	35
27595394	L-Tyrosine	Chen W	Targeting renal cell carcinoma with a HIF-2 antagonist.	Nature	2016	39
27783593	L-Tyrosine	Dong L	Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment.	Nature	2016	22
27913578	L-Tyrosine	Kobayashi Y	Characterization of EGFR T790M, L792F, and C797S Mutations as Mechanisms of Acquired Resistance to Afatinib in Lung Cancer.	Molecular cancer therapeutics	2017	8
28199309	L-Tyrosine	Compagno M	Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells.	Nature	2017	14
28271729	L-Tyrosine	Ahn MJ	EGFR TKI combination with immunotherapy in non-small cell lung cancer.	Expert opinion on drug safety	2017	10
28376152	L-Tyrosine	Chaib I	Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC.	Journal of the National Cancer Institute	2017	12
28414329	L-Tyrosine	Fischer K	Alternatively activated macrophages do not synthesize catecholamines or contribute to adipose tissue adaptive thermogenesis.	Nature medicine	2017	20
17210695	Vincristine	Iwanaga Y	Heterozygous deletion of mitotic arrest-deficient protein 1 (MAD1) increases the incidence of tumors in mice.	Cancer research	2007	63
17404107	Vincristine	Mohammad RM	Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1.	Clinical cancer research 	2007	60
19783987	Vincristine	Meacham CE	In vivo RNAi screening identifies regulators of actin dynamics as key determinants of lymphoma progression.	Nature genetics	2009	50
20542985	Vincristine	Cho D	Cytotoxicity of activated natural killer cells against pediatric solid tumors.	Clinical cancer research 	2010	65
21039467	Vincristine	Buhtoiarov IN	Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages.	Immunology	2011	40
23695022	Vincristine	Pasquier E	β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma.	British journal of cancer	2013	32
11701123	L-Lysine	Peters AH	Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability.	Cell	2001	471
12442173	L-Lysine	Bosanac I	Structure of the inositol 1,4,5-trisphosphate receptor binding core in complex with its ligand.	Nature	2002	83
14536086	L-Lysine	Wang H	mAM facilitates conversion by ESET of dimethyl to trimethyl lysine 9 of histone H3 to cause transcriptional repression.	Molecular cell	2003	91
14985713	L-Lysine	Gyory I	PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing.	Nature immunology	2004	121
15750587	L-Lysine	Gonzalo S	Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin.	Nature cell biology	2005	101
16195383	L-Lysine	Karnik SK	Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c.	Proceedings of the National Academy of Sciences of the United States of America	2005	100
16713561	L-Lysine	Massoumi R	Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling.	Cell	2006	146
17611497	L-Lysine	Carpten JD	A transforming mutation in the pleckstrin homology domain of AKT1 in cancer.	Nature	2007	387
17664295	L-Lysine	Langerak P	A/T mutagenesis in hypermutated immunoglobulin genes strongly depends on PCNAK164 modification.	The Journal of experimental medicine	2007	59
17943087	L-Lysine	Okada Y	Histone demethylase JHDM2A is critical for Tnp1 and Prm1 transcription and spermatogenesis.	Nature	2007	100
17967868	L-Lysine	Gupta A	The mammalian ortholog of Drosophila MOF that acetylates histone H4 lysine 16 is essential for embryogenesis and oncogenesis.	Molecular and cellular biology	2008	84
18280244	L-Lysine	Kurash JK	Methylation of p53 by Set7/9 mediates p53 acetylation and activity in vivo.	Molecular cell	2008	68
18787082	L-Lysine	Robertson AG	Genome-wide relationship between histone H3 lysine 4 mono- and tri-methylation and transcription factor binding.	Genome research	2008	88
19188440	L-Lysine	Misaghi S	Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1.	Molecular and cellular biology	2009	64
19433796	L-Lysine	Lee J	A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4.	Proceedings of the National Academy of Sciences of the United States of America	2009	64
19567879	L-Lysine	Ishii M	Epigenetic regulation of the alternatively activated macrophage phenotype.	Blood	2009	120
19575012	L-Lysine	Shaw T	Epigenetic reprogramming during wound healing: loss of polycomb-mediated silencing may enable upregulation of repair genes.	EMBO reports	2009	60
20018687	L-Lysine	Miyoshi N	Defined factors induce reprogramming of gastrointestinal cancer cells.	Proceedings of the National Academy of Sciences of the United States of America	2010	89
20093773	L-Lysine	Jin S	c-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis.	The Journal of clinical investigation	2010	49
20798234	L-Lysine	Feng Y	Early mammalian erythropoiesis requires the Dot1L methyltransferase.	Blood	2010	42
20818375	L-Lysine	Liu H	Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint.	Nature	2010	48
20959362	L-Lysine	Huang PH	Histone deacetylase inhibitors stimulate histone H3 lysine 4 methylation in part via transcriptional repression of histone H3 lysine 4 demethylases.	Molecular pharmacology	2011	40
21115810	L-Lysine	Cho HS	Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells.	Cancer research	2011	47
21317535	L-Lysine	Zhao R	Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers.	The Journal of clinical investigation	2011	39
21398221	L-Lysine	Jo SY	Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation.	Blood	2011	69
21551099	L-Lysine	Asp P	Genome-wide remodeling of the epigenetic landscape during myogenic differentiation.	Proceedings of the National Academy of Sciences of the United States of America	2011	112
21725364	L-Lysine	Niu X	The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C.	Oncogene	2012	48
21757686	L-Lysine	Tzatsos A	Lysine-specific demethylase 2B (KDM2B)-let-7-enhancer of zester homolog 2 (EZH2) pathway regulates cell cycle progression and senescence in primary cells.	The Journal of biological chemistry	2011	37
21764752	L-Lysine	Wang L	The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation.	Science	2011	59
21775285	L-Lysine	Sundaresan NR	The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy.	Science signaling	2011	83
21892211	L-Lysine	Taniguchi H	Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer.	Oncogene	2012	32
22045334	L-Lysine	Tang LY	Ablation of Smurf2 reveals an inhibition in TGF-β signalling through multiple mono-ubiquitination of Smad3.	The EMBO journal	2011	37
22053081	L-Lysine	Huang V	Upregulation of Cyclin B1 by miRNA and its implications in cancer.	Nucleic acids research	2012	91
22370893	L-Lysine	Au SL	Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis.	Hepatology	2012	73
22406747	L-Lysine	Schenk T	Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia.	Nature medicine	2012	134
22677129	L-Lysine	Tanaka S	Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia.	Blood	2012	57
22699452	L-Lysine	Sprüssel A	Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation.	Leukemia	2012	43
22722849	L-Lysine	Barber MF	SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation.	Nature	2012	111
23051747	L-Lysine	McCabe MT	EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations.	Nature	2012	430
23129632	L-Lysine	Luo W	Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression.	Proceedings of the National Academy of Sciences of the United States of America	2012	62
23178118	L-Lysine	Calabrese JM	Site-specific silencing of regulatory elements as a mechanism of X inactivation.	Cell	2012	60
23273982	L-Lysine	Cai L	An H3K36 methylation-engaging Tudor motif of polycomb-like proteins mediates PRC2 complex targeting.	Molecular cell	2013	55
23327920	L-Lysine	Heideman MR	Dosage-dependent tumor suppression by histone deacetylases 1 and 2 through regulation of c-Myc collaborating genes and p53 function.	Blood	2013	30
23361907	L-Lysine	Deshpande AJ	Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l.	Blood	2013	46
23543735	L-Lysine	Chen L	Lysine acetyltransferase GCN5 potentiates the growth of non-small cell lung cancer via promotion of E2F1, cyclin D1, and cyclin E1 expression.	The Journal of biological chemistry	2013	28
23545502	L-Lysine	Outchkourov NS	Balancing of histone H3K4 methylation states by the Kdm5c/SMCX histone demethylase modulates promoter and enhancer function.	Cell reports	2013	29
23576758	L-Lysine	Xu J	Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A.	Proceedings of the National Academy of Sciences of the United States of America	2013	51
23614352	L-Lysine	Konze KD	An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1.	ACS chemical biology	2013	105
23620515	L-Lysine	Knutson SK	Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2.	Proceedings of the National Academy of Sciences of the United States of America	2013	136
23624935	L-Lysine	Wang L	BRCA1 is a negative modulator of the PRC2 complex.	The EMBO journal	2013	38
23633675	L-Lysine	Ding X	Epigenetic activation of AP1 promotes squamous cell carcinoma metastasis.	Science signaling	2013	27
23686307	L-Lysine	Zou Z	Brd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelA.	Oncogene	2014	51
24081332	L-Lysine	Hu D	The MLL3/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers.	Molecular and cellular biology	2013	72
24200691	L-Lysine	Wagner KW	KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling.	The Journal of clinical investigation	2013	37
24200695	L-Lysine	Caganova M	Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis.	The Journal of clinical investigation	2013	46
24491801	L-Lysine	Kim JH	UTX and MLL4 coordinately regulate transcriptional programs for cell proliferation and invasiveness in breast cancer cells.	Cancer research	2014	38
24506869	L-Lysine	Sun RC	Hypoxic regulation of glutamine metabolism through HIF1 and SIAH2 supports lipid synthesis that is necessary for tumor growth.	Cell metabolism	2014	49
24516139	L-Lysine	Gonzalez ME	EZH2 expands breast stem cells through activation of NOTCH1 signaling.	Proceedings of the National Academy of Sciences of the United States of America	2014	43
24563539	L-Lysine	Knutson SK	Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphoma.	Molecular cancer therapeutics	2014	88
24582500	L-Lysine	Nam HJ	Phosphorylation of LSD1 by PKCα is crucial for circadian rhythmicity and phase resetting.	Molecular cell	2014	23
24656132	L-Lysine	Cheng J	A role for H3K4 monomethylation in gene repression and partitioning of chromatin readers.	Molecular cell	2014	50
24769394	L-Lysine	Wang YP	Regulation of G6PD acetylation by SIRT2 and KAT9 modulates NADPH homeostasis and cell survival during oxidative stress.	The EMBO journal	2014	34
24808134	L-Lysine	Thomson R	Evolution of the primate trypanolytic factor APOL1.	Proceedings of the National Academy of Sciences of the United States of America	2014	55
24816405	L-Lysine	Kryczek I	IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L.	Immunity	2014	59
24844570	L-Lysine	Chiba T	Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma.	International journal of cancer	2015	16
24847881	L-Lysine	Mazur PK	SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer.	Nature	2014	64
25101834	L-Lysine	Shpargel KB	KDM6 demethylase independent loss of histone H3 lysine 27 trimethylation during early embryonic development.	PLoS genetics	2014	27
25188243	L-Lysine	Popovic R	Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation.	PLoS genetics	2014	38
25393219	L-Lysine	Horne GA	Nanog requires BRD4 to maintain murine embryonic stem cell pluripotency and is suppressed by bromodomain inhibitor JQ1 together with Lefty1.	Stem cells and development	2015	17
25395428	L-Lysine	Xu B	Selective inhibition of EZH2 and EZH1 enzymatic activity by a small molecule suppresses MLL-rearranged leukemia.	Blood	2015	43
25419628	L-Lysine	Schliehe C	The methyltransferase Setdb2 mediates virus-induced susceptibility to bacterial superinfection.	Nature immunology	2015	26
25428914	L-Lysine	Zhang K	Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an EZH2 dependent manner.	Oncotarget	2015	53
25457167	L-Lysine	Saksouk N	Redundant mechanisms to form silent chromatin at pericentromeric regions rely on BEND3 and DNA methylation.	Molecular cell	2014	29
25477340	L-Lysine	Takeshima H	Identification of coexistence of DNA methylation and H3K27me3 specifically in cancer cells as a promising target for epigenetic therapy.	Carcinogenesis	2015	18
26132162	L-Lysine	Beerli RR	Sortase Enzyme-Mediated Generation of Site-Specifically Conjugated Antibody Drug Conjugates with High In Vitro and In Vivo Potency.	PloS one	2015	20
26328764	L-Lysine	Manna S	Histone H3 Lysine 27 demethylases Jmjd3 and Utx are required for T-cell differentiation.	Nature communications	2015	18
26366710	L-Lysine	Ortega-Molina A	The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development.	Nature medicine	2015	34
26437366	L-Lysine	LaFave LM	Loss of BAP1 function leads to EZH2-dependent transformation.	Nature medicine	2015	40
26459390	L-Lysine	Wan L	Aspirin, lysine, mifepristone and doxycycline combined can effectively and safely prevent and treat cancer metastasis: prevent seeds from gemmating on soil.	Oncotarget	2015	15
26503055	L-Lysine	Peng D	Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy.	Nature	2015	84
26551560	L-Lysine	Zylicz JJ	Chromatin dynamics and the role of G9a in gene regulation and enhancer silencing during early mouse development.	eLife	2015	18
26590165	L-Lysine	Hernando H	EZH2 Inhibition Blocks Multiple Myeloma Cell Growth through Upregulation of Epithelial Tumor Suppressor Genes.	Molecular cancer therapeutics	2016	16
26659182	L-Lysine	Cheloufi S	The histone chaperone CAF-1 safeguards somatic cell identity.	Nature	2015	24
26746851	L-Lysine	Choi SJ	HDAC6 regulates cellular viral RNA sensing by deacetylation of RIG-I.	The EMBO journal	2016	11
26748827	L-Lysine	Wienken M	MDM2 Associates with Polycomb Repressor Complex 2 and Enhances Stemness-Promoting Chromatin Modifications Independent of p53.	Molecular cell	2016	15
26757928	L-Lysine	Kim Y	Methylation-dependent regulation of HIF-1α stability restricts retinal and tumour angiogenesis.	Nature communications	2016	12
26942676	L-Lysine	Pan JA	TRIM21 Ubiquitylates SQSTM1/p62 and Suppresses Protein Sequestration to Regulate Redox Homeostasis.	Molecular cell	2016	13
26970896	L-Lysine	Feng Z	Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia.	Journal of hematology & oncology	2016	18
27135738	L-Lysine	Souroullas GP	An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation.	Nature medicine	2016	19
27212235	L-Lysine	Jadhav U	Acquired Tissue-Specific Promoter Bivalency Is a Basis for PRC2 Necessity in Adult Cells.	Cell	2016	13
27225932	L-Lysine	Vazquez BN	SIRT7 promotes genome integrity and modulates non-homologous end joining DNA repair.	The EMBO journal	2016	22
27335278	L-Lysine	Rau RE	DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia.	Blood	2016	12
11133773	N-Acetylneuraminic acid	Hartnell A	Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations.	Blood	2001	86
20555325	N-Acetylneuraminic acid	Surolia I	Functionally defective germline variants of sialic acid acetylesterase in autoimmunity.	Nature	2010	52
25061176	N-Acetylneuraminic acid	Glavey SV	The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma.	Blood	2014	21
25187624	N-Acetylneuraminic acid	Chen GY	Broad and direct interaction between TLR and Siglec families of pattern recognition receptors and its regulation by Neu1.	eLife	2014	22
17149590	Pyruvic acid	Wang H	MAFA controls genes implicated in insulin biosynthesis and secretion.	Diabetologia	2007	62
18292813	Pyruvic acid	Denechaud PD	ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver.	The Journal of clinical investigation	2008	59
19454652	Pyruvic acid	Davé SH	Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis.	Journal of leukocyte biology	2009	50
19884027	Pyruvic acid	Zierhut ML	Kinetic modeling of hyperpolarized 13C1-pyruvate metabolism in normal rats and TRAMP mice.	Journal of magnetic resonance	2010	56
20133837	Pyruvic acid	Clower CV	The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism.	Proceedings of the National Academy of Sciences of the United States of America	2010	134
20861672	Pyruvic acid	Pavlides S	The autophagic tumor stroma model of cancer: Role of oxidative stress and ketone production in fueling tumor cell metabolism.	Cell cycle	2010	96
21452021	Pyruvic acid	Wang ZY	LDH-A silencing suppresses breast cancer tumorigenicity through induction of oxidative stress mediated mitochondrial pathway apoptosis.	Breast cancer research and treatment	2012	35
23178880	Pyruvic acid	Yang W	ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect.	Nature cell biology	2012	151
23817426	Pyruvic acid	Husain Z	Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells.	Journal of immunology	2013	48
24023724	Pyruvic acid	Hill DK	Model free approach to kinetic analysis of real-time hyperpolarized 13C magnetic resonance spectroscopy data.	PloS one	2013	33
24120138	Pyruvic acid	Israelsen WJ	PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells.	Cell	2013	105
24197136	Pyruvic acid	Luo Y	Cancer usurps skeletal muscle as an energy repository.	Cancer research	2014	21
24672582	Pyruvic acid	Shen J	Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics.	Theranostics	2014	22
24726384	Pyruvic acid	Xie H	Targeting lactate dehydrogenase--a inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells.	Cell metabolism	2014	83
25186741	Pyruvic acid	Zhang Y	An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex.	The Journal of neuroscience 	2014	541
25514599	Pyruvic acid	Liu WR	PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma.	Oncotarget	2015	16
25818238	Pyruvic acid	Taniguchi K	MicroRNA-124 inhibits cancer cell growth through PTB1/PKM1/PKM2 feedback cascade in colorectal cancer.	Cancer letters	2015	25
26113084	Pyruvic acid	Rajeshkumar NV	Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function.	Cancer research	2015	18
26463117	Pyruvic acid	Arriola Apelo SI	Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system.	Aging cell	2016	21
27125672	Pyruvic acid	Dayton TL	Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinoma.	Genes & development	2016	15
11344269	Phosphate	Shimada T	Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.	Proceedings of the National Academy of Sciences of the United States of America	2001	256
12169661	Phosphate	Shenolikar S	Targeted disruption of the mouse NHERF-1 gene promotes internalization of proximal tubule sodium-phosphate cotransporter type IIa and renal phosphate wasting.	Proceedings of the National Academy of Sciences of the United States of America	2002	84
18177265	Phosphate	Kuro-o M	Klotho as a regulator of oxidative stress and senescence.	Biological chemistry	2008	60
19881538	Phosphate	Zhu K	Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells.	Oncogene	2010	97
20037143	Phosphate	Bai X	Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction.	European heart journal	2010	46
20553984	Phosphate	Mohanty C	The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation.	Biomaterials	2010	55
23129509	Phosphate	Wöhrle S	Pharmacological inhibition of fibroblast growth factor (FGF) receptor signaling ameliorates FGF23-mediated hypophosphatemic rickets.	Journal of bone and mineral research 	2013	28
24105680	Phosphate	Jovanovic IP	Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.	International journal of cancer	2014	45
25877890	Phosphate	Fu J	STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade.	Science translational medicine	2015	69
27876571	Phosphate	Yang Y	Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.	Gastroenterology	2017	18
16606824	Docetaxel	Farokhzad OC	Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2006	334
17606733	Docetaxel	Marangoni E	A new model of patient tumor-derived breast cancer xenografts for preclinical assays.	Clinical cancer research 	2007	119
17626183	Docetaxel	Rottenberg S	Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer.	Proceedings of the National Academy of Sciences of the United States of America	2007	71
17909051	Docetaxel	Loberg RD	Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo.	Cancer research	2007	91
18006843	Docetaxel	Halder J	Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma.	Cancer research	2007	69
18172275	Docetaxel	Haass NK	The mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor AZD6244 (ARRY-142886) induces growth arrest in melanoma cells and tumor regression when combined with docetaxel.	Clinical cancer research 	2008	81
18314475	Docetaxel	Merritt WM	Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth.	Journal of the National Cancer Institute	2008	89
18519787	Docetaxel	Garnett CT	Combination of docetaxel and recombinant vaccine enhances T-cell responses and antitumor activity: effects of docetaxel on immune enhancement.	Clinical cancer research 	2008	61
18645028	Docetaxel	Meng Y	Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa.	Molecular cancer therapeutics	2008	60
19147587	Docetaxel	Kim RH	Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis.	Cancer research	2009	73
19826044	Docetaxel	Gan L	Inhibition of the androgen receptor as a novel mechanism of taxol chemotherapy in prostate cancer.	Cancer research	2009	52
21698156	Docetaxel	Zhou H	M402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasis.	PloS one	2011	44
21768359	Docetaxel	Oakes SR	Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737.	Proceedings of the National Academy of Sciences of the United States of America	2012	50
22139708	Docetaxel	Feng B	MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3.	Cancer	2012	38
22294718	Docetaxel	Davies BR	Preclinical pharmacology of AZD5363, an inhibitor of AKT: pharmacodynamics, antitumor activity, and correlation of monotherapy activity with genetic background.	Molecular cancer therapeutics	2012	69
22425996	Docetaxel	Chen Z	A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response.	Nature	2012	141
22491949	Docetaxel	Hrkach J	Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile.	Science translational medicine	2012	221
22952424	Docetaxel	Domanska UM	CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy.	Neoplasia	2012	39
23100512	Docetaxel	Kodumudi KN	Blockade of myeloid-derived suppressor cells after induction of lymphopenia improves adoptive T cell therapy in a murine model of melanoma.	Journal of immunology	2012	33
23340294	Docetaxel	Schott AF	Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors.	Clinical cancer research 	2013	44
23386691	Docetaxel	Shen H	Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery.	Clinical cancer research 	2013	34
23589177	Docetaxel	Vrignaud P	Preclinical antitumor activity of cabazitaxel, a semisynthetic taxane active in taxane-resistant tumors.	Clinical cancer research 	2013	26
24695093	Docetaxel	Yang ZZ	Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas.	Biomaterials	2014	21
24985346	Docetaxel	Ono M	Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells.	Science signaling	2014	105
25156255	Docetaxel	Di Mitri D	Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer.	Nature	2014	42
26153498	Docetaxel	Maia AR	Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model.	Annals of oncology 	2015	17
26859684	Docetaxel	Black M	Activation of the PD-1/PD-L1 immune checkpoint confers tumor cell chemoresistance associated with increased metastasis.	Oncotarget	2016	19
18096707	Bleomycin	Muro AF	An essential role for fibronectin extra type III domain A in pulmonary fibrosis.	American journal of respiratory and critical care medicine	2008	82
19646463	Bleomycin	Cho HY	Nrf2 protects against airway disorders.	Toxicology and applied pharmacology	2010	62
22815997	Bleomycin	Patel AS	Autophagy in idiopathic pulmonary fibrosis.	PloS one	2012	74
23459460	Bleomycin	Lino Cardenas CL	miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1.	PLoS genetics	2013	62
25533958	Bleomycin	Vaughan AE	Lineage-negative progenitors mobilize to regenerate lung epithelium after major injury.	Nature	2015	88
14514658	Sulforaphane	Singh AV	Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo.	Carcinogenesis	2004	94
16166336	Sulforaphane	Conaway CC	Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice.	Cancer research	2005	77
16407454	Sulforaphane	Myzak MC	Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice.	FASEB journal 	2006	98
16951197	Sulforaphane	Keum YS	Mechanism of action of sulforaphane: inhibition of p38 mitogen-activated protein kinase isoforms contributing to the induction of antioxidant response element-mediated heme oxygenase-1 in human hepatoma HepG2 cells.	Cancer research	2006	62
17259330	Sulforaphane	Myzak MC	Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects.	Experimental biology and medicine	2007	101
19223537	Sulforaphane	Singh SV	Sulforaphane inhibits prostate carcinogenesis and pulmonary metastasis in TRAMP mice in association with increased cytotoxicity of natural killer cells.	Cancer research	2009	65
20530687	Sulforaphane	Rausch V	Synergistic activity of sorafenib and sulforaphane abolishes pancreatic cancer stem cell characteristics.	Cancer research	2010	46
23416117	Sulforaphane	Zhang C	Sulforaphane enhances Nrf2 expression in prostate cancer TRAMP C1 cells through epigenetic regulation.	Biochemical pharmacology	2013	37
24441674	Sulforaphane	Su ZY	Requirement and epigenetics reprogramming of Nrf2 in suppression of tumor promoter TPA-induced mouse skin cell transformation by sulforaphane.	Cancer prevention research	2014	31
11248092	Benzo[a]pyrene	Ramos-Gomez M	Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice.	Proceedings of the National Academy of Sciences of the United States of America	2001	286
11694642	Benzo[a]pyrene	Talalay P	Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism.	The Journal of nutrition	2001	92
15665283	Benzo[a]pyrene	Tommasi S	Tumor susceptibility of Rassf1a knockout mice.	Cancer research	2005	70
25995008	Benzo[a]pyrene	Krais AM	The impact of p53 on DNA damage and metabolic activation of the environmental carcinogen benzoapyrene: effects in Trp53(+/+), Trp53(+/-) and Trp53(-/-) mice.	Archives of toxicology	2016	13
26443852	Benzo[a]pyrene	Nik-Zainal S	The genome as a record of environmental exposure.	Mutagenesis	2015	17
2163307	D-Glucose	Miyazaki J	Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms.	Endocrinology	1990	287
9784492	D-Glucose	Moitra J	Life without white fat: a transgenic mouse.	Genes & development	1998	168
10449430	D-Glucose	Su CG	A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response.	The Journal of clinical investigation	1999	128
11171994	D-Glucose	Haase VH	Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor.	Proceedings of the National Academy of Sciences of the United States of America	2001	167
11739396	D-Glucose	Razani B	Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities.	The Journal of biological chemistry	2002	159
12610293	D-Glucose	Longo VD	Evolutionary medicine: from dwarf model systems to healthy centenarians?	Science	2003	163
12618528	D-Glucose	Matsusue K	Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.	The Journal of clinical investigation	2003	134
15047622	D-Glucose	Kim HJ	Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo.	Diabetes	2004	116
15199412	D-Glucose	Horie Y	Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas.	The Journal of clinical investigation	2004	165
15380518	D-Glucose	Arap MA	Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands.	Cancer cell	2004	116
15837624	D-Glucose	Shankar DB	The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia.	Cancer cell	2005	65
16125352	D-Glucose	Anisimov VN	Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.	Experimental gerontology	2005	120
16172168	D-Glucose	Kamba T	VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature.	American journal of physiology. Heart and circulatory physiology	2006	202
16288285	D-Glucose	Testa JR	AKT signaling in normal and malignant cells.	Oncogene	2005	84
16460269	D-Glucose	Biddinger SB	From mice to men: insights into the insulin resistance syndromes.	Annual review of physiology	2006	191
16625210	D-Glucose	Foukas LC	Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation.	Nature	2006	152
16873678	D-Glucose	Dentin R	Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.	Diabetes	2006	102
16936195	D-Glucose	Wente W	Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways.	Diabetes	2006	97
17084711	D-Glucose	Schneider JG	ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome.	Cell metabolism	2006	73
17283114	D-Glucose	Yang F	Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor.	Cancer research	2007	132
17409411	D-Glucose	Feng Z	The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways.	Cancer research	2007	177
17428181	D-Glucose	Postic C	ChREBP, a transcriptional regulator of glucose and lipid metabolism.	Annual review of nutrition	2007	90
17889646	D-Glucose	Dai C	Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis.	Cell	2007	300
17908561	D-Glucose	MacAulay K	Glycogen synthase kinase 3alpha-specific regulation of murine hepatic glycogen metabolism.	Cell metabolism	2007	92
17932564	D-Glucose	Handschin C	Abnormal glucose homeostasis in skeletal muscle-specific PGC-1alpha knockout mice reveals skeletal muscle-pancreatic beta cell crosstalk.	The Journal of clinical investigation	2007	126
17981124	D-Glucose	Cheng J	SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia.	Cell	2007	170
18322014	D-Glucose	Hui ST	Txnip balances metabolic and growth signaling via PTEN disulfide reduction.	Proceedings of the National Academy of Sciences of the United States of America	2008	75
18354169	D-Glucose	Jacobs SR	Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways.	Journal of immunology	2008	176
18378900	D-Glucose	Raffaghello L	Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy.	Proceedings of the National Academy of Sciences of the United States of America	2008	105
18460329	D-Glucose	Anderson KA	Hypothalamic CaMKK2 contributes to the regulation of energy balance.	Cell metabolism	2008	101
18594509	D-Glucose	Jia S	Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis.	Nature	2008	240
18690216	D-Glucose	Zhan Y	Cytosporone B is an agonist for nuclear orphan receptor Nur77.	Nature chemical biology	2008	66
18974394	D-Glucose	Greenberger LM	A RNA antagonist of hypoxia-inducible factor-1alpha, EZN-2968, inhibits tumor cell growth.	Molecular cancer therapeutics	2008	53
19272022	D-Glucose	Ooms LM	The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease.	The Biochemical journal	2009	72
19276390	D-Glucose	Robey IF	Bicarbonate increases tumor pH and inhibits spontaneous metastases.	Cancer research	2009	160
19541609	D-Glucose	Shackelford DB	mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2009	78
19625659	D-Glucose	Elmasri H	Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells.	FASEB journal 	2009	61
19632185	D-Glucose	Burikhanov R	The tumor suppressor Par-4 activates an extrinsic pathway for apoptosis.	Cell	2009	73
19633655	D-Glucose	Liu J	Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice.	Nature medicine	2009	192
19641492	D-Glucose	Kajimura S	Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex.	Nature	2009	209
19706786	D-Glucose	Xu J	Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.	American journal of physiology. Endocrinology and metabolism	2009	75
19808896	D-Glucose	Ye R	Grp78 heterozygosity promotes adaptive unfolded protein response and attenuates diet-induced obesity and insulin resistance.	Diabetes	2010	59
19883376	D-Glucose	Wang F	Brd2 disruption in mice causes severe obesity without Type 2 diabetes.	The Biochemical journal	2009	46
20074525	D-Glucose	Rodgers JT	Cdc2-like kinase 2 is an insulin-regulated suppressor of hepatic gluconeogenesis.	Cell metabolism	2010	48
20141841	D-Glucose	Zhong L	The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha.	Cell	2010	266
20364083	D-Glucose	Ahuja P	Myc controls transcriptional regulation of cardiac metabolism and mitochondrial biogenesis in response to pathological stress in mice.	The Journal of clinical investigation	2010	49
20512147	D-Glucose	Zhu H	Lin28a transgenic mice manifest size and puberty phenotypes identified in human genetic association studies.	Nature genetics	2010	103
20692331	D-Glucose	Lu Y	Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice.	Free radical biology & medicine	2010	57
21084751	D-Glucose	Bricambert J	Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice.	The Journal of clinical investigation	2010	70
21291474	D-Glucose	Uchida Y	Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors.	Journal of neurochemistry	2011	93
21363910	D-Glucose	Claus SP	Colonization-induced host-gut microbial metabolic interaction.	mBio	2011	99
21386129	D-Glucose	Anisimov VN	If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice.	Aging	2011	72
21459323	D-Glucose	Li Y	AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice.	Cell metabolism	2011	241
21467168	D-Glucose	Dong D	A critical role for GRP78/BiP in the tumor microenvironment for neovascularization during tumor growth and metastasis.	Cancer research	2011	48
21804540	D-Glucose	Pajvani UB	Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner.	Nature medicine	2011	48
21865645	D-Glucose	Ravassard P	A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion.	The Journal of clinical investigation	2011	90
21914785	D-Glucose	Bhalla K	PGC1α promotes tumor growth by inducing gene expression programs supporting lipogenesis.	Cancer research	2011	52
21930938	D-Glucose	Zhang C	Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect.	Proceedings of the National Academy of Sciences of the United States of America	2011	94
21962509	D-Glucose	Zhu H	The Lin28/let-7 axis regulates glucose metabolism.	Cell	2011	235
22105852	D-Glucose	Yang SB	Rapamycin induces glucose intolerance in mice by reducing islet mass, insulin content, and insulin sensitivity.	Journal of molecular medicine	2012	36
22237023	D-Glucose	Boström P	A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis.	Nature	2012	636
22258505	D-Glucose	He C	Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis.	Nature	2012	276
22275356	D-Glucose	Lynch TP	Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis.	The Journal of biological chemistry	2012	70
22326218	D-Glucose	Yuneva MO	The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type.	Cell metabolism	2012	152
22396530	D-Glucose	Ji Y	Activation of natural killer T cells promotes M2 Macrophage polarization in adipose tissue and improves systemic glucose tolerance via interleukin-4 (IL-4)/STAT6 protein signaling axis in obesity.	The Journal of biological chemistry	2012	60
22401813	D-Glucose	Garcia-Cao I	Systemic elevation of PTEN induces a tumor-suppressive metabolic state.	Cell	2012	101
22469977	D-Glucose	Alikhani N	Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model.	Oncogene	2013	33
22496159	D-Glucose	Cheng S	Metabolite profiling identifies pathways associated with metabolic risk in humans.	Circulation	2012	116
22645355	D-Glucose	Kleiner S	Development of insulin resistance in mice lacking PGC-1α in adipose tissues.	Proceedings of the National Academy of Sciences of the United States of America	2012	72
22960655	D-Glucose	Aggarwal G	Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in β cells and mice.	Gastroenterology	2012	31
22984531	D-Glucose	Safdie F	Fasting enhances the response of glioma to chemo- and radiotherapy.	PloS one	2012	33
23040072	D-Glucose	Su X	TAp63 is a master transcriptional regulator of lipid and glucose metabolism.	Cell metabolism	2012	38
23142079	D-Glucose	Dominy JE Jr	The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis.	Molecular cell	2012	63
23374352	D-Glucose	Ma L	Control of nutrient stress-induced metabolic reprogramming by PKCζ in tumorigenesis.	Cell	2013	52
23674815	D-Glucose	Clem BF	Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer.	Molecular cancer therapeutics	2013	45
23911236	D-Glucose	Patra KC	Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer.	Cancer cell	2013	136
24030385	D-Glucose	Saha A	Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality.	Blood	2013	44
24037094	D-Glucose	Wei K	A liver Hif-2α-Irs2 pathway sensitizes hepatic insulin signaling and is modulated by Vegf inhibition.	Nature medicine	2013	28
24064762	D-Glucose	Li F	Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity.	Nature communications	2013	93
24141775	D-Glucose	Chen WT	GRP78 as a regulator of liver steatosis and cancer progression mediated by loss of the tumor suppressor PTEN.	Oncogene	2014	24
24305049	D-Glucose	Rosenfeldt MT	p53 status determines the role of autophagy in pancreatic tumour development.	Nature	2013	162
24411942	D-Glucose	Roberts LD	β-Aminoisobutyric acid induces browning of white fat and hepatic β-oxidation and is inversely correlated with cardiometabolic risk factors.	Cell metabolism	2014	75
24613355	D-Glucose	Chen YJ	De novo formation of insulin-producing "neo-β cell islets" from intestinal crypts.	Cell reports	2014	33
24655348	D-Glucose	Leontieva OV	Weekly administration of rapamycin improves survival and biomarkers in obese male mice on high-fat diet.	Aging cell	2014	32
24744147	D-Glucose	Olivier-Van Stichelen S	O-GlcNAcylation stabilizes β-catenin through direct competition with phosphorylation at threonine 41.	FASEB journal 	2014	23
24796972	D-Glucose	Qi Y	Bile acid signaling in lipid metabolism: metabolomic and lipidomic analysis of lipid and bile acid markers linked to anti-obesity and anti-diabetes in mice.	Biochimica et biophysica acta	2015	23
24870244	D-Glucose	Lee Y	Cyclin D1-Cdk4 controls glucose metabolism independently of cell cycle progression.	Nature	2014	31
24875857	D-Glucose	Karsli-Uzunbas G	Autophagy is required for glucose homeostasis and lung tumor maintenance.	Cancer discovery	2014	78
25038826	D-Glucose	Bi P	Inhibition of Notch signaling promotes browning of white adipose tissue and ameliorates obesity.	Nature medicine	2014	49
25047839	D-Glucose	Li Z	Plk1 phosphorylation of PTEN causes a tumor-promoting metabolic state.	Molecular and cellular biology	2014	21
25059582	D-Glucose	Lamming DW	Depletion of Rictor, an essential protein component of mTORC2, decreases male lifespan.	Aging cell	2014	29
25071025	D-Glucose	Li LO	Compartmentalized acyl-CoA metabolism in skeletal muscle regulates systemic glucose homeostasis.	Diabetes	2015	15
25261994	D-Glucose	Mayers JR	Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development.	Nature medicine	2014	85
25317558	D-Glucose	Gnad T	Adenosine activates brown adipose tissue and recruits beige adipocytes via A2A receptors.	Nature	2014	42
25352637	D-Glucose	Fuster JJ	Noncanonical Wnt signaling promotes obesity-induced adipose tissue inflammation and metabolic dysfunction independent of adipose tissue expansion.	Diabetes	2015	24
25402613	D-Glucose	Li W	Long-term persistence and development of induced pancreatic beta cells generated by lineage conversion of acinar cells.	Nature biotechnology	2014	23
25425577	D-Glucose	Kim DH	A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity.	The EMBO journal	2015	20
25525878	D-Glucose	Mashimo T	Acetate is a bioenergetic substrate for human glioblastoma and brain metastases.	Cell	2014	120
25576058	D-Glucose	Cifarelli V	Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated Mechanisms.	Diabetes	2015	21
25581519	D-Glucose	Tang C	Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes.	Nature medicine	2015	30
25857301	D-Glucose	Minciacchi VR	Large oncosomes contain distinct protein cargo and represent a separate functional class of tumor-derived extracellular vesicles.	Oncotarget	2015	37
25887760	D-Glucose	Fu QF	Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.	Journal of hematology & oncology	2015	25
25963540	D-Glucose	O-Sullivan I	FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization.	Nature communications	2015	26
26046242	D-Glucose	Jin D	Lack of Vitamin D Receptor Causes Dysbiosis and Changes the Functions of the Murine Intestinal Microbiome.	Clinical therapeutics	2015	25
26148234	D-Glucose	Hagenbuchner J	BIRC5/Survivin as a target for glycolysis inhibition in high-stage neuroblastoma.	Oncogene	2016	14
26168293	D-Glucose	Hong S	Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization.	Nature medicine	2015	24
26197299	D-Glucose	Flynn CR	Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery.	Nature communications	2015	19
26302408	D-Glucose	Cardaci S	Pyruvate carboxylation enables growth of SDH-deficient cells by supporting aspartate biosynthesis.	Nature cell biology	2015	39
26321679	D-Glucose	Chang CH	Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.	Cell	2015	192
26443705	D-Glucose	Zhang H	Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1.	Science signaling	2015	24
26542580	D-Glucose	Perelis M	Pancreatic β cell enhancers regulate rhythmic transcription of genes controlling insulin secretion.	Science	2015	49
26641266	D-Glucose	Incio J	Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages.	PloS one	2015	23
26774962	D-Glucose	Quaegebeur A	Deletion or Inhibition of the Oxygen Sensor PHD1 Protects against Ischemic Stroke via Reprogramming of Neuronal Metabolism.	Cell metabolism	2016	13
26876562	D-Glucose	Svensson KJ	A Secreted Slit2 Fragment Regulates Adipose Tissue Thermogenesis and Metabolic Function.	Cell metabolism	2016	13
26950362	D-Glucose	Helman A	p16(Ink4a)-induced senescence of pancreatic beta cells enhances insulin secretion.	Nature medicine	2016	30
26999507	D-Glucose	Wang C	Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody.	Nano letters	2016	17
27153497	D-Glucose	Masri S	Lung Adenocarcinoma Distally Rewires Hepatic Circadian Homeostasis.	Cell	2016	25
27374330	D-Glucose	Long JZ	The Secreted Enzyme PM20D1 Regulates Lipidated Amino Acid Uncouplers of Mitochondria.	Cell	2016	16
27580405	D-Glucose	Yun JH	Endothelial STAT3 Activation Increases Vascular Leakage Through Downregulating Tight Junction Proteins: Implications for Diabetic Retinopathy.	Journal of cellular physiology	2017	6
28199306	D-Glucose	Wolfson RL	KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1.	Nature	2017	19
28273060	D-Glucose	Mosialou I	MC4R-dependent suppression of appetite by bone-derived lipocalin 2.	Nature	2017	15
7958843	L-Cysteine	Kumar S	Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1 beta-converting enzyme.	Genes & development	1994	120
9600969	L-Cysteine	Babic AM	CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth.	Proceedings of the National Academy of Sciences of the United States of America	1998	113
10458605	L-Cysteine	Bromberg JF	Stat3 as an oncogene.	Cell	1999	799
15314073	L-Cysteine	Nylandsted J	Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization.	The Journal of experimental medicine	2004	130
16481467	L-Cysteine	Gocheva V	Distinct roles for cysteine cathepsin genes in multistage tumorigenesis.	Genes & development	2006	129
16707449	L-Cysteine	Vasiljeva O	Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer.	Cancer research	2006	88
16818644	L-Cysteine	Rofstad EK	Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice.	Cancer research	2006	147
17828252	L-Cysteine	Blum G	Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes.	Nature chemical biology	2007	110
18641636	L-Cysteine	Junutula JR	Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index.	Nature biotechnology	2008	180
19381019	L-Cysteine	Qing J	Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice.	The Journal of clinical investigation	2009	66
19795409	L-Cysteine	Bateman A	The granulin gene family: from cancer to dementia.	BioEssays 	2009	110
20133781	L-Cysteine	Sevenich L	Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice.	Proceedings of the National Academy of Sciences of the United States of America	2010	47
20213804	L-Cysteine	Sonnylal S	Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis.	Arthritis and rheumatism	2010	57
20703838	L-Cysteine	Kim YS	Intestinal goblet cells and mucins in health and disease: recent insights and progress.	Current gastroenterology reports	2010	164
21969517	L-Cysteine	Von Hoff DD	Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial.	Journal of clinical oncology 	2011	260
22653731	L-Cysteine	Janda CY	Structural basis of Wnt recognition by Frizzled.	Science	2012	174
23034282	L-Cysteine	Lapalombella R	Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia.	Blood	2012	91
23770776	L-Cysteine	Kung Sutherland MS	SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML.	Blood	2013	65
24067278	L-Cysteine	Neesse A	SPARC independent drug delivery and antitumour effects of nab-paclitaxel in genetically engineered mice.	Gut	2014	41
26169969	L-Cysteine	Hidalgo M	SPARC Expression Did Not Predict Efficacy of nab-Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial.	Clinical cancer research 	2015	30
15177029	Sulfate	Koziel L	Ext1-dependent heparan sulfate regulates the range of Ihh signaling during endochondral ossification.	Developmental cell	2004	79
19360105	Sulfate	Zcharia E	Newly generated heparanase knock-out mice unravel co-regulation of heparanase and matrix metalloproteinases.	PloS one	2009	51
21880786	Sulfate	Stenzel D	Integrin-dependent and -independent functions of astrocytic fibronectin in retinal angiogenesis.	Development	2011	39
22033227	Sulfate	Teng YH	Molecular functions of syndecan-1 in disease.	Matrix biology 	2012	64
22406535	Sulfate	Said N	RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration.	The Journal of clinical investigation	2012	41
24492943	Sulfate	Gao W	Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy.	Hepatology	2014	24
11740565	Cytidine	Petersen S	AID is required to initiate Nbs1/gamma-H2AX focus formation and mutations at sites of class switching.	Nature	2001	178
12618505	Cytidine	Cheng JC	Inhibition of DNA methylation and reactivation of silenced genes by zebularine.	Journal of the National Cancer Institute	2003	96
12732658	Cytidine	Okazaki IM	Constitutive expression of AID leads to tumorigenesis.	The Journal of experimental medicine	2003	132
12907622	Cytidine	Nowak AK	Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors.	Cancer research	2003	94
17000121	Cytidine	Omori SA	Regulation of class-switch recombination and plasma cell differentiation by phosphatidylinositol 3-kinase signaling.	Immunity	2006	73
17452520	Cytidine	Crouch EE	Regulation of AID expression in the immune response.	The Journal of experimental medicine	2007	87
18066064	Cytidine	Pasqualucci L	AID is required for germinal center-derived lymphomagenesis.	Nature genetics	2008	135
18678733	Cytidine	Takizawa M	AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development.	The Journal of experimental medicine	2008	71
19805370	Cytidine	Bauman DR	25-Hydroxycholesterol secreted by macrophages in response to Toll-like receptor activation suppresses immunoglobulin A production.	Proceedings of the National Academy of Sciences of the United States of America	2009	73
23836645	Cytidine	Neesse A	CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer.	Proceedings of the National Academy of Sciences of the United States of America	2013	48
23995783	Cytidine	Weizman N	Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase.	Oncogene	2014	45
24670820	Cytidine	Olivier M	Modelling mutational landscapes of human cancers in vitro.	Scientific reports	2014	20
25483776	Cytidine	Meng FL	Convergent transcription at intragenic super-enhancers targets AID-initiated genomic instability.	Cell	2014	54
25483777	Cytidine	Qian J	B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity.	Cell	2014	71
26255562	Cytidine	Nagathihalli NS	Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer.	Gastroenterology	2015	16
26276629	Cytidine	Robbiani DF	Plasmodium Infection Promotes Genomic Instability and AID-Dependent B Cell Lymphoma.	Cell	2015	29
3670292	Neomycin	Chen C	High-efficiency transformation of mammalian cells by plasmid DNA.	Molecular and cellular biology	1987	1478
10220414	Neomycin	Mao X	Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice.	Proceedings of the National Academy of Sciences of the United States of America	1999	132
16237115	Neomycin	Numasaki M	IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis.	Journal of immunology	2005	118
18519586	Neomycin	Haiko P	Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos.	Molecular and cellular biology	2008	55
26908603	Neomycin	Toonen JA	NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.	Human molecular genetics	2016	13
18045775	Sulfite	Al-Mahdawi S	The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues.	Human molecular genetics	2008	90
19084528	Sulfite	Yu J	Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.	Gastroenterology	2009	53
20062804	Sulfite	Yu S	Nrf2 expression is regulated by epigenetic mechanisms in prostate cancer of TRAMP mice.	PloS one	2010	64
21772049	Sulfite	Kalac M	HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL.	Blood	2011	37
21787756	Sulfite	Khor TO	Pharmacodynamics of curcumin as DNA hypomethylation agent in restoring the expression of Nrf2 via promoter CpGs demethylation.	Biochemical pharmacology	2011	42
24098911	Sulfite	Lu KH	Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression.	BMC cancer	2013	80
26271101	Sulfite	Tuorto F	The tRNA methyltransferase Dnmt2 is required for accurate polypeptide synthesis during haematopoiesis.	The EMBO journal	2015	20
11085525	Cisplatin	Plumb JA	Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter.	Cancer research	2000	96
17146434	Cisplatin	Ambrosini G	Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1.	Oncogene	2007	55
17292828	Cisplatin	Reinhardt HC	p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage.	Cancer cell	2007	174
17473206	Cisplatin	Donawho CK	ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models.	Clinical cancer research 	2007	210
18206965	Cisplatin	Lim ST	Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation.	Molecular cell	2008	151
18316592	Cisplatin	Ohta T	Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth.	Cancer research	2008	174
18559613	Cisplatin	Evers B	Selective inhibition of BRCA2-deficient mammary tumor cell growth by AZD2281 and cisplatin.	Clinical cancer research 	2008	68
19657384	Cisplatin	Cerniglia GJ	Epidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacy.	PloS one	2009	47
19783996	Cisplatin	Gonfloni S	Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death.	Nature medicine	2009	79
19881547	Cisplatin	Tesniere A	Immunogenic death of colon cancer cells treated with oxaliplatin.	Oncogene	2010	142
20215556	Cisplatin	Sikora AG	Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy.	Clinical cancer research 	2010	43
20940707	Cisplatin	Kallifatidis G	Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate.	Molecular therapy 	2011	45
21124918	Cisplatin	Leung EL	Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.	PloS one	2010	115
21266349	Cisplatin	Liccardi G	EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment.	Cancer research	2011	73
21353530	Cisplatin	Otvos L Jr	Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer.	European journal of cancer	2011	38
21425153	Cisplatin	Hsu HS	Chemoresistance of lung cancer stemlike cells depends on activation of Hsp27.	Cancer	2011	40
21532889	Cisplatin	Rattan R	Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo.	Neoplasia	2011	85
21726833	Cisplatin	Lee TK	CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation.	Cell stem cell	2011	148
21909139	Cisplatin	Yue P	Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells.	Oncogene	2012	43
22157765	Cisplatin	Zou Z	MicroRNA-30a sensitizes tumor cells to cis-platinum via suppressing beclin 1-mediated autophagy.	The Journal of biological chemistry	2012	47
22252008	Cisplatin	Maycotte P	Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy.	Autophagy	2012	86
22308459	Cisplatin	Meirelles K	Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance.	Proceedings of the National Academy of Sciences of the United States of America	2012	39
22406827	Cisplatin	Guo XL	Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cells.	Cancer letters	2012	44
22516258	Cisplatin	Nakasone ES	Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance.	Cancer cell	2012	112
23251001	Cisplatin	Kimple RJ	Development and characterization of HPV-positive and HPV-negative head and neck squamous cell carcinoma tumorgrafts.	Clinical cancer research 	2013	31
23461856	Cisplatin	Ma L	Cancer stem-like cell properties are regulated by EGFR/AKT/β-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma.	The FEBS journal	2013	26
23537295	Cisplatin	Abubaker K	Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden.	Molecular cancer	2013	55
23604128	Cisplatin	Barckhausen C	Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/XPC-mediated DNA repair.	Oncogene	2014	26
24165223	Cisplatin	Sun XP	Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.	The FEBS journal	2014	20
24502656	Cisplatin	Lu L	Combined PD-1 blockade and GITR triggering induce a potent antitumor immunity in murine cancer models and synergizes with chemotherapeutic drugs.	Journal of translational medicine	2014	25
24583641	Cisplatin	Phesse TJ	Endogenous c-Myc is essential for p53-induced apoptosis in response to DNA damage in vivo.	Cell death and differentiation	2014	27
25026298	Cisplatin	Ha K	Histone deacetylase inhibitor treatment induces 'BRCAness' and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells.	Oncotarget	2014	25
25114235	Cisplatin	Xue W	Small RNA combination therapy for lung cancer.	Proceedings of the National Academy of Sciences of the United States of America	2014	56
25339352	Cisplatin	Tao S	Oncogenic KRAS confers chemoresistance by upregulating NRF2.	Cancer research	2014	48
25432176	Cisplatin	Kolev VN	PI3K/mTOR dual inhibitor VS-5584 preferentially targets cancer stem cells.	Cancer research	2015	42
25504633	Cisplatin	Osman AA	Wee-1 kinase inhibition overcomes cisplatin resistance associated with high-risk TP53 mutations in head and neck cancer through mitotic arrest followed by senescence.	Molecular cancer therapeutics	2015	20
25537512	Cisplatin	Chiu WT	FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.	Oncotarget	2015	35
25607838	Cisplatin	Morigi M	Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury.	The Journal of clinical investigation	2015	35
25658419	Cisplatin	Xu J	β-Catenin is required for the tumorigenic behavior of triple-negative breast cancer cells.	PloS one	2015	18
25871396	Cisplatin	Ma SR	Anterior gradient protein 2 expression in high grade head and neck squamous cell carcinoma correlated with cancer stem cell and epithelial mesenchymal transition.	Oncotarget	2015	20
25995442	Cisplatin	Liu G	Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers.	Journal of the National Cancer Institute	2015	24
26020117	Cisplatin	Cioffi M	Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer.	Scientific reports	2015	22
26517239	Cisplatin	Vendetti FP	The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo.	Oncotarget	2015	26
26598503	Cisplatin	Gobbo J	Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer.	Journal of the National Cancer Institute	2016	13
26654944	Cisplatin	Choi EJ	FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells.	Oncotarget	2016	12
27381626	Cisplatin	Ter Brugge P	Mechanisms of Therapy Resistance in Patient-Derived Xenograft Models of BRCA1-Deficient Breast Cancer.	Journal of the National Cancer Institute	2016	11
27803105	Cisplatin	Yokoyama Y	BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer.	Cancer research	2016	13
8402885	Etoposide	Lowe SW	p53-dependent apoptosis modulates the cytotoxicity of anticancer agents.	Cell	1993	453
16707462	Etoposide	Zhao Y	Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441.	Cancer research	2006	108
17187072	Etoposide	Obeid M	Calreticulin exposure dictates the immunogenicity of cancer cell death.	Nature medicine	2007	488
18259198	Etoposide	Michalak EM	In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute.	Cell death and differentiation	2008	66
21455219	Etoposide	Laussmann MA	Proteasome inhibition can induce an autophagy-dependent apical activation of caspase-8.	Cell death and differentiation	2011	37
21911424	Etoposide	Josefsson EC	Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets.	The Journal of experimental medicine	2011	42
23512991	Etoposide	Batey MA	Preclinical evaluation of a novel ATM inhibitor, KU59403, in vitro and in vivo in p53 functional and dysfunctional models of human cancer.	Molecular cancer therapeutics	2013	32
25605014	Etoposide	Kirk JS	Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancer.	Oncotarget	2015	16
26015568	Etoposide	Carpio MA	BCL-2 family member BOK promotes apoptosis in response to endoplasmic reticulum stress.	Proceedings of the National Academy of Sciences of the United States of America	2015	20
27091611	Etoposide	Jia H	Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents.	Biochimica et biophysica acta	2016	12
8646779	Sirolimus	Nakayama K	Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.	Cell	1996	378
11504908	Sirolimus	Neshat MS	Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.	Proceedings of the National Academy of Sciences of the United States of America	2001	217
11875047	Sirolimus	Kwiatkowski DJ	A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells.	Human molecular genetics	2002	224
12039858	Sirolimus	Humar R	Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling.	FASEB journal 	2002	89
14561707	Sirolimus	Zhang H	Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR.	The Journal of clinical investigation	2003	206
15029198	Sirolimus	Wendel HG	Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy.	Nature	2004	282
15156201	Sirolimus	Majumder PK	mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.	Nature medicine	2004	282
15705789	Sirolimus	Hammerman PS	Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival.	Blood	2005	74
15805275	Sirolimus	Dasgupta B	Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors.	Cancer research	2005	81
15937108	Sirolimus	Johannessen CM	The NF1 tumor suppressor critically regulates TSC2 and mTOR.	Proceedings of the National Academy of Sciences of the United States of America	2005	158
16341243	Sirolimus	Thomas GV	Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer.	Nature medicine	2006	169
16446424	Sirolimus	Furuya F	Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone beta receptor.	Proceedings of the National Academy of Sciences of the United States of America	2006	65
16489002	Sirolimus	Klos KS	ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells.	Cancer research	2006	61
16715125	Sirolimus	Wang X	Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation.	Oncogene	2006	77
16799564	Sirolimus	Androutsellis-Theotokis A	Notch signalling regulates stem cell numbers in vitro and in vivo.	Nature	2006	271
16904612	Sirolimus	Sodhi A	The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor.	Cancer cell	2006	65
16915281	Sirolimus	Bernardi R	PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR.	Nature	2006	132
17172425	Sirolimus	Kuo PL	Plumbagin induces G2-M arrest and autophagy by inhibiting the AKT/mammalian target of rapamycin pathway in breast cancer cells.	Molecular cancer therapeutics	2006	75
17332326	Sirolimus	Li M	Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway.	Cancer research	2007	70
17363557	Sirolimus	Mabuchi S	RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer.	Cancer research	2007	59
17409454	Sirolimus	Petricoin EF 3rd	Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival.	Cancer research	2007	71
17496901	Sirolimus	Hernando E	The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas.	Nature medicine	2007	78
18164202	Sirolimus	Johannessen CM	TORC1 is essential for NF1-associated malignancies.	Current biology 	2008	69
18198340	Sirolimus	DeYoung MP	Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling.	Genes & development	2008	222
18296647	Sirolimus	Schmid T	Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion.	Cancer research	2008	53
18342602	Sirolimus	Ozcan U	Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis.	Molecular cell	2008	165
18354499	Sirolimus	Knutson SK	Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks.	The EMBO journal	2008	92
18495876	Sirolimus	Meikle L	Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function.	The Journal of neuroscience 	2008	168
18551192	Sirolimus	Bordeleau ME	Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model.	The Journal of clinical investigation	2008	91
18568033	Sirolimus	Ehninger D	Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis.	Nature medicine	2008	270
18650380	Sirolimus	Schewe DM	ATF6alpha-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2008	67
18664580	Sirolimus	Mills JR	mTORC1 promotes survival through translational control of Mcl-1.	Proceedings of the National Academy of Sciences of the United States of America	2008	112
18684977	Sirolimus	Golovina TN	CD28 costimulation is essential for human T regulatory expansion and function.	Journal of immunology	2008	55
18713735	Sirolimus	Schieke SM	Mitochondrial metabolism modulates differentiation and teratoma formation capacity in mouse embryonic stem cells.	The Journal of biological chemistry	2008	56
18725988	Sirolimus	Carracedo A	Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer.	The Journal of clinical investigation	2008	507
18725989	Sirolimus	Kinkade CW	Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model.	The Journal of clinical investigation	2008	158
18768809	Sirolimus	Fujishita T	Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in ApcDelta716 mice.	Proceedings of the National Academy of Sciences of the United States of America	2008	57
19029981	Sirolimus	Engelman JA	Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers.	Nature medicine	2008	484
19033662	Sirolimus	Lu Z	The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells.	The Journal of clinical investigation	2008	117
19103993	Sirolimus	Zhu W	Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway.	Circulation	2009	55
19139015	Sirolimus	Czerninski R	Targeting mammalian target of rapamycin by rapamycin prevents tumor progression in an oral-specific chemical carcinogenesis model.	Cancer prevention research	2009	47
19185849	Sirolimus	Guertin DA	mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice.	Cancer cell	2009	149
19234517	Sirolimus	Hartman TR	The role of the Birt-Hogg-Dubé protein in mTOR activation and renal tumorigenesis.	Oncogene	2009	62
19246562	Sirolimus	Cullion K	Targeting the Notch1 and mTOR pathways in a mouse T-ALL model.	Blood	2009	50
19261747	Sirolimus	Puzio-Kuter AM	Inactivation of p53 and Pten promotes invasive bladder cancer.	Genes & development	2009	98
19282848	Sirolimus	Dankort D	Braf(V600E) cooperates with Pten loss to induce metastatic melanoma.	Nature genetics	2009	324
19326431	Sirolimus	Narayanan NK	Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice.	International journal of cancer	2009	60
19420259	Sirolimus	Di Nardo A	Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner.	The Journal of neuroscience 	2009	63
19451225	Sirolimus	James MF	NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth.	Molecular and cellular biology	2009	69
19501590	Sirolimus	Mueller MT	Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer.	Gastroenterology	2009	81
19602587	Sirolimus	Huang J	Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors.	Cancer research	2009	46
19625624	Sirolimus	Guo D	The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2009	84
19773376	Sirolimus	Kim KW	Combined Bcl-2/mammalian target of rapamycin inhibition leads to enhanced radiosensitization via induction of apoptosis and autophagy in non-small cell lung tumor xenograft model.	Clinical cancer research 	2009	47
19789349	Sirolimus	Konstantinidou G	Dual phosphoinositide 3-kinase/mammalian target of rapamycin blockade is an effective radiosensitizing strategy for the treatment of non-small cell lung cancer harboring K-RAS mutations.	Cancer research	2009	56
19817806	Sirolimus	Wong M	Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies.	Epilepsia	2010	59
19843504	Sirolimus	Hudon V	Renal tumour suppressor function of the Birt-Hogg-Dubé syndrome gene product folliculin.	Journal of medical genetics	2010	47
19920197	Sirolimus	Fu L	Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagy.	Cancer research	2009	53
19934303	Sirolimus	Miller TW	Inhibition of mammalian target of rapamycin is required for optimal antitumor effect of HER2 inhibitors against HER2-overexpressing cancer cells.	Clinical cancer research 	2009	53
19934433	Sirolimus	Chen C	mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells.	Science signaling	2009	181
20008935	Sirolimus	Olive V	miR-19 is a key oncogenic component of mir-17-92.	Genes & development	2009	235
20038818	Sirolimus	Tsang CK	mTOR binds to the promoters of RNA polymerase I- and III-transcribed genes.	Cell cycle	2010	47
20042677	Sirolimus	Deng L	A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis.	The American journal of pathology	2010	57
20080688	Sirolimus	Hung KE	Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment.	Proceedings of the National Academy of Sciences of the United States of America	2010	80
20080710	Sirolimus	Alain T	Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production.	Proceedings of the National Academy of Sciences of the United States of America	2010	46
20139716	Sirolimus	Blagosklonny MV	Calorie restriction: decelerating mTOR-driven aging from cells to organisms (including humans).	Cell cycle	2010	85
20160026	Sirolimus	Pang X	Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT/mammalian target of rapamycin pathway.	Cancer research	2010	44
20371718	Sirolimus	Cirstea D	Dual inhibition of akt/mammalian target of rapamycin pathway by nanoparticle albumin-bound-rapamycin and perifosine induces antitumor activity in multiple myeloma.	Molecular cancer therapeutics	2010	48
20498714	Sirolimus	Squarize CH	Accelerated wound healing by mTOR activation in genetically defined mouse models.	PloS one	2010	40
20563248	Sirolimus	Molina JR	Invasive glioblastoma cells acquire stemness and increased Akt activation.	Neoplasia	2010	62
20606252	Sirolimus	Korotchkina LG	The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway.	Aging	2010	162
20668229	Sirolimus	Green AS	The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation.	Blood	2010	53
20686120	Sirolimus	Hoang B	Targeting TORC2 in multiple myeloma with a new mTOR kinase inhibitor.	Blood	2010	42
20686178	Sirolimus	Andersen JN	Pathway-based identification of biomarkers for targeted therapeutics: personalized oncology with PI3K pathway inhibitors.	Science translational medicine	2010	57
20876733	Sirolimus	Lee DY	Neurofibromatosis-1 regulates neuroglial progenitor proliferation and glial differentiation in a brain region-specific manner.	Genes & development	2010	49
20890040	Sirolimus	Schreiber TH	Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation.	The Journal of clinical investigation	2010	51
20978191	Sirolimus	Zhang F	mTOR complex component Rictor interacts with PKCzeta and regulates cancer cell metastasis.	Cancer research	2010	49
21076392	Sirolimus	Balamurugan K	The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis.	The EMBO journal	2010	43
21079150	Sirolimus	Zhang S	Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production.	Blood	2011	52
21228155	Sirolimus	Rieker C	Nucleolar disruption in dopaminergic neurons leads to oxidative damage and parkinsonism through repression of mammalian target of rapamycin signaling.	The Journal of neuroscience 	2011	42
21285988	Sirolimus	Wang Y	Temsirolimus, an mTOR inhibitor, enhances anti-tumour effects of heat shock protein cancer vaccines.	British journal of cancer	2011	38
21289308	Sirolimus	Yoshimi A	Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins.	Blood	2011	35
21357822	Sirolimus	Shende P	Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice.	Circulation	2011	72
21403402	Sirolimus	Feliciano DM	Single-cell Tsc1 knockout during corticogenesis generates tuber-like lesions and reduces seizure threshold in mice.	The Journal of clinical investigation	2011	54
21413931	Sirolimus	Pearce LR	Protor-1 is required for efficient mTORC2-mediated activation of SGK1 in the kidney.	The Biochemical journal	2011	53
21501832	Sirolimus	Jaramillo M	Leishmania repression of host translation through mTOR cleavage is required for parasite survival and infection.	Cell host & microbe	2011	43
21564534	Sirolimus	Hippen KL	Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease.	American journal of transplantation 	2011	88
21670596	Sirolimus	Oh WJ	mTOR complex 2 signaling and functions.	Cell cycle	2011	154
21746920	Sirolimus	Parkhitko A	Tumorigenesis in tuberous sclerosis complex is autophagy and p62/sequestosome 1 (SQSTM1)-dependent.	Proceedings of the National Academy of Sciences of the United States of America	2011	79
21804531	Sirolimus	Peña-Llopis S	Regulation of TFEB and V-ATPases by mTORC1.	The EMBO journal	2011	122
21907282	Sirolimus	Carson RP	Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin.	Neurobiology of disease	2012	57
21975930	Sirolimus	Patel V	Decreased lymphangiogenesis and lymph node metastasis by mTOR inhibition in head and neck cancer.	Cancer research	2011	52
21993994	Sirolimus	Ho C	AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways.	Hepatology	2012	55
22143671	Sirolimus	Willems L	The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia.	Leukemia	2012	46
22186785	Sirolimus	Criollo A	Autophagy is required for the activation of NFκB.	Cell cycle	2012	31
22234835	Sirolimus	Fang Y	MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.	Hepatology	2012	103
22290600	Sirolimus	De Angel RE	The enhancing effects of obesity on mammary tumor growth and Akt/mTOR pathway activation persist after weight loss and are reversed by RAD001.	Molecular carcinogenesis	2013	26
22409888	Sirolimus	Molinolo AA	mTOR as a molecular target in HPV-associated oral and cervical squamous carcinomas.	Clinical cancer research 	2012	38
22439642	Sirolimus	Vinci M	Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation.	BMC biology	2012	138
22457330	Sirolimus	Menon S	Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice.	Science signaling	2012	51
22504094	Sirolimus	Chang Y	miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions.	Gastroenterology	2012	53
22552098	Sirolimus	Thoreen CC	A unifying model for mTORC1-mediated regulation of mRNA translation.	Nature	2012	370
22605338	Sirolimus	Wang Y	Anticancer peptidylarginine deiminase (PAD) inhibitors regulate the autophagy flux and the mammalian target of rapamycin complex 1 activity.	The Journal of biological chemistry	2012	49
22763451	Sirolimus	Tsai PT	Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice.	Nature	2012	176
22826320	Sirolimus	Amiel E	Inhibition of mechanistic target of rapamycin promotes dendritic cell activation and enhances therapeutic autologous vaccination in mice.	Journal of immunology	2012	40
22826565	Sirolimus	Zeng Z	Targeting of mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironment.	Blood	2012	38
22836754	Sirolimus	Wang J	B-Raf activation cooperates with PTEN loss to drive c-Myc expression in advanced prostate cancer.	Cancer research	2012	31
22859719	Sirolimus	Sun ZJ	Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model.	Clinical cancer research 	2012	41
22872574	Sirolimus	Roberts PJ	Combined PI3K/mTOR and MEK inhibition provides broad antitumor activity in faithful murine cancer models.	Clinical cancer research 	2012	65
22907434	Sirolimus	Du W	ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer.	Oncogene	2013	27
22958934	Sirolimus	Kalaitzidis D	mTOR complex 1 plays critical roles in hematopoiesis and Pten-loss-evoked leukemogenesis.	Cell stem cell	2012	65
23090679	Sirolimus	Janes MR	Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in models of B-cell acute lymphoblastic leukemia.	Leukemia	2013	37
23123587	Sirolimus	Reith RM	Loss of Tsc2 in Purkinje cells is associated with autistic-like behavior in a mouse model of tuberous sclerosis complex.	Neurobiology of disease	2013	42
23152448	Sirolimus	Kaul A	Pediatric glioma-associated KIAA1549:BRAF expression regulates neuroglial cell growth in a cell type-specific and mTOR-dependent manner.	Genes & development	2012	33
23172145	Sirolimus	Gkogkas CG	Autism-related deficits via dysregulated eIF4E-dependent translational control.	Nature	2013	133
23173671	Sirolimus	Cui L	MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.	BMC cancer	2012	31
23187803	Sirolimus	Leontieva OV	Hyper-mitogenic drive coexists with mitotic incompetence in senescent cells.	Cell cycle	2012	64
23298947	Sirolimus	Dutta D	Upregulated autophagy protects cardiomyocytes from oxidative stress-induced toxicity.	Autophagy	2013	27
23929677	Sirolimus	Sinha RA	Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice.	Hepatology	2014	48
23972597	Sirolimus	Cao R	Translational control of entrainment and synchrony of the suprachiasmatic circadian clock by mTOR/4E-BP1 signaling.	Neuron	2013	27
24270418	Sirolimus	Liu SC	Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance.	The Journal of clinical investigation	2013	29
24282255	Sirolimus	Hasty P	eRapa restores a normal life span in a FAP mouse model.	Cancer prevention research	2014	20
24292708	Sirolimus	Berezhnoy A	Aptamer-targeted inhibition of mTOR in T cells enhances antitumor immunity.	The Journal of clinical investigation	2014	43
24311635	Sirolimus	Kahn J	The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells.	Neuro-oncology	2014	23
24428799	Sirolimus	Schmeisser H	New function of type I IFN: induction of autophagy.	Journal of interferon & cytokine research 	2014	24
24474794	Sirolimus	Liu X	Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK.	Proceedings of the National Academy of Sciences of the United States of America	2014	68
24671992	Sirolimus	Wahl SE	Mammalian target of rapamycin promotes oligodendrocyte differentiation, initiation and extent of CNS myelination.	The Journal of neuroscience 	2014	41
24671993	Sirolimus	Bercury KK	Conditional ablation of raptor or rictor has differential impact on oligodendrocyte differentiation and CNS myelination.	The Journal of neuroscience 	2014	33
24717934	Sirolimus	Morran DC	Targeting mTOR dependency in pancreatic cancer.	Gut	2014	25
24910242	Sirolimus	Umemura A	Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition.	Cell metabolism	2014	27
24931163	Sirolimus	Dodd KM	mTORC1 drives HIF-1α and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3.	Oncogene	2015	24
24973821	Sirolimus	Marçais A	The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells.	Nature immunology	2014	73
25015820	Sirolimus	Zhang L	Mammalian target of rapamycin complex 1 orchestrates invariant NKT cell differentiation and effector function.	Journal of immunology	2014	26
25082895	Sirolimus	Cornu M	Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21.	Proceedings of the National Academy of Sciences of the United States of America	2014	34
25175012	Sirolimus	Zhu L	TSC1 controls macrophage polarization to prevent inflammatory disease.	Nature communications	2014	40
25259925	Sirolimus	Peng M	Sestrins function as guanine nucleotide dissociation inhibitors for Rag GTPases to control mTORC1 signaling.	Cell	2014	52
25307878	Sirolimus	Lee DH	Synergistic effect of JQ1 and rapamycin for treatment of human osteosarcoma.	International journal of cancer	2015	23
25383520	Sirolimus	Faller WJ	mTORC1-mediated translational elongation limits intestinal tumour initiation and growth.	Nature	2015	61
25450580	Sirolimus	Xu K	mTOR signaling in tumorigenesis.	Biochimica et biophysica acta	2014	34
25464856	Sirolimus	Staron MM	The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8(+) T cells during chronic infection.	Immunity	2014	66
25534823	Sirolimus	Kaul A	Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth.	Neuro-oncology	2015	17
25537496	Sirolimus	Martin SK	Brief report: the differential roles of mTORC1 and mTORC2 in mesenchymal stem cell differentiation.	Stem cells	2015	22
25601637	Sirolimus	Kong B	A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling.	Gut	2016	14
25813405	Sirolimus	Wang Y	CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling.	Cancer letters	2015	45
26311737	Sirolimus	Tsai JP	Licochalcone A induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone A-induced apoptosis of human cervical cancer cells.	Oncotarget	2015	22
26476289	Sirolimus	Li L	Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans.	Journal of hepatology	2016	12
26565512	Sirolimus	Qiang L	Autophagy positively regulates DNA damage recognition by nucleotide excision repair.	Autophagy	2016	12
26695882	Sirolimus	Baar EL	Sex- and tissue-specific changes in mTOR signaling with age in C57BL/6J mice.	Aging cell	2016	19
26698918	Sirolimus	Martinez-Lopez N	Autophagy in the CNS and Periphery Coordinate Lipophagy and Lipolysis in the Brown Adipose Tissue and Liver.	Cell metabolism	2016	20
26884599	Sirolimus	Ishizawa J	ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies.	Science signaling	2016	29
26884601	Sirolimus	Viel S	TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway.	Science signaling	2016	24
26886608	Sirolimus	Xie R	Targeted Disruption of miR-17-92 Impairs Mouse Spermatogenesis by Activating mTOR Signaling Pathway.	Medicine	2016	11
26912861	Sirolimus	Ben-Sahra I	mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle.	Science	2016	59
27064903	Sirolimus	Verbist KC	Metabolic maintenance of cell asymmetry following division in activated T lymphocytes.	Nature	2016	45
27161823	Sirolimus	Gaubitz C	TORC2 Structure and Function.	Trends in biochemical sciences	2016	29
27777238	Sirolimus	Tasian SK	Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia.	Blood	2017	15
28162974	Sirolimus	Vila IK	A UBE2O-AMPKα2 Axis that Promotes Tumor Initiation and Progression Offers Opportunities for Therapy.	Cancer cell	2017	7
14517555	Tamoxifen	Balbín M	Loss of collagenase-2 confers increased skin tumor susceptibility to male mice.	Nature genetics	2003	119
15187022	Tamoxifen	Göthert JR	Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium.	Blood	2004	86
15716339	Tamoxifen	Andreu P	Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine.	Development	2005	84
15756033	Tamoxifen	Cohen BD	Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751,871.	Clinical cancer research 	2005	86
17306315	Tamoxifen	Waalkes MP	Transplacental arsenic carcinogenesis in mice.	Toxicology and applied pharmacology	2007	59
17932118	Tamoxifen	Lantinga-van Leeuwen IS	Kidney-specific inactivation of the Pkd1 gene induces rapid cyst formation in developing kidneys and a slow onset of disease in adult mice.	Human molecular genetics	2007	63
18263895	Tamoxifen	Patel V	Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia.	Human molecular genetics	2008	128
20495363	Tamoxifen	Bonuccelli G	The reverse Warburg effect: glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts.	Cell cycle	2010	73
21048142	Tamoxifen	Konopka W	MicroRNA loss enhances learning and memory in mice.	The Journal of neuroscience 	2010	103
21521783	Tamoxifen	Nguyen AT	DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis.	Blood	2011	66
21852537	Tamoxifen	Garcia D	Validation of MdmX as a therapeutic target for reactivating p53 in tumors.	Genes & development	2011	36
22241473	Tamoxifen	Bonzo JA	Suppression of hepatocyte proliferation by hepatocyte nuclear factor 4α in adult mice.	The Journal of biological chemistry	2012	49
22484425	Tamoxifen	Schulte JH	MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells.	Oncogene	2013	29
22750464	Tamoxifen	Troeger JS	Deactivation of hepatic stellate cells during liver fibrosis resolution in mice.	Gastroenterology	2012	105
23143302	Tamoxifen	Nishio M	Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice.	The Journal of clinical investigation	2012	37
23315968	Tamoxifen	Walesky C	Hepatocyte nuclear factor 4 alpha deletion promotes diethylnitrosamine-induced hepatocellular carcinoma in rodents.	Hepatology	2013	28
23589310	Tamoxifen	Khurana SS	The hyaluronic acid receptor CD44 coordinates normal and metaplastic gastric epithelial progenitor cell proliferation.	The Journal of biological chemistry	2013	32
24746818	Tamoxifen	Luo X	Isolation and molecular characterization of circulating melanoma cells.	Cell reports	2014	32
25474590	Tamoxifen	Zhou X	Chondrocytes transdifferentiate into osteoblasts in endochondral bone during development, postnatal growth and fracture healing in mice.	PLoS genetics	2014	70
25480918	Tamoxifen	López-Arribillaga E	Bmi1 regulates murine intestinal stem cell proliferation and self-renewal downstream of Notch.	Development	2015	19
25792709	Tamoxifen	Gougelet A	Antitumour activity of an inhibitor of miR-34a in liver cancer with β-catenin-mutations.	Gut	2016	13
25964370	Tamoxifen	Walker JA	Bcl11b is essential for group 2 innate lymphoid cell development.	The Journal of experimental medicine	2015	37
26009011	Tamoxifen	Alexandrova EM	Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment.	Nature	2015	49
26341973	Tamoxifen	Jing Y	Chondrocytes Directly Transform into Bone Cells in Mandibular Condyle Growth.	Journal of dental research	2015	17
26538583	Tamoxifen	Tran KA	Endothelial β-Catenin Signaling Is Required for Maintaining Adult Blood-Brain Barrier Integrity and Central Nervous System Homeostasis.	Circulation	2016	11
26592447	Tamoxifen	Bailey JM	p53 mutations cooperate with oncogenic Kras to promote adenocarcinoma from pancreatic ductal cells.	Oncogene	2016	13
26677984	Tamoxifen	Choi E	Expression of Activated Ras in Gastric Chief Cells of Mice Leads to the Full Spectrum of Metaplastic Lineage Transitions.	Gastroenterology	2016	17
16314486	Ethyl carbamate	Stearman RS	Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model.	The American journal of pathology	2005	91
16489016	Ethyl carbamate	Kim IM	The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer.	Cancer research	2006	114
17909629	Ethyl carbamate	Yanagi S	Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice.	The Journal of clinical investigation	2007	62
23143308	Ethyl carbamate	Maeda Y	Kras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung.	The Journal of clinical investigation	2012	36
23610445	Ethyl carbamate	Satoh H	Nrf2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis.	Cancer research	2013	50
25284582	Ethyl carbamate	Zhou J	Differential roles of STAT3 in the initiation and growth of lung cancer.	Oncogene	2015	19
25363767	Ethyl carbamate	Westcott PM	The mutational landscapes of genetic and chemical models of Kras-driven lung cancer.	Nature	2015	58
12138111	Cytosine	Chen T	A novel Dnmt3a isoform produced from an alternative promoter localizes to euchromatin and its expression correlates with active de novo methylation.	The Journal of biological chemistry	2002	95
19047171	Cytosine	Jiang L	Global hypomethylation of genomic DNA in cancer-associated myofibroblasts.	Cancer research	2008	58
21059933	Cytosine	Rishi V	CpG methylation of half-CRE sequences creates C/EBPalpha binding sites that activate some tissue-specific genes.	Proceedings of the National Academy of Sciences of the United States of America	2010	72
22323818	Cytosine	Song J	Structure-based mechanistic insights into DNMT1-mediated maintenance DNA methylation.	Science	2012	67
23401851	Cytosine	Hussain S	The mouse cytosine-5 RNA methyltransferase NSun2 is a component of the chromatoid body and required for testis differentiation.	Molecular and cellular biology	2013	33
23434322	Cytosine	Spruijt CG	Dynamic readers for 5-(hydroxy)methylcytosine and its oxidized derivatives.	Cell	2013	272
23641003	Cytosine	Raddatz G	Dnmt2-dependent methylomes lack defined DNA methylation patterns.	Proceedings of the National Academy of Sciences of the United States of America	2013	65
24156278	Cytosine	Iurlaro M	A screen for hydroxymethylcytosine and formylcytosine binding proteins suggests functions in transcription and chromatin regulation.	Genome biology	2013	71
25063673	Cytosine	Blanco S	Aberrant methylation of tRNAs links cellular stress to neuro-developmental disorders.	The EMBO journal	2014	71
25870282	Cytosine	Chen L	MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2015	61
26586431	Cytosine	Zhao Z	Combined Loss of Tet1 and Tet2 Promotes B Cell, but Not Myeloid Malignancies, in Mice.	Cell reports	2015	22
24984260	Melanin	Yen ST	Somatic mosaicism and allele complexity induced by CRISPR/Cas9 RNA injections in mouse zygotes.	Developmental biology	2014	63
15917471	Acetaldehyde	Pearce DJ	Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples.	Stem cells	2005	88
17628016	Acetaldehyde	Bar EE	Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma.	Stem cells	2007	191
18591932	Acetaldehyde	Korkaya H	HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion.	Oncogene	2008	211
18790753	Acetaldehyde	Feldmann G	An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer.	Molecular cancer therapeutics	2008	89
18829980	Acetaldehyde	Kallifatidis G	Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling.	Gut	2009	62
19072981	Acetaldehyde	Chu P	Characterization of a subpopulation of colon cancer cells with stem cell-like properties.	International journal of cancer	2009	51
19544409	Acetaldehyde	Burger PE	High aldehyde dehydrogenase activity: a novel functional marker of murine prostate stem/progenitor cells.	Stem cells	2009	49
20010854	Acetaldehyde	Li T	ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome.	Laboratory investigation; a journal of technical methods and pathology	2010	111
20019840	Acetaldehyde	Vesuna F	Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression.	Neoplasia	2009	66
20028757	Acetaldehyde	Charafe-Jauffret E	Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.	Clinical cancer research 	2010	238
20073073	Acetaldehyde	Clay MR	Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase.	Head & neck	2010	140
20164446	Acetaldehyde	Rasheed ZA	Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma.	Journal of the National Cancer Institute	2010	139
20309879	Acetaldehyde	Wang L	Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity.	International journal of cancer	2011	37
20388854	Acetaldehyde	Li Y	Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells.	Clinical cancer research 	2010	126
20422001	Acetaldehyde	Deng S	Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers.	PloS one	2010	153
20804964	Acetaldehyde	Ishizawa K	Tumor-initiating cells are rare in many human tumors.	Cell stem cell	2010	78
20959469	Acetaldehyde	Todaro M	Tumorigenic and metastatic activity of human thyroid cancer stem cells.	Cancer research	2010	60
21224357	Acetaldehyde	Liu S	Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks.	Cancer research	2011	167
21304978	Acetaldehyde	Shankar S	Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition.	PloS one	2011	79
21695188	Acetaldehyde	Kim MP	ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.	PloS one	2011	105
21856769	Acetaldehyde	Visus C	Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.	Clinical cancer research 	2011	48
21900397	Acetaldehyde	Lin L	STAT3 is necessary for proliferation and survival in colon cancer-initiating cells.	Cancer research	2011	70
22020330	Acetaldehyde	Canino C	SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells.	Oncogene	2012	33
22162267	Acetaldehyde	Tang AL	UM-SCC-104: a new human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell line.	Head & neck	2012	32
22222226	Acetaldehyde	Wang YC	ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome.	The American journal of pathology	2012	53
22262762	Acetaldehyde	Gerber JM	A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia.	Blood	2012	68
22438320	Acetaldehyde	Germann M	Stem-like cells with luminal progenitor phenotype survive castration in human prostate cancer.	Stem cells	2012	35
22733132	Acetaldehyde	Gong C	Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cells.	Oncogene	2013	65
22887839	Acetaldehyde	Luo Y	ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets.	Stem cells	2012	72
23650391	Acetaldehyde	Mao P	Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3.	Proceedings of the National Academy of Sciences of the United States of America	2013	131
23975425	Acetaldehyde	Qian X	N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties.	Oncogene	2014	33
24652403	Acetaldehyde	Panni RZ	Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer.	Cancer immunology, immunotherapy 	2014	28
25155611	Acetaldehyde	Oberbeck N	Maternal aldehyde elimination during pregnancy preserves the fetal genome.	Molecular cell	2014	21
25445694	Acetaldehyde	Li SY	Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.	Journal of controlled release 	2015	20
26421710	Acetaldehyde	Farnie G	High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.	Oncotarget	2015	30
27634934	Acetaldehyde	Keysar SB	Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.	Journal of the National Cancer Institute	2017	8
24031018	Lipid A	Hagar JA	Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock.	Science	2013	174
25119034	Lipid A	Shi J	Inflammatory caspases are innate immune receptors for intracellular LPS.	Nature	2014	205
26555265	Lipid A	Marty-Roix R	Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants.	The Journal of biological chemistry	2016	14
12477054	Topotecan	Allen JD	Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C.	Molecular cancer therapeutics	2002	111
17975156	Topotecan	de Vries NA	P-glycoprotein and breast cancer resistance protein: two dominant transporters working together in limiting the brain penetration of topotecan.	Clinical cancer research 	2007	68
19584228	Topotecan	Rapisarda A	Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition.	Molecular cancer therapeutics	2009	53
21795476	Topotecan	Kummar S	Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas.	Cancer research	2011	80
22158865	Topotecan	Patel AG	Enhanced killing of cancer cells by poly(ADP-ribose) polymerase inhibitors and topoisomerase I inhibitors reflects poisoning of both enzymes.	The Journal of biological chemistry	2012	35
18339878	Curcumin	Subramaniam D	Diphenyl difluoroketone: a curcumin derivative with potent in vivo anticancer activity.	Cancer research	2008	50
19714451	Curcumin	Padhye S	Fluorocurcumins as cyclooxygenase-2 inhibitor: molecular docking, pharmacokinetics and tissue distribution in mice.	Pharmaceutical research	2009	49
20215512	Curcumin	Lin L	Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells.	Cancer research	2010	73
21915101	Curcumin	Zhuang X	Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain.	Molecular therapy 	2011	163
23299930	Curcumin	Liang Y	Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.	Hepatology	2013	53
23548270	Curcumin	Yu CC	miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer.	Cancer research	2013	40
23894315	Curcumin	Roy S	Difluorinated-curcumin (CDF) restores PTEN expression in colon cancer cells by down-regulating miR-21.	PloS one	2013	27
26116834	Curcumin	Taverna S	Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21.	Oncotarget	2015	15
8630372	Nitric oxide	Dinarello CA	Biologic basis for interleukin-1 in disease.	Blood	1996	686
10952959	Nitric oxide	Lee RJ	VEGF gene delivery to myocardium: deleterious effects of unregulated expression.	Circulation	2000	135
11248803	Nitric oxide	Diefenbach A	Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.	Nature immunology	2000	187
12154060	Nitric oxide	Gupta K	Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth.	Cancer research	2002	91
12892711	Nitric oxide	Gratton JP	Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice.	Cancer cell	2003	77
14611673	Nitric oxide	Tanaka T	A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate.	Cancer science	2003	179
15958541	Nitric oxide	Huang B	Toll-like receptors on tumor cells facilitate evasion of immune surveillance.	Cancer research	2005	140
16227992	Nitric oxide	Chen J	Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo.	Nature medicine	2005	150
16357187	Nitric oxide	Sinha P	Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis.	Cancer research	2005	70
16424049	Nitric oxide	Huang B	Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host.	Cancer research	2006	329
17101732	Nitric oxide	Serafini P	Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function.	The Journal of experimental medicine	2006	198
18972444	Nitric oxide	Wang YD	Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response.	Hepatology	2008	102
20439747	Nitric oxide	Ahn YH	Electrophilic tuning of the chemoprotective natural product sulforaphane.	Proceedings of the National Academy of Sciences of the United States of America	2010	43
20923780	Nitric oxide	Kaur S	Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47.	The Journal of biological chemistry	2010	59
21680779	Nitric oxide	Mundy-Bosse BL	Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice.	Cancer research	2011	48
21729780	Nitric oxide	Eyler CE	Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2.	Cell	2011	88
22065738	Nitric oxide	Liao S	Impaired lymphatic contraction associated with immunosuppression.	Proceedings of the National Academy of Sciences of the United States of America	2011	81
22266027	Nitric oxide	Roberts DD	The matricellular protein thrombospondin-1 globally regulates cardiovascular function and responses to stress via CD47.	Matrix biology 	2012	48
22517765	Nitric oxide	Zimmerman MA	Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fas-mediated apoptosis of T cells.	American journal of physiology. Gastrointestinal and liver physiology	2012	51
22840843	Nitric oxide	Daley-Bauer LP	Cytomegalovirus impairs antiviral CD8+ T cell immunity by recruiting inflammatory monocytes.	Immunity	2012	32
22893683	Nitric oxide	Shaked H	Chronic epithelial NF-κB activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation.	Proceedings of the National Academy of Sciences of the United States of America	2012	43
22936024	Nitric oxide	Tamoutounour S	CD64 distinguishes macrophages from dendritic cells in the gut and reveals the Th1-inducing role of mesenteric lymph node macrophages during colitis.	European journal of immunology	2012	113
23401008	Nitric oxide	He Y	The protein kinase PKR is critical for LPS-induced iNOS production but dispensable for inflammasome activation in macrophages.	European journal of immunology	2013	31
23661553	Nitric oxide	Pang Y	TGF-β signaling in myeloid cells is required for tumor metastasis.	Cancer discovery	2013	27
23733335	Nitric oxide	Mussai F	Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment.	Blood	2013	31
24452999	Nitric oxide	Ling W	Mesenchymal stem cells use IDO to regulate immunity in tumor microenvironment.	Cancer research	2014	35
25370534	Nitric oxide	Shen L	Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models.	Cancer immunology research	2015	16
25710962	Nitric oxide	Ager EI	Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy.	Journal of the National Cancer Institute	2015	21
25849745	Nitric oxide	Granados-Principal S	Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.	Breast cancer research 	2015	30
25985180	Nitric oxide	Finisguerra V	MET is required for the recruitment of anti-tumoural neutrophils.	Nature	2015	39
26956697	Nitric oxide	Wang J	Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression.	The Journal of pathology	2016	17
27865009	Nitric oxide	Gao Y	Melatonin synergizes the chemotherapeutic effect of 5-fluorouracil in colon cancer by suppressing PI3K/AKT and NF-κB/iNOS signaling pathways.	Journal of pineal research	2017	10
28112734	Nitric oxide	Zhao X	JNK1 negatively controls antifungal innate immunity by suppressing CD23 expression.	Nature medicine	2017	7
15087398	Plerixafor	Tavor S	CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice.	Cancer research	2004	78
15574767	Plerixafor	Smith MC	CXCR4 regulates growth of both primary and metastatic breast cancer.	Cancer research	2004	213
16489019	Plerixafor	Yasumoto K	Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer.	Cancer research	2006	62
17893878	Plerixafor	Kajiyama H	Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma.	International journal of cancer	2008	79
19050309	Plerixafor	Nervi B	Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.	Blood	2009	148
19588204	Plerixafor	Matsusue R	Hepatic stellate cells promote liver metastasis of colon cancer cells by the action of SDF-1/CXCR4 axis.	Annals of surgical oncology	2009	45
20179352	Plerixafor	Kioi M	Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.	The Journal of clinical investigation	2010	207
21618540	Plerixafor	Ping YF	The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.	The Journal of pathology	2011	52
21742774	Plerixafor	Righi E	CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer.	Cancer research	2011	51
22045709	Plerixafor	Gourni E	PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent.	Journal of nuclear medicine 	2011	38
22049516	Plerixafor	Juarez JG	Sphingosine-1-phosphate facilitates trafficking of hematopoietic stem cells and their mobilization by CXCR4 antagonists in mice.	Blood	2012	40
22871210	Plerixafor	Zhang SS	CD133(+)CXCR4(+) colon cancer cells exhibit metastatic potential and predict poor prognosis of patients.	BMC medicine	2012	46
24242874	Plerixafor	Chen Y	Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen-positive myeloid cell infiltration in mice.	Hepatology	2014	32
24277834	Plerixafor	Feig C	Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer.	Proceedings of the National Academy of Sciences of the United States of America	2013	169
25444927	Plerixafor	Guan G	The HIF-1α/CXCR4 pathway supports hypoxia-induced metastasis of human osteosarcoma cells.	Cancer letters	2015	16
26031918	Plerixafor	Cho BS	Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy.	Blood	2015	20
26996301	Plerixafor	Wang HH	Mesenchymal stem cells generate pericytes to promote tumor recurrence via vasculogenesis after stereotactic body radiation therapy.	Cancer letters	2016	12
27481956	Plerixafor	Hatzistergos KE	Stimulatory Effects of Mesenchymal Stem Cells on cKit+ Cardiac Stem Cells Are Mediated by SDF1/CXCR4 and SCF/cKit Signaling Pathways.	Circulation research	2016	13
9887098	Hyaluronan	Yu Q	Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion.	Genes & development	1999	145
11278811	Hyaluronan	Prevo R	Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium.	The Journal of biological chemistry	2001	97
11731267	Hyaluronan	Csoka AB	The six hyaluronidase-like genes in the human and mouse genomes.	Matrix biology 	2001	112
19218337	Hyaluronan	Bharadwaj AG	Spontaneous metastasis of prostate cancer is promoted by excess hyaluronan synthesis and processing.	The American journal of pathology	2009	52
19965872	Hyaluronan	Takahashi E	Tumor necrosis factor-alpha regulates transforming growth factor-beta-dependent epithelial-mesenchymal transition by promoting hyaluronan-CD44-moesin interaction.	The Journal of biological chemistry	2010	58
21673348	Hyaluronan	Ellis SL	The relationship between bone, hemopoietic stem cells, and vasculature.	Blood	2011	42
23633482	Hyaluronan	Hiraga T	Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production.	Cancer research	2013	69
23760401	Hyaluronan	Bjorklund CC	Evidence of a role for CD44 and cell adhesion in mediating resistance to lenalidomide in multiple myeloma: therapeutic implications.	Leukemia	2014	24
23783513	Hyaluronan	Tian X	High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat.	Nature	2013	130
16187797	Gefitinib	Greulich H	Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants.	PLoS medicine	2005	192
18292095	Gefitinib	Soeda A	Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells.	The Journal of biological chemistry	2008	57
19435898	Gefitinib	Mukherjee B	EGFRvIII and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastoma.	Cancer research	2009	74
22414764	Gefitinib	Blivet-Van Eggelpoël MJ	Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells.	Journal of hepatology	2012	39
23307622	Gefitinib	Cufí S	Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatment.	Oncotarget	2012	33
24983493	Gefitinib	Zhou JY	MicroRNA-34a overcomes HGF-mediated gefitinib resistance in EGFR mutant lung cancer cells partly by targeting MET.	Cancer letters	2014	21
23940356	Lapatinib	Hanker AB	Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies.	Proceedings of the National Academy of Sciences of the United States of America	2013	43
24097864	Lapatinib	Phillips GD	Dual targeting of HER2-positive cancer with trastuzumab emtansine and pertuzumab: critical role for neuregulin blockade in antitumor response to combination therapy.	Clinical cancer research 	2014	36
24518603	Lapatinib	Liu YJ	HER2, MET and FGFR2 oncogenic driver alterations define distinct molecular segments for targeted therapies in gastric carcinoma.	British journal of cancer	2014	31
8169003	Ornithine	Wu HC	Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells.	International journal of cancer	1994	144
15894264	Ornithine	Nilsson JA	Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation.	Cancer cell	2005	71
20432256	Ornithine	Song G	MicroRNAs control hepatocyte proliferation during liver regeneration.	Hepatology	2010	55
8700231	L-Threonine	Nussenzweig A	Requirement for Ku80 in growth and immunoglobulin V(D)J recombination.	Nature	1996	184
9155017	L-Threonine	Waskiewicz AJ	Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2.	The EMBO journal	1997	225
9334355	L-Threonine	Serra R	Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis.	The Journal of cell biology	1997	117
9539744	L-Threonine	Novak A	Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways.	Proceedings of the National Academy of Sciences of the United States of America	1998	102
10545105	L-Threonine	Harada N	Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene.	The EMBO journal	1999	438
10574705	L-Threonine	Piek E	TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells.	Journal of cell science	1999	118
10772805	L-Threonine	Beppu H	BMP type II receptor is required for gastrulation and early development of mouse embryos.	Developmental biology	2000	96
11509733	L-Threonine	Ylikorkala A	Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice.	Science	2001	89
11920677	L-Threonine	Ten Dijke P	Regulation of cell proliferation by Smad proteins.	Journal of cellular physiology	2002	103
11923871	L-Threonine	Suzuki N	Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4.	Nature	2002	141
12796778	L-Threonine	Toyo-oka K	14-3-3epsilon is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller-Dieker syndrome.	Nature genetics	2003	102
12891359	L-Threonine	Liou YC	Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration.	Nature	2003	108
15103331	L-Threonine	Yada M	Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7.	The EMBO journal	2004	240
15199164	L-Threonine	Mikkers H	Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors.	Molecular and cellular biology	2004	93
16236519	L-Threonine	Malumbres M	Mammalian cyclin-dependent kinases.	Trends in biochemical sciences	2005	262
16453000	L-Threonine	Ratajczak J	Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery.	Leukemia	2006	338
16554819	L-Threonine	Pastorino L	The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production.	Nature	2006	135
17187069	L-Threonine	Hsu YM	The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens.	Nature immunology	2007	122
17291758	L-Threonine	Steegmaier M	BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo.	Current biology 	2007	242
17379520	L-Threonine	Guo C	RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network.	Current biology 	2007	73
17676035	L-Threonine	Ji H	LKB1 modulates lung cancer differentiation and metastasis.	Nature	2007	327
17911593	L-Threonine	Tili E	Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock.	Journal of immunology	2007	418
18806775	L-Threonine	Wang Z	Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy.	Nature	2008	93
19276360	L-Threonine	Hoeflich KP	Antitumor efficacy of the novel RAF inhibitor GDC-0879 is predicted by BRAFV600E mutational status and sustained extracellular signal-regulated kinase/mitogen-activated protein kinase pathway suppression.	Cancer research	2009	55
19609947	L-Threonine	Bai D	Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and Akt.	International journal of cancer	2009	67
19879149	L-Threonine	Le Guezennec X	WIP1 phosphatase at the crossroads of cancer and aging.	Trends in biochemical sciences	2010	48
20360563	L-Threonine	Albers HM	Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation.	Proceedings of the National Academy of Sciences of the United States of America	2010	65
20460511	L-Threonine	Cammareri P	Aurora-a is essential for the tumorigenic capacity and chemoresistance of colorectal cancer stem cells.	Cancer research	2010	42
20580720	L-Threonine	Lee G	Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitis.	Gastroenterology	2010	57
20679220	L-Threonine	Ueda T	Combined deficiency for MAP kinase-interacting kinase 1 and 2 (Mnk1 and Mnk2) delays tumor development.	Proceedings of the National Academy of Sciences of the United States of America	2010	51
21266350	L-Threonine	Wang X	Phosphorylation regulates c-Myc's oncogenic activity in the mammary gland.	Cancer research	2011	51
21368761	L-Threonine	Zhang H	Functional complementation between FADD and RIP1 in embryos and lymphocytes.	Nature	2011	154
21490399	L-Threonine	Chan AC	Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice.	The Journal of clinical investigation	2011	38
21638088	L-Threonine	Capper D	Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody.	Acta neuropathologica	2011	79
22547771	L-Threonine	Flechsig P	LY2109761 attenuates radiation-induced pulmonary murine fibrosis via reversal of TGF-β and BMP-associated proinflammatory and proangiogenic signals.	Clinical cancer research 	2012	42
22552290	L-Threonine	Saini S	miRNA-708 control of CD44(+) prostate cancer-initiating cells.	Cancer research	2012	38
22710160	L-Threonine	Cai J	BMP signaling in vascular diseases.	FEBS letters	2012	61
23209306	L-Threonine	Ricke RM	Bub1 kinase activity drives error correction and mitotic checkpoint control but not tumor suppression.	The Journal of cell biology	2012	34
23249624	L-Threonine	Mittapalli RK	Mechanisms limiting distribution of the threonine-protein kinase B-RaF(V600E) inhibitor dabrafenib to the brain: implications for the treatment of melanoma brain metastases.	The Journal of pharmacology and experimental therapeutics	2013	28
23715154	L-Threonine	Liu Y	Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer.	Cancer discovery	2013	38
24497535	L-Threonine	Wong WW	cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1- and RIPK3-dependent manner.	Blood	2014	38
24799700	L-Threonine	Philip NH	Caspase-8 mediates caspase-1 processing and innate immune defense in response to bacterial blockade of NF-κB and MAPK signaling.	Proceedings of the National Academy of Sciences of the United States of America	2014	43
24801365	L-Threonine	Souchet B	Excitation/inhibition balance and learning are modified by Dyrk1a gene dosage.	Neurobiology of disease	2014	23
25015821	L-Threonine	Polykratis A	Cutting edge: RIPK1 Kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo.	Journal of immunology	2014	53
25042806	L-Threonine	Goodwin JM	An AMPK-independent signaling pathway downstream of the LKB1 tumor suppressor controls Snail1 and metastatic potential.	Molecular cell	2014	32
26073081	L-Threonine	Fedorenko IV	Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells.	Oncogene	2016	14
27463676	L-Threonine	Dorand RD	Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity.	Science	2016	26
27487218	L-Threonine	Strilic B	Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis.	Nature	2016	19
27626381	L-Threonine	Eil R	Ionic immune suppression within the tumour microenvironment limits T cell effector function.	Nature	2016	30
9395435	L-Serine	Sells MA	Human p21-activated kinase (Pak1) regulates actin organization in mammalian cells.	Current biology 	1997	206
9447975	L-Serine	Schönwasser DC	Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes.	Molecular and cellular biology	1998	156
10197582	L-Serine	Korsmeyer SJ	BCL-2 gene family and the regulation of programmed cell death.	Cancer research	1999	123
10364156	L-Serine	Coussens LM	Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis.	Genes & development	1999	220
10710310	L-Serine	Hirao A	DNA damage-induced activation of p53 by the checkpoint kinase Chk2.	Science	2000	285
11333986	L-Serine	Bulavin DV	Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase.	Nature	2001	128
11805292	L-Serine	Liou YC	Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes.	Proceedings of the National Academy of Sciences of the United States of America	2002	94
12527751	L-Serine	Wolf K	Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis.	The Journal of cell biology	2003	378
12531874	L-Serine	Lévesque JP	Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide.	The Journal of clinical investigation	2003	164
12629547	L-Serine	Plant PJ	A polarity complex of mPar-6 and atypical PKC binds, phosphorylates and regulates mammalian Lgl.	Nature cell biology	2003	105
12897845	L-Serine	Pilch DR	Characteristics of gamma-H2AX foci at DNA double-strand breaks sites.	Biochemistry and cell biology = Biochimie et biologie cellulaire	2003	133
15509788	L-Serine	Martins LM	Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice.	Molecular and cellular biology	2004	93
16906133	L-Serine	Pellegrini M	Autophosphorylation at serine 1987 is dispensable for murine Atm activation in vivo.	Nature	2006	62
17101782	L-Serine	Tan Y	Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes.	Molecular and cellular biology	2007	89
17160391	L-Serine	Chang YS	Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models.	Cancer chemotherapy and pharmacology	2007	108
17456473	L-Serine	Thakurdas SM	The mast cell-restricted tryptase mMCP-6 has a critical immunoprotective role in bacterial infections.	The Journal of biological chemistry	2007	65
17460049	L-Serine	Ju X	Akt1 governs breast cancer progression in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2007	82
17906618	L-Serine	Plun-Favreau H	The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1.	Nature cell biology	2007	151
19131594	L-Serine	Wegrzyn J	Function of mitochondrial Stat3 in cellular respiration.	Science	2009	246
19717635	L-Serine	List K	Epithelial integrity is maintained by a matriptase-dependent proteolytic pathway.	The American journal of pathology	2009	54
19920354	L-Serine	Santos AM	Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice.	The Journal of clinical investigation	2009	88
20133717	L-Serine	Zhang M	Selective targeting of radiation-resistant tumor-initiating cells.	Proceedings of the National Academy of Sciences of the United States of America	2010	70
20140016	L-Serine	Wang J	Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma.	Oncogene	2010	46
20651683	L-Serine	Choi JH	Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.	Nature	2010	247
21233335	L-Serine	Konicek BW	Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastases.	Cancer research	2011	52
21382551	L-Serine	Sun Y	Phosphorylation state of Olig2 regulates proliferation of neural progenitors.	Neuron	2011	41
21538350	L-Serine	Thaiparambil JT	Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation.	International journal of cancer	2011	55
21668992	L-Serine	Lee HO	FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells.	BMC cancer	2011	48
21698133	L-Serine	Marshall GM	SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stability.	PLoS genetics	2011	47
21710321	L-Serine	Bidart M	BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomain.	Cellular and molecular life sciences 	2012	34
22128155	L-Serine	Ho KK	Phosphorylation of FOXO3a on Ser-7 by p38 promotes its nuclear localization in response to doxorubicin.	The Journal of biological chemistry	2012	35
23045282	L-Serine	Hsu YL	Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/snail signaling pathway.	Oncogene	2013	28
23306062	L-Serine	Laine A	Senescence sensitivity of breast cancer cells is defined by positive feedback loop between CIP2A and E2F1.	Cancer discovery	2013	32
23332762	L-Serine	Yan J	Inactivation of BAD by IKK inhibits TNFα-induced apoptosis independently of NF-κB activation.	Cell	2013	27
23376950	L-Serine	Braumüller H	T-helper-1-cell cytokines drive cancer into senescence.	Nature	2013	146
23449797	L-Serine	Jha HC	H2AX phosphorylation is important for LANA-mediated Kaposi's sarcoma-associated herpesvirus episome persistence.	Journal of virology	2013	33
23898178	L-Serine	Thapa RJ	Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases.	Proceedings of the National Academy of Sciences of the United States of America	2013	80
24040362	L-Serine	Zins K	A Rac1/Cdc42 GTPase-specific small molecule inhibitor suppresses growth of primary human prostate cancer xenografts and prolongs survival in mice.	PloS one	2013	26
24204027	L-Serine	Khanna A	Cancerous inhibitor of protein phosphatase 2A, an emerging human oncoprotein and a potential cancer therapy target.	Cancer research	2013	43
24469043	L-Serine	Sales KU	Non-hematopoietic PAR-2 is essential for matriptase-driven pre-malignant progression and potentiation of ras-mediated squamous cell carcinogenesis.	Oncogene	2015	16
24488013	L-Serine	Miao H	EphA2 promotes infiltrative invasion of glioma stem cells in vivo through cross-talk with Akt and regulates stem cell properties.	Oncogene	2015	30
24503642	L-Serine	Brosens JJ	Uterine selection of human embryos at implantation.	Scientific reports	2014	24
24591637	L-Serine	Wang S	Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer.	Proceedings of the National Academy of Sciences of the United States of America	2014	32
24657168	L-Serine	Rao F	Inositol pyrophosphates mediate the DNA-PK/ATM-p53 cell death pathway by regulating CK2 phosphorylation of Tti1/Tel2.	Molecular cell	2014	24
25195567	L-Serine	Paulo JA	Effects of MEK inhibitors GSK1120212 and PD0325901 in vivo using 10-plex quantitative proteomics and phosphoproteomics.	Proteomics	2015	23
25409143	L-Serine	Banks AS	An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ.	Nature	2015	46
25497381	L-Serine	Koromilas AE	Roles of the translation initiation factor eIF2α serine 51 phosphorylation in cancer formation and treatment.	Biochimica et biophysica acta	2015	25
25550516	L-Serine	Cipolletta D	Appearance and disappearance of the mRNA signature characteristic of Treg cells in visceral adipose tissue: age, diet, and PPARγ effects.	Proceedings of the National Academy of Sciences of the United States of America	2015	20
25590801	L-Serine	Rajesh K	Phosphorylation of the translation initiation factor eIF2α at serine 51 determines the cell fate decisions of Akt in response to oxidative stress.	Cell death & disease	2015	21
25601544	L-Serine	Zhang L	NDR functions as a physiological YAP1 kinase in the intestinal epithelium.	Current biology 	2015	22
25860938	L-Serine	Principe M	Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells.	Oncotarget	2015	24
25915831	L-Serine	Vicuña L	The serine protease inhibitor SerpinA3N attenuates neuropathic pain by inhibiting T cell-derived leukocyte elastase.	Nature medicine	2015	22
26416733	L-Serine	Usami Y	SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef.	Nature	2015	54
28279977	L-Serine	Pan CW	AKT-phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1-MAPK interaction.	The EMBO journal	2017	7
10728691	Celecoxib	Masferrer JL	Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.	Cancer research	2000	178
11606477	Celecoxib	Grösch S	COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.	FASEB journal 	2001	87
19218449	Celecoxib	Hu M	Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast.	Proceedings of the National Academy of Sciences of the United States of America	2009	68
20124728	Celecoxib	Hirota Y	Uterine-specific p53 deficiency confers premature uterine senescence and promotes preterm birth in mice.	The Journal of clinical investigation	2010	65
21324923	Celecoxib	Fujita M	COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells.	Cancer research	2011	94
21730361	Celecoxib	Nakanishi Y	COX-2 inhibition alters the phenotype of tumor-associated macrophages from M2 to M1 in ApcMin/+ mouse polyps.	Carcinogenesis	2011	44
26261008	Celecoxib	Wang D	Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.	Gastroenterology	2015	26
8622766	All-trans-retinoic acid	Zhang J	Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2.	Nature	1996	127
9488655	All-trans-retinoic acid	Wang ZG	Role of PML in cell growth and the retinoic acid pathway.	Science	1998	142
10469643	All-trans-retinoic acid	Quadro L	Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein.	The EMBO journal	1999	129
10688798	All-trans-retinoic acid	Meng X	Regulation of cell fate decision of undifferentiated spermatogonia by GDNF.	Science	2000	290
11491531	All-trans-retinoic acid	Steinle A	Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family.	Immunogenetics	2001	97
15003116	All-trans-retinoic acid	Sempere LF	Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation.	Genome biology	2004	524
15030763	All-trans-retinoic acid	Yashiro K	Regulation of retinoic acid distribution is required for proximodistal patterning and outgrowth of the developing mouse limb.	Developmental cell	2004	78
16399080	All-trans-retinoic acid	Guris DL	Dose-dependent interaction of Tbx1 and Crkl and locally aberrant RA signaling in a model of del22q11 syndrome.	Developmental cell	2006	63
17475874	All-trans-retinoic acid	Venkataraman T	Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses.	Journal of immunology	2007	117
17574023	All-trans-retinoic acid	Walkley CR	A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency.	Cell	2007	152
17581589	All-trans-retinoic acid	Nurieva R	Essential autocrine regulation by IL-21 in the generation of inflammatory T cells.	Nature	2007	511
17584971	All-trans-retinoic acid	MacLean G	Apoptotic extinction of germ cells in testes of Cyp26b1 knockout mice.	Endocrinology	2007	72
17653195	All-trans-retinoic acid	Malathi K	Small self-RNA generated by RNase L amplifies antiviral innate immunity.	Nature	2007	183
18164222	All-trans-retinoic acid	Yang XO	T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma.	Immunity	2008	483
19797526	All-trans-retinoic acid	Guibal FC	Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia.	Blood	2009	49
21531907	All-trans-retinoic acid	Herquel B	Transcription cofactors TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes that suppress murine hepatocellular carcinoma.	Proceedings of the National Academy of Sciences of the United States of America	2011	40
22291094	All-trans-retinoic acid	Shaw MH	Microbiota-induced IL-1β, but not IL-6, is critical for the development of steady-state TH17 cells in the intestine.	The Journal of experimental medicine	2012	103
22484541	All-trans-retinoic acid	Liu CX	Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells.	Nature chemical biology	2012	31
22908322	All-trans-retinoic acid	Schlenner SM	Smad3 binding to the foxp3 enhancer is dispensable for the development of regulatory T cells with the exception of the gut.	The Journal of experimental medicine	2012	39
22945631	All-trans-retinoic acid	Ruocco MG	Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects.	The Journal of clinical investigation	2012	57
23166357	All-trans-retinoic acid	Jung H	RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which control cell cycle entry.	The Journal of experimental medicine	2012	42
24931123	All-trans-retinoic acid	Zhu J	Antiviral activity of human OASL protein is mediated by enhancing signaling of the RIG-I RNA sensor.	Immunity	2014	40
25119032	All-trans-retinoic acid	Goubau D	Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5'-diphosphates.	Nature	2014	94
25557055	All-trans-retinoic acid	Sato S	The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus.	Immunity	2015	62
25586558	All-trans-retinoic acid	Cao AT	Interleukin (IL)-21 promotes intestinal IgA response to microbiota.	Mucosal immunology	2015	15
25894825	All-trans-retinoic acid	Ilkow CS	Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity.	Nature medicine	2015	27
27096319	All-trans-retinoic acid	Blank T	Brain Endothelial- and Epithelial-Specific Interferon Receptor Chain 1 Drives Virus-Induced Sickness Behavior and Cognitive Impairment.	Immunity	2016	12
15122762	Carbon tetrachloride	Radaeva S	Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation.	Hepatology	2004	170
20618941	Carbon tetrachloride	Fujii T	Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor.	BMC gastroenterology	2010	44
22198715	Carbon tetrachloride	Gur C	NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis.	Gut	2012	31
23842754	Carbon tetrachloride	Tan Z	IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation.	Journal of immunology	2013	45
24677197	Carbon tetrachloride	Fuchs BC	Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.	Hepatology	2014	68
26385087	Carbon tetrachloride	Klein S	Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis.	Gut	2017	5
27001906	Carbon tetrachloride	Hyun J	MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression.	Nature communications	2016	20
15098032	Imatinib	Hu Y	Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia.	Nature genetics	2004	108
15557593	Imatinib	Pietras K	A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer.	Journal of clinical oncology 	2005	112
16618932	Imatinib	Williams RT	Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemia.	Proceedings of the National Academy of Sciences of the United States of America	2006	86
17077147	Imatinib	Hu Y	Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice.	Proceedings of the National Academy of Sciences of the United States of America	2006	117
18232728	Imatinib	Pietras K	Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting.	PLoS medicine	2008	113
18818703	Imatinib	Hu Y	beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia.	Leukemia	2009	65
19169242	Imatinib	Zhao C	Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia.	Nature	2009	240
19878872	Imatinib	O'Hare T	AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance.	Cancer cell	2009	235
20621681	Imatinib	Bardsley MR	Kitlow stem cells cause resistance to Kit/platelet-derived growth factor alpha inhibitors in murine gastrointestinal stromal tumors.	Gastroenterology	2010	41
21665148	Imatinib	Schmidt T	Loss or inhibition of stromal-derived PlGF prolongs survival of mice with imatinib-resistant Bcr-Abl1(+) leukemia.	Cancer cell	2011	38
21873989	Imatinib	Balachandran VP	Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido.	Nature medicine	2011	140
23505219	Imatinib	Cadamuro M	Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma.	Hepatology	2013	28
23518349	Imatinib	Takeishi S	Ablation of Fbxw7 eliminates leukemia-initiating cells by preventing quiescence.	Cancer cell	2013	41
24778155	Imatinib	Herrmann H	Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia.	Blood	2014	28
28329763	Imatinib	Wylie AA	The allosteric inhibitor ABL001 enables dual targeting of BCR-ABL1.	Nature	2017	6
12538485	Sunitinib	Mendel DB	In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship.	Clinical cancer research 	2003	393
18310500	Sunitinib	Hipp MM	Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses.	Blood	2008	71
19887629	Sunitinib	Lee SL	Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model.	Proceedings of the National Academy of Sciences of the United States of America	2009	59
21633954	Sunitinib	Farsaci B	Consequence of dose scheduling of sunitinib on host immune response elements and vaccine combination therapy.	International journal of cancer	2012	42
22308314	Sunitinib	Conley SJ	Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia.	Proceedings of the National Academy of Sciences of the United States of America	2012	160
22484816	Sunitinib	Maione F	Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice.	The Journal of clinical investigation	2012	36
22585997	Sunitinib	Sennino B	Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors.	Cancer discovery	2012	98
22965162	Sunitinib	Piao Y	Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype.	Neuro-oncology	2012	54
25361735	Sunitinib	Huang H	VEGF suppresses T-lymphocyte infiltration in the tumor microenvironment through inhibition of NF-κB-induced endothelial activation.	FASEB journal 	2015	22
16609043	Erlotinib	Sarkaria JN	Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response.	Clinical cancer research 	2006	112
16730237	Erlotinib	Ji H	The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies.	Cancer cell	2006	130
19238632	Erlotinib	Tang Z	Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer.	British journal of cancer	2008	59
19452131	Erlotinib	Li T	Skin toxicities associated with epidermal growth factor receptor inhibitors.	Targeted oncology	2009	52
20603615	Erlotinib	Ye X	An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies.	Oncogene	2010	71
9661897	Paclitaxel	Baselga J	Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts.	Cancer research	1998	130
11325840	Paclitaxel	Machiels JP	Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice.	Cancer research	2001	130
11861387	Paclitaxel	Hu L	Inhibition of phosphatidylinositol 3'-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models.	Cancer research	2002	85
16061675	Paclitaxel	Landen CN Jr	Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery.	Cancer research	2005	192
17234791	Paclitaxel	Hou DY	Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses.	Cancer research	2007	146
17611683	Paclitaxel	Kajiyama H	Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells.	International journal of oncology	2007	127
17965935	Paclitaxel	Zhou J	NF-kappaB pathway inhibitors preferentially inhibit breast cancer stem-like cells.	Breast cancer research and treatment	2008	55
18772115	Paclitaxel	Shaked Y	Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents.	Cancer cell	2008	130
19665763	Paclitaxel	Inaba T	Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma.	Gynecologic oncology	2009	47
20378772	Paclitaxel	Sugahara KN	Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs.	Science	2010	206
20829328	Paclitaxel	Lockman PR	Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer.	Clinical cancer research 	2010	135
21204585	Paclitaxel	Sun TM	Simultaneous delivery of siRNA and paclitaxel via a "two-in-one" micelleplex promotes synergistic tumor suppression.	ACS nano	2011	67
22039576	Paclitaxel	DeNardo DG	Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy.	Cancer discovery	2011	404
22335738	Paclitaxel	Stone RL	Paraneoplastic thrombocytosis in ovarian cancer.	The New England journal of medicine	2012	130
23208505	Paclitaxel	Lock FE	Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.	Oncogene	2013	49
23359505	Paclitaxel	Sevko A	Antitumor effect of paclitaxel is mediated by inhibition of myeloid-derived suppressor cells and chronic inflammation in the spontaneous melanoma model.	Journal of immunology	2013	31
23391723	Paclitaxel	Bhola NE	TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer.	The Journal of clinical investigation	2013	106
23514751	Paclitaxel	Khongkow M	SIRT6 modulates paclitaxel and epirubicin resistance and survival in breast cancer.	Carcinogenesis	2013	29
23871962	Paclitaxel	Swaminathan SK	CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer.	Journal of controlled release 	2013	27
23932498	Paclitaxel	Cui Y	Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment.	Biomaterials	2013	25
23943797	Paclitaxel	Cieply B	Epithelial-mesenchymal transition and tumor suppression are controlled by a reciprocal feedback loop between ZEB1 and Grainyhead-like-2.	Cancer research	2013	39
24170767	Paclitaxel	Liu N	BAY 80-6946 is a highly selective intravenous PI3K inhibitor with potent p110α and p110δ activities in tumor cell lines and xenograft models.	Molecular cancer therapeutics	2013	32
24502925	Paclitaxel	Bergfeld SA	Bone marrow-derived mesenchymal stromal cells promote survival and drug resistance in tumor cells.	Molecular cancer therapeutics	2014	20
24619206	Paclitaxel	Wu SY	2'-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity.	Nature communications	2014	22
25239937	Paclitaxel	Alewine C	Efficacy of RG7787, a next-generation mesothelin-targeted immunotoxin, against triple-negative breast and gastric cancers.	Molecular cancer therapeutics	2014	28
25483077	Paclitaxel	Yano S	Tumor-targeting Salmonella typhimurium A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapy.	Cell cycle	2014	43
25595279	Paclitaxel	Gonzalez-Villasana V	Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian Cancer.	Clinical cancer research 	2015	19
25716473	Paclitaxel	Shiao SL	TH2-Polarized CD4(+) T Cells and Macrophages Limit Efficacy of Radiotherapy.	Cancer immunology research	2015	28
25818419	Paclitaxel	Jiang L	Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response.	Biomaterials	2015	20
25934888	Paclitaxel	Yen WC	Targeting Notch signaling with a Notch2/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency.	Clinical cancer research 	2015	42
26573793	Paclitaxel	Peng J	Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer.	Cancer research	2015	24
28125674	Paclitaxel	Makker PG	Characterisation of Immune and Neuroinflammatory Changes Associated with Chemotherapy-Induced Peripheral Neuropathy.	PloS one	2017	7
28209618	Paclitaxel	Chen MW	The STAT3-miRNA-92-Wnt Signaling Pathway Regulates Spheroid Formation and Malignant Progression in Ovarian Cancer.	Cancer research	2017	7
19726678	Sorafenib	Bai S	MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib.	The Journal of biological chemistry	2009	157
20570927	Sorafenib	Zhang W	Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects.	Clinical cancer research 	2010	92
20616044	Sorafenib	Wüstehube J	Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling.	Proceedings of the National Academy of Sciences of the United States of America	2010	47
21368833	Sorafenib	Inuzuka H	SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction.	Nature	2011	195
22318717	Sorafenib	Ma WL	Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis.	Hepatology	2012	35
23796475	Sorafenib	Kapanadze T	Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma.	Journal of hepatology	2013	33
24700742	Sorafenib	Xiang Q	Cabozantinib suppresses tumor growth and metastasis in hepatocellular carcinoma by a dual blockade of VEGFR2 and MET.	Clinical cancer research 	2014	26
24811485	Sorafenib	Graham RM	Inhibition of the vacuolar ATPase induces Bnip3-dependent death of cancer cells and a reduction in tumor burden and metastasis.	Oncotarget	2014	21
25053293	Sorafenib	Fernando J	A mesenchymal-like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells.	International journal of cancer	2015	23
25216638	Sorafenib	Rudalska R	In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer.	Nature medicine	2014	43
25938543	Sorafenib	Dai W	By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice.	Oncotarget	2015	24
26154152	Sorafenib	Won C	Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma.	Hepatology	2015	21
26592953	Sorafenib	Govaere O	Laminin-332 sustains chemoresistance and quiescence as part of the human hepatic cancer stem cell niche.	Journal of hepatology	2016	13
15256671	Dasatinib	Shah NP	Overriding imatinib resistance with a novel ABL kinase inhibitor.	Science	2004	350
19451690	Dasatinib	Sos ML	Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions.	The Journal of clinical investigation	2009	104
20303350	Dasatinib	Morton JP	Dasatinib inhibits the development of metastases in a mouse model of pancreatic ductal adenocarcinoma.	Gastroenterology	2010	46
21282564	Dasatinib	Baker AM	The role of lysyl oxidase in SRC-dependent proliferation and metastasis of colorectal cancer.	Journal of the National Cancer Institute	2011	43
22169110	Dasatinib	Packer LM	Nilotinib and MEK inhibitors induce synthetic lethality through paradoxical activation of RAF in drug-resistant chronic myeloid leukemia.	Cancer cell	2011	42
22184410	Dasatinib	Hamilton A	Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival.	Blood	2012	88
26321221	Dasatinib	Churchman ML	Efficacy of Retinoids in IKZF1-Mutated BCR-ABL1 Acute Lymphoblastic Leukemia.	Cancer cell	2015	26
10639156	N,N'-dinitrosopiperazine	Shimizu Y	Benzoapyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor.	Proceedings of the National Academy of Sciences of the United States of America	2000	98
11544530	N,N'-dinitrosopiperazine	Krimpenfort P	Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice.	Nature	2001	140
12878730	N,N'-dinitrosopiperazine	Fingerle-Rowson G	The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting.	Proceedings of the National Academy of Sciences of the United States of America	2003	96
14734483	N,N'-dinitrosopiperazine	Tang XH	Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice.	Clinical cancer research 	2004	85
16103220	N,N'-dinitrosopiperazine	List K	Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation.	Genes & development	2005	70
16880406	N,N'-dinitrosopiperazine	Myung SJ	15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis.	Proceedings of the National Academy of Sciences of the United States of America	2006	89
17283139	N,N'-dinitrosopiperazine	Krelin Y	Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors.	Cancer research	2007	73
20093774	N,N'-dinitrosopiperazine	Lin RK	The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients.	The Journal of clinical investigation	2010	65
20924108	N,N'-dinitrosopiperazine	Elyakim E	hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy.	Cancer research	2010	42
22532166	N,N'-dinitrosopiperazine	Ho PL	Stat3 activation in urothelial stem cells leads to direct progression to invasive bladder cancer.	Cancer research	2012	34
23273920	N,N'-dinitrosopiperazine	Schwitalla S	Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors.	Cancer cell	2013	60
23926199	N,N'-dinitrosopiperazine	Poon SL	Genome-wide mutational signatures of aristolochic acid and its application as a screening tool.	Science translational medicine	2013	55
25901316	N,N'-dinitrosopiperazine	Souza-Fonseca-Guimaraes F	NK cells require IL-28R for optimal in vivo activity.	Proceedings of the National Academy of Sciences of the United States of America	2015	25
16239969	Clodronate	Nakao S	Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth.	The Journal of clinical investigation	2005	76
17460736	Clodronate	Gazzaniga S	Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft.	The Journal of investigative dermatology	2007	74
20145121	Clodronate	Meng Y	Blockade of tumor necrosis factor alpha signaling in tumor-associated macrophages as a radiosensitizing strategy.	Cancer research	2010	48
21411646	Clodronate	Zattoni M	Brain infiltration of leukocytes contributes to the pathophysiology of temporal lobe epilepsy.	The Journal of neuroscience 	2011	48
22273460	Clodronate	Bonde AK	Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors.	BMC cancer	2012	55
23645836	Clodronate	De Filippo K	Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation.	Blood	2013	97
25536148	Clodronate	Schmall A	Macrophage and cancer cell cross-talk via CCR2 and CX3CR1 is a fundamental mechanism driving lung cancer.	American journal of respiratory and critical care medicine	2015	20
25888329	Clodronate	Beatty GL	Exclusion of T Cells From Pancreatic Carcinomas in Mice Is Regulated by Ly6C(low) F4/80(+) Extratumoral Macrophages.	Gastroenterology	2015	33
26522085	Clodronate	Hanna BS	Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivo.	Leukemia	2016	19
16723399	Irinotecan	Agrelo R	Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer.	Proceedings of the National Academy of Sciences of the United States of America	2006	74
18560594	Irinotecan	Dylla SJ	Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy.	PloS one	2008	174
20167811	Irinotecan	de Groot JF	Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice.	Neuro-oncology	2010	166
22825584	Irinotecan	Julien S	Characterization of a large panel of patient-derived tumor xenografts representing the clinical heterogeneity of human colorectal cancer.	Clinical cancer research 	2012	77
23081779	Irinotecan	Kobayashi S	LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution.	Stem cells	2012	38
18577219	Decitabine	Silber J	miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.	BMC medicine	2008	301
22002305	Decitabine	Ramachandran I	Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.	Oncogene	2012	35
22237753	Decitabine	Sun CY	Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation.	Kidney international	2012	35
23079745	Decitabine	Kim JK	Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b.	Hepatology	2013	68
23236145	Decitabine	Leonova KI	p53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs.	Proceedings of the National Academy of Sciences of the United States of America	2013	72
23318422	Decitabine	Xiang Y	MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine.	Oncogene	2014	49
23493348	Decitabine	Huang X	Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia.	Clinical cancer research 	2013	44
23856509	Decitabine	Koukos G	MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis.	Gastroenterology	2013	51
25224413	Decitabine	Bejar R	TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients.	Blood	2014	76
27623509	Decitabine	Lucarini V	Combining Type I Interferons and 5-Aza-2'-Deoxycitidine to Improve Anti-Tumor Response against Melanoma.	The Journal of investigative dermatology	2017	7
18006697	Bortezomib	Chauhan D	Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myeloma.	Blood	2008	63
18097016	Bortezomib	Hallett WH	Sensitization of tumor cells to NK cell-mediated killing by proteasome inhibition.	Journal of immunology	2008	54
19436050	Bortezomib	Hideshima T	Bortezomib induces canonical nuclear factor-kappaB activation in multiple myeloma cells.	Blood	2009	105
20233973	Bortezomib	Dasmahapatra G	The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo.	Blood	2010	48
20388793	Bortezomib	Grisendi G	Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy.	Cancer research	2010	53
20505158	Bortezomib	Ikeda H	PI3K/p110{delta} is a novel therapeutic target in multiple myeloma.	Blood	2010	65
20805366	Bortezomib	Chauhan D	A novel orally active proteasome inhibitor ONX 0912 triggers in vitro and in vivo cytotoxicity in multiple myeloma.	Blood	2010	48
21444945	Bortezomib	Neznanov N	Proteotoxic stress targeted therapy (PSTT): induction of protein misfolding enhances the antitumor effect of the proteasome inhibitor bortezomib.	Oncotarget	2011	53
21874163	Bortezomib	Xue W	Response and resistance to NF-κB inhibitors in mouse models of lung adenocarcinoma.	Cancer discovery	2011	37
21917757	Bortezomib	Neri P	Bortezomib-induced "BRCAness" sensitizes multiple myeloma cells to PARP inhibitors.	Blood	2011	35
22572880	Bortezomib	Arora R	Survivin is a therapeutic target in Merkel cell carcinoma.	Science translational medicine	2012	40
22763387	Bortezomib	Hurchla MA	The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects.	Leukemia	2013	31
23341542	Bortezomib	Vandenberg CJ	ABT-199, a new Bcl-2-specific BH3 mimetic, has in vivo efficacy against aggressive Myc-driven mouse lymphomas without provoking thrombocytopenia.	Blood	2013	63
24721791	Bortezomib	Moros A	Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma.	Leukemia	2014	21
24928860	Bortezomib	Wang J	Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells.	Blood	2014	48
25398450	Bortezomib	Nijhof IS	Preclinical Evidence for the Therapeutic Potential of CD38-Targeted Immuno-Chemotherapy in Multiple Myeloma Patients Refractory to Lenalidomide and Bortezomib.	Clinical cancer research 	2015	17
11069615	Doxycycline	Diamond I	Conditional gene expression in the epidermis of transgenic mice using the tetracycline-regulated transactivators tTA and rTA linked to the keratin 5 promoter.	The Journal of investigative dermatology	2000	94
11751631	Doxycycline	Fisher GH	Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes.	Genes & development	2001	193
12498714	Doxycycline	Moody SE	Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis.	Cancer cell	2002	114
15882627	Doxycycline	Hochedlinger K	Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues.	Cell	2005	292
16954387	Doxycycline	Sharma VM	Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc.	Molecular and cellular biology	2006	103
17450133	Doxycycline	Sarkisian CJ	Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.	Nature cell biology	2007	153
18371448	Doxycycline	Stadtfeld M	Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse.	Cell stem cell	2008	284
19898465	Doxycycline	Guo X	TAp63 induces senescence and suppresses tumorigenesis in vivo.	Nature cell biology	2009	98
21293062	Doxycycline	Hiramatsu K	Generation of hyaline cartilaginous tissue from mouse adult dermal fibroblast culture by defined factors.	The Journal of clinical investigation	2011	44
22105174	Doxycycline	Chakravarty D	Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation.	The Journal of clinical investigation	2011	67
22158040	Doxycycline	Hsu TI	Sp1 expression regulates lung tumor progression.	Oncogene	2012	37
22908324	Doxycycline	Reis M	Endothelial Wnt/β-catenin signaling inhibits glioma angiogenesis and normalizes tumor blood vessels by inducing PDGF-B expression.	The Journal of experimental medicine	2012	35
25965570	Doxycycline	Shirai CL	Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo.	Cancer cell	2015	34
26091037	Doxycycline	Dow LE	Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer.	Cell	2015	80
17200371	Gemcitabine	Korpanty G	Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature.	Clinical cancer research 	2007	75
17332349	Gemcitabine	Feldmann G	Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers.	Cancer research	2007	242
17404099	Gemcitabine	Nomi T	Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer.	Clinical cancer research 	2007	211
17617589	Gemcitabine	Sinha P	Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response.	Journal of immunology	2007	222
18413796	Gemcitabine	Melisi D	LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis.	Molecular cancer therapeutics	2008	93
20332237	Gemcitabine	Dineen SP	Smac mimetic increases chemotherapy response and improves survival in mice with pancreatic cancer.	Cancer research	2010	43
20388795	Gemcitabine	Vincent J	5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity.	Cancer research	2010	206
20683663	Gemcitabine	Du Z	Pancreatic cancer cells resistant to chemoradiotherapy rich in "stem-cell-like" tumor cells.	Digestive diseases and sciences	2011	54
21148071	Gemcitabine	Dangi-Garimella S	Three-dimensional collagen I promotes gemcitabine resistance in pancreatic cancer through MT1-MMP-mediated expression of HMGA2.	Cancer research	2011	37
21408027	Gemcitabine	Bao B	Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer.	PloS one	2011	73
21436454	Gemcitabine	Beatty GL	CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans.	Science	2011	405
21864475	Gemcitabine	Li C	c-Met is a marker of pancreatic cancer stem cells and therapeutic target.	Gastroenterology	2011	119
21903606	Gemcitabine	Stokes JB	Inhibition of focal adhesion kinase by PF-562,271 inhibits the growth and metastasis of pancreatic cancer concomitant with altering the tumor microenvironment.	Molecular cancer therapeutics	2011	57
22653638	Gemcitabine	Sumida K	Anti-IL-6 receptor mAb eliminates myeloid-derived suppressor cells and inhibits tumor growth by enhancing T-cell responses.	European journal of immunology	2012	33
22926062	Gemcitabine	Tongu M	Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo.	Cancer immunology, immunotherapy 	2013	34
23202296	Gemcitabine	Bruchard M	Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth.	Nature medicine	2013	139
23222511	Gemcitabine	Fokas E	Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.	Cell death & disease	2012	57
23348422	Gemcitabine	Kozono S	Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells.	Cancer research	2013	26
23402593	Gemcitabine	Lee GY	Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer.	ACS nano	2013	47
23593991	Gemcitabine	Thompson R	The cancer therapeutic potential of Chk1 inhibitors: how mechanistic studies impact on clinical trial design.	British journal of clinical pharmacology	2013	35
23626745	Gemcitabine	Lesterhuis WJ	Synergistic effect of CTLA-4 blockade and cancer chemotherapy in the induction of anti-tumor immunity.	PloS one	2013	31
24148817	Gemcitabine	Reid G	Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma.	Annals of oncology 	2013	33
24856586	Gemcitabine	Özdemir BC	Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival.	Cancer cell	2014	307
24859161	Gemcitabine	Li L	Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and β-catenin signaling in pancreatic ductal adenocarcinoma cells.	Gastroenterology	2014	29
24919854	Gemcitabine	Gelbert LM	Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine.	Investigational new drugs	2014	57
25277192	Gemcitabine	Khan S	MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer.	Oncotarget	2014	33
25402324	Gemcitabine	Hiroshima Y	Efficacy of tumor-targeting Salmonella typhimurium A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX) and cell line mouse models.	Oncotarget	2014	53
25639539	Gemcitabine	Zhao Y	Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer.	Targeted oncology	2015	23
25834145	Gemcitabine	Duluc C	Pharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance.	EMBO molecular medicine	2015	20
25889214	Gemcitabine	Li Z	The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer.	Journal of translational medicine	2015	45
26036346	Gemcitabine	Tréhoux S	Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells.	Biochimica et biophysica acta	2015	20
26077591	Gemcitabine	Miller BW	Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy.	EMBO molecular medicine	2015	33
26560028	Gemcitabine	Zheng X	Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.	Nature	2015	289
27216178	Gemcitabine	Schultz MJ	The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype.	Cancer research	2016	12
17415413	Doxorubicin	Biswas S	Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression.	The Journal of clinical investigation	2007	100
17823410	Doxorubicin	Corney DC	MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.	Cancer research	2007	223
17891174	Doxorubicin	Ma S	CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.	Oncogene	2008	209
18574145	Doxorubicin	Burgess DJ	Topoisomerase levels determine chemotherapy response in vitro and in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2008	87
19168635	Doxorubicin	Lee K	Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells.	Proceedings of the National Academy of Sciences of the United States of America	2009	83
19584283	Doxorubicin	Fornari F	MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.	Cancer research	2009	117
19956757	Doxorubicin	Liao D	Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model.	PloS one	2009	109
20145127	Doxorubicin	Lee C	Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index.	Cancer research	2010	63
20388796	Doxorubicin	Yoo BK	Molecular mechanism of chemoresistance by astrocyte elevated gene-1.	Cancer research	2010	46
20460510	Doxorubicin	Adhikari AS	CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance.	Cancer research	2010	80
20668064	Doxorubicin	Zhang X	Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway.	Cancer research	2010	48
21573140	Doxorubicin	Zheng GX	A latent pro-survival function for the mir-290-295 cluster in mouse embryonic stem cells.	PLoS genetics	2011	37
21967065	Doxorubicin	Choi KY	Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy.	ACS nano	2011	38
21996747	Doxorubicin	Lo PK	CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling.	Oncogene	2012	53
22152097	Doxorubicin	Pham PV	Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.	Journal of translational medicine	2011	36
22281424	Doxorubicin	Xiao Y	Multifunctional unimolecular micelles for cancer-targeted drug delivery and positron emission tomography imaging.	Biomaterials	2012	42
22405901	Doxorubicin	Yang FY	Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme.	Journal of controlled release 	2012	33
22952218	Doxorubicin	Manzoor AA	Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors.	Cancer research	2012	61
24004438	Doxorubicin	Jang SC	Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors.	ACS nano	2013	62
24136231	Doxorubicin	Fan YH	USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis.	Cell death & disease	2013	30
24345736	Doxorubicin	Tian Y	A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy.	Biomaterials	2014	126
25079333	Doxorubicin	Tavora B	Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy.	Nature	2014	21
25330770	Doxorubicin	Liu JC	Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2K.	EMBO molecular medicine	2014	25
25348805	Doxorubicin	Paranjape AN	Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog.	BMC cancer	2014	31
25368020	Doxorubicin	Park EY	Targeting of miR34a-NOTCH1 axis reduced breast cancer stemness and chemoresistance.	Cancer research	2014	38
25789975	Doxorubicin	Hall JR	Long noncoding RNA lincRNA-p21 is the major mediator of UVB-induced and p53-dependent apoptosis in keratinocytes.	Cell death & disease	2015	16
25900794	Doxorubicin	Hu Y	miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.	Breast cancer research and treatment	2015	20
26552700	Doxorubicin	Picaud S	Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy.	Cancer research	2015	36
26787820	Doxorubicin	Blake SJ	Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy.	Cancer discovery	2016	15
27890659	Doxorubicin	Pi F	RNA nanoparticles harboring annexin A2 aptamer can target ovarian cancer for tumor-specific doxorubicin delivery.	Nanomedicine 	2017	7
18835033	Resveratrol	Wang RH	Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice.	Cancer cell	2008	260
18851829	Resveratrol	Wang RH	Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis.	Molecular cell	2008	116
19503100	Resveratrol	Boily G	SirT1-null mice develop tumors at normal rates but are poorly protected by resveratrol.	Oncogene	2009	52
9271434	Tetracycline	Sewing A	High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1.	Molecular and cellular biology	1997	107
10428026	Tetracycline	Sternlicht MD	The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis.	Cell	1999	224
10488335	Tetracycline	Felsher DW	Reversible tumorigenesis by MYC in hematopoietic lineages.	Molecular cell	1999	282
11175856	Tetracycline	D'Cruz CM	c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations.	Nature medicine	2001	135
11983872	Tetracycline	Cheon SS	beta-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds.	Proceedings of the National Academy of Sciences of the United States of America	2002	93
16200064	Tetracycline	Dickins RA	Probing tumor phenotypes using stable and regulated synthetic microRNA precursors.	Nature genetics	2005	222
19118031	Tetracycline	Snoek R	In vivo knockdown of the androgen receptor results in growth inhibition and regression of well-established, castration-resistant prostate tumors.	Clinical cancer research 	2009	54
21931765	Tetracycline	de Antonellis P	MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma.	PloS one	2011	57
19359544	Bicalutamide	Tran C	Development of a second-generation antiandrogen for treatment of advanced prostate cancer.	Science	2009	469
22266222	Bicalutamide	Clegg NJ	ARN-509: a novel antiandrogen for prostate cancer treatment.	Cancer research	2012	107
10411544	Fluorouracil	Ashkenazi A	Safety and antitumor activity of recombinant soluble Apo2 ligand.	The Journal of clinical investigation	1999	416
19276252	Fluorouracil	Sakamoto K	Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth.	Clinical cancer research 	2009	62
19497284	Fluorouracil	Hofmann I	Hedgehog signaling is dispensable for adult murine hematopoietic stem cell function and hematopoiesis.	Cell stem cell	2009	59
25712124	Fluorouracil	Prabhu VV	Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem-like Cells in an Akt/Foxo3a/TRAIL-Dependent Manner.	Cancer research	2015	30
25820415	Fluorouracil	Kawai T	Keratin 19, a Cancer Stem Cell Marker in Human Hepatocellular Carcinoma.	Clinical cancer research 	2015	23
26494468	Fluorouracil	Alam SK	DNA damage-induced ephrin-B2 reverse signaling promotes chemoresistance and drives EMT in colorectal carcinoma harboring mutant p53.	Cell death and differentiation	2016	11
19147766	Temozolomide	Russo AL	In vitro and in vivo radiosensitization of glioblastoma cells by the poly (ADP-ribose) polymerase inhibitor E7016.	Clinical cancer research 	2009	47
19265662	Temozolomide	Bleau AM	PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells.	Cell stem cell	2009	239
20530668	Temozolomide	McEllin B	PTEN loss compromises homologous recombination repair in astrocytes: implications for glioblastoma therapy with temozolomide or poly(ADP-ribose) polymerase inhibitors.	Cancer research	2010	81
21768296	Temozolomide	Mitchell DA	Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans.	Blood	2011	45
22156195	Temozolomide	Agnihotri S	Alkylpurine-DNA-N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients.	The Journal of clinical investigation	2012	32
22173583	Temozolomide	Kanai R	Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells.	Journal of the National Cancer Institute	2012	36
23404835	Temozolomide	Joshi K	MELK-dependent FOXM1 phosphorylation is essential for proliferation of glioma stem cells.	Stem cells	2013	48
24608791	Temozolomide	Auffinger B	Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy.	Cell death and differentiation	2014	58
25437539	Temozolomide	Stewart E	Targeting the DNA repair pathway in Ewing sarcoma.	Cell reports	2014	30
26217019	Temozolomide	Hopkins TA	Mechanistic Dissection of PARP1 Trapping and the Impact on In Vivo Tolerability and Efficacy of PARP Inhibitors.	Molecular cancer research 	2015	29
27020328	Temozolomide	Pitter KL	Corticosteroids compromise survival in glioblastoma.	Brain 	2016	14
27793847	Temozolomide	Nagel ZD	DNA Repair Capacity in Multiple Pathways Predicts Chemoresistance in Glioblastoma Multiforme.	Cancer research	2017	8
21057493	5-Methylcytosine	Ko M	Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2.	Nature	2010	346
21803851	5-Methylcytosine	Li Z	Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies.	Blood	2011	163
21873190	5-Methylcytosine	Ko M	Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice.	Proceedings of the National Academy of Sciences of the United States of America	2011	137
22391558	5-Methylcytosine	Yang H	Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation.	Oncogene	2013	140
23353889	5-Methylcytosine	Deplus R	TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS.	The EMBO journal	2013	150
23403289	5-Methylcytosine	Hahn MA	Dynamics of 5-hydroxymethylcytosine and chromatin marks in Mammalian neurogenesis.	Cell reports	2013	132
24270360	5-Methylcytosine	Jeong M	Large conserved domains of low DNA methylation maintained by Dnmt3a.	Nature genetics	2014	88
24735881	5-Methylcytosine	Dawlaty MM	Loss of Tet enzymes compromises proper differentiation of embryonic stem cells.	Developmental cell	2014	56
25915124	5-Methylcytosine	Etchegaray JP	The histone deacetylase SIRT6 controls embryonic stem cell fate via TET-mediated production of 5-hydroxymethylcytosine.	Nature cell biology	2015	34
26903244	5-Methylcytosine	Yue X	Control of Foxp3 stability through modulation of TET activity.	The Journal of experimental medicine	2016	32
27869820	5-Methylcytosine	Tsagaratou A	TET proteins regulate the lineage specification and TCR-mediated expansion of iNKT cells.	Nature immunology	2017	8
1680859	1-Phosphatidyl-D-myo-inositol	Caughey B	The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive.	The Journal of biological chemistry	1991	157
9671496	1-Phosphatidyl-D-myo-inositol	Murphy MA	Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice.	Molecular and cellular biology	1998	104
10497129	1-Phosphatidyl-D-myo-inositol	Di Cristofano A	Impaired Fas response and autoimmunity in Pten+/- mice.	Science	1999	117
10700233	1-Phosphatidyl-D-myo-inositol	Granovsky M	Suppression of tumor growth and metastasis in Mgat5-deficient mice.	Nature medicine	2000	111
11470893	1-Phosphatidyl-D-myo-inositol	Enari M	Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody.	Proceedings of the National Academy of Sciences of the United States of America	2001	106
12897778	1-Phosphatidyl-D-myo-inositol	Matsunaga T	Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia.	Nature medicine	2003	143
15231645	1-Phosphatidyl-D-myo-inositol	Yang L	Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt.	Cancer research	2004	142
15574782	1-Phosphatidyl-D-myo-inositol	Adhami VM	Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer.	Cancer research	2004	73
16169464	1-Phosphatidyl-D-myo-inositol	Stanger BZ	Pten constrains centroacinar cell expansion and malignant transformation in the pancreas.	Cancer cell	2005	112
16339315	1-Phosphatidyl-D-myo-inositol	Zhao JJ	The oncogenic properties of mutant p110alpha and p110beta phosphatidylinositol 3-kinases in human mammary epithelial cells.	Proceedings of the National Academy of Sciences of the United States of America	2005	128
16783365	1-Phosphatidyl-D-myo-inositol	Kim MS	Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis.	Nature neuroscience	2006	89
17210696	1-Phosphatidyl-D-myo-inositol	Maroulakou IG	Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice.	Cancer research	2007	108
17341655	1-Phosphatidyl-D-myo-inositol	Blanco-Aparicio C	PTEN, more than the AKT pathway.	Carcinogenesis	2007	120
17360431	1-Phosphatidyl-D-myo-inositol	Schmelzle T	Functional role and oncogene-regulated expression of the BH3-only factor Bmf in mammary epithelial anoikis and morphogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2007	66
17372210	1-Phosphatidyl-D-myo-inositol	Mehrian-Shai R	Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer.	Proceedings of the National Academy of Sciences of the United States of America	2007	62
18082964	1-Phosphatidyl-D-myo-inositol	Fraser MM	Phosphatase and tensin homolog, deleted on chromosome 10 deficiency in brain causes defects in synaptic structure, transmission and plasticity, and myelination abnormalities.	Neuroscience	2008	64
18174526	1-Phosphatidyl-D-myo-inositol	Martinez SC	Inhibition of Foxo1 protects pancreatic islet beta-cells against fatty acid and endoplasmic reticulum stress-induced apoptosis.	Diabetes	2008	59
18328427	1-Phosphatidyl-D-myo-inositol	Kleber S	Yes and PI3K bind CD95 to signal invasion of glioblastoma.	Cancer cell	2008	88
18794877	1-Phosphatidyl-D-myo-inositol	Endersby R	PTEN signaling in brain: neuropathology and tumorigenesis.	Oncogene	2008	69
19176381	1-Phosphatidyl-D-myo-inositol	Almog N	Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype.	Cancer research	2009	73
19279572	1-Phosphatidyl-D-myo-inositol	Kalaany NY	Tumours with PI3K activation are resistant to dietary restriction.	Nature	2009	128
19351816	1-Phosphatidyl-D-myo-inositol	Miller KA	Oncogenic Kras requires simultaneous PI3K signaling to induce ERK activation and transform thyroid epithelial cells in vivo.	Cancer research	2009	47
19491266	1-Phosphatidyl-D-myo-inositol	Dillon RL	Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progression.	Cancer research	2009	57
19567914	1-Phosphatidyl-D-myo-inositol	Schoeberl B	Therapeutically targeting ErbB3: a key node in ligand-induced activation of the ErbB receptor-PI3K axis.	Science signaling	2009	114
20081861	1-Phosphatidyl-D-myo-inositol	Houghton AM	Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth.	Nature medicine	2010	120
20212113	1-Phosphatidyl-D-myo-inositol	Chagpar RB	Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase.	Proceedings of the National Academy of Sciences of the United States of America	2010	61
20388916	1-Phosphatidyl-D-myo-inositol	Poliseno L	Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation.	Science signaling	2010	166
20424120	1-Phosphatidyl-D-myo-inositol	Dillon RL	Distinct biological roles for the akt family in mammary tumor progression.	Cancer research	2010	60
21324922	1-Phosphatidyl-D-myo-inositol	Adams JR	Cooperation between Pik3ca and p53 mutations in mouse mammary tumor formation.	Cancer research	2011	38
21596819	1-Phosphatidyl-D-myo-inositol	Murugan AK	Anaplastic thyroid cancers harbor novel oncogenic mutations of the ALK gene.	Cancer research	2011	45
21613208	1-Phosphatidyl-D-myo-inositol	Suvasini R	Insulin growth factor-2 binding protein 3 (IGF2BP3) is a glioblastoma-specific marker that activates phosphatidylinositol 3-kinase/mitogen-activated protein kinase (PI3K/MAPK) pathways by modulating IGF-2.	The Journal of biological chemistry	2011	38
21628414	1-Phosphatidyl-D-myo-inositol	Kuchenbauer F	Comprehensive analysis of mammalian miRNA* species and their role in myeloid cells.	Blood	2011	38
21670491	1-Phosphatidyl-D-myo-inositol	Hart JR	Phosphorylation of AKT: a mutational analysis.	Oncotarget	2011	37
21822287	1-Phosphatidyl-D-myo-inositol	Liu P	Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and PI3K pathway-independent mechanisms.	Nature medicine	2011	93
21900500	1-Phosphatidyl-D-myo-inositol	Alam H	Novel function of keratins 5 and 14 in proliferation and differentiation of stratified epithelial cells.	Molecular biology of the cell	2011	37
22588880	1-Phosphatidyl-D-myo-inositol	Ni J	Functional characterization of an isoform-selective inhibitor of PI3K-p110β as a potential anticancer agent.	Cancer discovery	2012	56
23236232	1-Phosphatidyl-D-myo-inositol	Sukawa Y	Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer.	World journal of gastroenterology	2012	32
23604117	1-Phosphatidyl-D-myo-inositol	Zhu X	Synergy between Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway.	Oncogene	2014	21
24567396	1-Phosphatidyl-D-myo-inositol	Gorrini C	Estrogen controls the survival of BRCA1-deficient cells via a PI3K-NRF2-regulated pathway.	Proceedings of the National Academy of Sciences of the United States of America	2014	20
24569712	1-Phosphatidyl-D-myo-inositol	Nakahata S	Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers.	Nature communications	2014	28
24762440	1-Phosphatidyl-D-myo-inositol	Yang Y	ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism.	The Journal of clinical investigation	2014	40
25001183	1-Phosphatidyl-D-myo-inositol	Hu J	microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.	European journal of cancer	2014	33
25183785	1-Phosphatidyl-D-myo-inositol	Rubashkin MG	Force engages vinculin and promotes tumor progression by enhancing PI3K activation of phosphatidylinositol (3,4,5)-triphosphate.	Cancer research	2014	41
25650317	1-Phosphatidyl-D-myo-inositol	Ghosh JC	Adaptive mitochondrial reprogramming and resistance to PI3K therapy.	Journal of the National Cancer Institute	2015	27
25976245	1-Phosphatidyl-D-myo-inositol	Crespo I	Molecular and Genomic Alterations in Glioblastoma Multiforme.	The American journal of pathology	2015	19
27199435	1-Phosphatidyl-D-myo-inositol	Quail DF	The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas.	Science	2016	42
